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Abstract 
Gene delivery relies upon the encapsulation of a gene of interest, which is then ideally 
delivered to target cells. For gene therapy applications, viral vectors are the most efficient vectors 
currently being studied, accounting for more than 67% of ongoing clinical trials, however, they have 
several potential disadvantages, chief among them being safety concerns. In contrary, non-viral 
vectors have advantages over viral vectors. In the first chapter we have reviewed non-viral gene 
therapy using gemini surfactants which is an unique approach to medicine that can be adapted 
towards the treatment of various diseases. The chemical structure of the surfactant (variations in the 
alkyl tail length and spacer/head group) and the resulting physicochemical properties of the 
lipoplexes are critical parameters for efficient gene transfection. Moreover, studying the interaction 
of the surfactant with DNA can help in designing an efficient vector and understanding how 
transfection complexes overcome various cellular barriers. This chapter provides an overview of the 
various types of gemini surfactants designed for gene therapy and their transfection efficiency, with a 
focus on the novel methods (Langmuir Blodgett monolayer studies, AFM, DSC, ITC, SAXS) used to 
understand their interaction with DNA.  
The lack of understanding of how DNA influences the arrangement of vector components 
during the complexation of DNA, as well as their interaction with biological membranes is still a 
major barrier faced by non-viral vectors. Hence the aim of work in this project is to characterize the 
arrangement of the gemini surfactants and phospholipids that make up the transfection vector (both 
in the presence and absence of DNA) as well as the effect of these components on model biological 
membranes using Brewster’s Angle Microscopy (BAM), Atomic force microscopy (AFM), Kelvin 
probe force microscopy (KPFM) and Polarization Modulated Infrared Reflectance Absorption 
Spectroscopy (PM-IRRAS). 
Our current project focuses on gemini surfactants 16-7-16 and 16-7NH-16 or mixed gemini 
surfactant and helper lipid (DOPE) interaction at the air-water interface in the presence or absence of 
DNA. According to the surface pressure- area (π-A) isotherm, the 16-7NH-16 based systems formed 
the most stable monolayer in all pHs (pH 4, 7 and 9) compared to 16-7-16 based systems. The 
observed monolayer remained mostly in the liquid expanded (LE) or liquid expanded-liquid 
condensed (LE-LC) phase as evident from the compressibility modulus values. DOPE causes 
condensation in the mixed gemini/DOPE/DNA system in which antagonistic mixing behavior of 
DOPE is observed.  Moreover, the BAM images showed fibril structures of the 16-7NH-
16/DOPE/DNA system at pH 4, which was further confirmed by the AFM and KPFM studies. This 
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signifies the electrostatic interactions between the positively charged gemini quaternary amine head 
group with the negatively charged phosphate group of DNA molecules. The PM-IRRAS study 
revealed that the complex system (gemini/DOPE/DNA) undergoes several interactions, among them 
the electrostatic, ion-dipole and hydrophobic interaction is the major factor playing the role in the 
interactions. 
In chapter V we have shown the interaction of the gemini/DOPE/DNA system on the model 
endosomal membrane (DPPC/cholesterol=75/25%). While mixing the DPPC and cholesterol, it 
forms a homogeneous film with the solid phase observed at the natural cell membrane surface 
pressure range (30-35 mN/m) at pH 4. The mixed 16-7-16 and 16-7NH-16 based system fluidized the 
model membrane at pH 4. The fluidization effect was strongly pH dependent for the 16-7NH-16 
based system. This system undergoes protonation, and forms strong complex with the DOPE/DNA 
with a net positive charge, consequently adsorbing and penetrating into the model membrane. PM-
IRRAS study revealed that the 16-7NH-16 based system was better than 16-7-16 in terms of 
enhanced membrane fluidization. This study suggests the idea that the gemini/DOPE/DNA based 
system may interact with the endosomal membrane, disrupt the membrane and release the DNA into 
the cytoplasm at low pH. 
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Chapter I 
Interactions between DNA and Gemini surfactant: impact on gene therapy. 
1.1. Introduction 
1.1.1. Gene therapy 
Gene therapy is a promising strategy for the treatment of various inherited and acquired 
diseases. Frederick Griffith discovered the bacterial transformation of a non-virulent R form of Type 
I pneumococcus into a heat inactivated virulent S form of type II pneumococcus in 1928 [1]. This 
discovery paved the way for the journey of modern gene therapy. The ultimate goal of gene therapy 
is to obtain a desired therapeutic effect in the treatment of a given disease, by delivery of a gene or 
genes in order to enable cells to generate therapeutic proteins [2, 3]. In general, gene therapy utilizes 
nucleic acids or oligonucleotides, which can be combined with a specific delivery vehicle (vector) to 
exert the desired therapeutic effect. The therapeutic effect(s) could be either 1) insertion of a normal 
or functional gene into the host cells to repair genetic disorders by replacing or correcting the 
defective gene; or 2) repression of an over expressing gene [4]. Gene therapy is a broad research 
arena and a detailed review is beyond the scope of this thesis; however the readers are referred to the 
recent review article on the history of gene therapy by Wirth et al. [5]; as well as a review on the 
different techniques and strategies for a successful non-viral gene therapy by Ibraheem et al. [6]. 
1.1.2. Classification of gene therapy 
Gene therapy can be categorized into two broad classes: viral vector mediated and non-viral 
vector mediated gene therapy. To date viral vectors are considered to be the most efficient delivery 
vector in gene therapy. As of 2015, there are approximately 2142 gene therapy clinical trials either 
completed or under way in 36 countries in which most (approximately 67%) of the delivery systems 
utilize different viral vectors [7]. The breakdown of gene therapy clinical trials according to the 
delivery system used is depicted in Figure 1.1 [7]. Viruses have evolved themselves to efficiently 
gain access to host cells, and facilitate their replication by using the host cellular machineries. These 
features make the viral vectors superior and widely used vectors in gene delivery over its counterpart 
non-viral vectors. For gene delivery application, the viral vectors are designed in such a way that the 
vector utilizes the viral infection pathway but circumvent the expression of viral genes that lead to 
replication and toxicity. This is achieved by deleting or suppressing specific coding regions from the 
viral genome; and leaving intact those sequences necessary for functions such as packaging the 
vector genome into the virus capsid or the integration of vector DNA into the host chromatin [8]. 
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Regardless of their high delivery efficiency, viral vectors suffer from several potential drawbacks 
such as toxicity, immunogenicity, limitations to the size of the therapeutic gene, production and 
packing problems, as well as high cost of production. Additionally, clinical trial failures led to the 
death of one patient in a clinical trial for the treatment of a rare metabolic disorder (ornithine 
transcarbamylase deficiency) in 1999, and the observation of a leukemia-like disease resulting from a 
genetic therapy in an early clinical trial for the treatment of severe combined immunodeficiency 
disorder (X-SCID) in 2002 [9, 10]. Therefore, the debate regarding the use of viral vectors in gene 
therapy applications has reached new levels, and delayed research in the field for several years [11].  
Felgner and colleagues demonstrated the successful delivery of a gene using a non-viral 
cationic lipid-based vector, in 1987 [12]. Non-viral vector mediated gene therapy approaches are 
generally considered: safe (non-toxic and non-immunogenic with proper selection of vector 
components); cost-effective; and relative to viral vectors, they are easy to manufacture. The main 
disadvantage of non-viral vectors is their low transfection efficiency in vivo [13]. To overcome this 
challenge, substantial research has been carried out in the design of novel non-viral vector systems. A 
lack of consistency in how transfection efficiencies are reported significantly hampers the ability to 
compare not only vector systems, but also results obtained for different cell lines. In an attempt to 
address the transfection efficiency accurately, in this review we are reporting transfection efficiencies 
exactly as they were reported in the original research articles we cite. We have, where appropriate, 
tried to link results from different types of measurements in a qualitative fashion, and include the 
actual numeric values for transfection efficiency when these have been reported. 
 
Figure 1.1. Vectors used in the current gene therapy clinical trials; adapted from reference [7]. 
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1.1.3. Challenges in the design of an efficient non-viral gene therapy system  
Transfection is the process by which the plasmids (DNA) are delivered to targeted cells. To 
achieve a successful gene therapy, expression of the delivered gene in the target cell is required. To 
do so, DNA has to travel across various extracellular, cellular, and intracellular barriers (Figure 1.2) 
[14]; several review articles have been published on this topic and are provided as references [15-22]. 
Briefly, the extracellular barriers include skin, blood cells, plasma components, the reticulo-
endothelial system, and the immune system. The cell membrane itself is the main cellular barrier, and 
for the case of non-viral vectors it gets across primarily by endocytosis. Subsequently, the next major 
barrier is endosomal escape, which must occur before the endosome matures into the acidic 
lysosome, whose hostile environment would degrade the plasmid prior to nuclear uptake and 
expression. The trafficking within the cytosol, nuclear localization, and passage across the nuclear 
membrane are considered to be the additional intracellular barriers [15-22]. Figure 1.2 illustrates the 
various barriers to transfection. Over the past two decades the non-viral vector mediated clinical 
trials are minimal, for instance, only ~6 % of the ongoing clinical trials are based on the lipofection 
[7]. This is an indication that the knowledge from in vitro studies are not effectively translated into 
the in vivo models. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2. Summary of the extra- and intracellular barriers faced by non-viral gene therapies 
following systematic delivery. Adapted from the reference [14]. The lipoplex/polyplex is considered 
to be remained at the early endosome around 2-5 min (pH 6.5), late endosome around 10-15 min (pH 
5-6) and in lysosome around 30-35 min (pH 4-5) [23]. 
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Figure 1.3. Building blocks of multifunctional non-viral DNA delivery systems. Different types 
of cationic lipids can be used to create a lipid-based nanoparticulate system (soft nanoparticle) e.g. 
liposomes, lipoplexes and solid lipid particles. Introduction of pH-sensitive lipids, surfactants or 
polymers can facilitate the endosomal escape. Grafting of polyethylene glycol (PEG) lipids provides 
the inert, nonionic, hydrophilic and flexible polymer coating around the nanoparticles which 
facilitates the biological and colloidal stability of the nanoparticles. Cell specific binding of the 
nanoparticles can be achieved by incorporating specific ligands having the selective binding to the 
cell surface receptors. A nuclear localization signal moiety (ligand) can be anchored to the surface of 
the nanoparticle which will remain intact during the endosomal uptake as well as release, and 
enhance the nuclear localization of specific DNA. Adapted from reference [24]. 
 
Thus, an emerging question arises; specifically “How does one tailor an efficient delivery 
vector which can bypass the extracellular barriers, be readily absorbed via endocytosis followed by 
fast endosomal escape, facilitate trafficking through the intracellular matrix to the nucleus, facilitate 
nuclear import, finally resulting in expression of the desired protein encoded by the DNA?” To 
achieve this, researchers have developed an enormous variety of non-viral DNA vectors consisting of 
cationic lipids, surfactants, or polymers, where the cationic component serves to efficiently bind and 
compact the DNA plasmid, and the vector as a whole is able to deliver the gene of interest to a target 
cell population, where it can then be expressed producing the therapeutic protein of interest. Figure 
1.3 demonstrates ideal building blocks of a non-viral gene delivery system with various functional 
properties that are important to enhance the overall efficiency of the system [24]. 
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1.2. Cationic lipids and surfactants as non-viral gene delivery agents 
Cationic lipid/DNA complexes (also known as lipoplexes) are extensively used systems in gene 
therapy and effectively absorbs to the predominantly anionic plasma membrane of mammalian cells 
via electrostatic interactions. In general, lipoplexes (and polyplexes for cationic polymer based 
vectors) possesses higher transfection efficiency in numerous cell lines when compared with other 
non-viral delivery systems, including niosomes (non-ionic surfactant vesicles) or anionic liposomes 
(due to the absence of positive charges) [25, 26]. Despite this fact, lack of knowledge about the 
interactions between the complexes and cellular components is a major challenge to overcome the 
poor transfection efficiency of lipoplex vectors, relative to viral vectors. To facilitate the 
development of improved lipoplex vectors, understanding the complex interactions that occur 
between the vector, the plasmid, and the cellular environment in which a lipoplex may be found, is 
crucial. Such studies will allow for the development of new systems that are specifically designed to 
overcome the various barriers to transfection, introduced above. 
Several important physical and physicochemical parameter(s) to be considered while designing a 
lipoplex for gene delivery have been reviewed by Donkuru et al. [24]. Briefly, to facilitate the 
endocytosis a particle size of the lipoplexes of less than 200 nm is considered to be ideal. The charge 
ratio of lipoplex (+/-) and the zeta potential is another crucial parameter for gene transfection. For a 
complete charge neutralization of the negatively charged phosphate group of DNA, a minimum 
cationic lipid/surfactant to DNA of 1:1 is necessary. On the other hand, an overall positive zeta 
potential value is required for the strong electrostatic interaction of lipoplexes with the negatively 
charged cell membrane. The most commonly used charge ratios are 2:1, 5:1, and 10:1; nevertheless, 
there still does not appear to be any correlations between charge ratio and transfection efficiency that 
would apply across all cationic systems. Instead, the optimal charge ratio, while always greater than 
1:1, is very dependent on the chemical structure of the cationic component in the vector system [27]. 
Additionally, variations in the charge ratio of lipoplexes can influence the various shapes non-viral 
systems assemble into [27], for example, rods, globules, spheres and toroids, filamentous or fibrous 
structures and netlike structures. Typically nanoparticles with smaller particle sizes (<500 nm) form 
spherical structures [24, 27, 28]. While there is no direct correlation between the lipoplex 
morphology and the transfection efficiency, the internal packing arrangement (i.e lamellar, 
hexagonal, cubic, etc.) of lipids/surfactants within the lipoplex is reported to have significant impact 
in gene transfection [29]. It is believed that the inverted hexagonal structure is preferable over the 
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lamellar structure for efficient transfection [30-32], however, there are numerous exceptions to this 
conclusion reported in the literature [33-38].  
1.2.1. Gemini surfactants as transfection vectors 
Since Felgner’s work in 1987 [12], tremendous effort has been made to design more efficient 
cationic lipid based vectors. Mintzer and Simanek in 2009 published a comprehensive review on this 
broad subject area to which readers are referred for an overview [39]. The focus of our current 
review is on a small subset of cationic lipid based vectors, those in which the cationic lipid has been 
replaced by a cationic “gemini” surfactant. In 1991, Menger [40, 41] was the first to use the term 
“Gemini surfactant” for the description of a family of amphiphilic (surfactant) molecules, consisting 
of two head groups (positively charged) and two aliphatic chains covalently linked by a flexible or 
rigid spacer group (Figure 1.4) [42, 43]. Since then the term gemini has been used to describe nearly 
every possible combination of multiple tail-multiple head group surfactant (including now gemini 
lipids having 4 tails and 2 head groups), even those which are non-symmetrical in nature; the reader 
is referred to the excellent text by Zana and Xia for a more complete discussion of the field of gemini 
surfactant research [44]. The unique structural features of the gemini surfactant results in a number of 
potential advantages in numerous industrial applications. For gene therapy applications, the structure 
results in lower critical micelle concentrations (CMCs) relative to the related monomer surfactant 
(for example, dodecyltrimethylammonium bromide (DTAB) is considered to be the monomer for the 
12-s-12 series of gemini surfactants and has a cmc of approximately 12 mM compared to 
approximately 1 mM for the 12-3-12 surfactant), structural flexibility resulting in an ability to form 
various aggregate structures/morphologies, improved condensation of DNA, ease of manufacture, 
low production cost, and low toxicity [40-43]. Specific aspects of the gemini surfactant structure, 
relevant to gene therapy, are described in more detail, below. Additionally, the gemini surfactants 
used in this current project will be described in the section 1.6.4e.  
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Figure 1.4. Chemical structure of the most commonly studied gemini surfactant, the N,N’-bis 
(dimethylalkyl)-alkane-diammonium-dibromide series, or “m-s-m”, Two traditional monomeric 
surfactants with R= CmH2m+1 alkyl tails are connected at their quarternary ammonium heads via a 
polymethylene chain containing “s”methylene units. Here, m= the number of carbon atoms in the 
alkyl tails, s= the number of atoms making up the spacer group. [42, 43]. For instance, a 12-s-12 
series of gemini surfactants depicts that the surfactant has fixed 12 carbon length of alkyl chains, and 
a variable number of carbon spacer linked with the quaternary ammonium heads.  
1.2.2. Variation in gemini surfactant structure 
A large number of gemini surfactants with widely varied chemical structures have been 
shown to be efficient transfection vectors both in vitro and in vivo. In an earlier review article we 
have focused on describing the bulk of research having been carried out regarding the use of gemini 
surfactants as transfection vectors [42]. Thus, the remainder of this review will focus on specific 
structural features that may be important in modifying the interaction(s) between the surfactants and 
DNA, and therefore could be used to improve the transfection efficiency of the gemini surfactants. 
1.2.3. Variations in tail length 
Gemini surfactants possess different physicochemical properties brought about through 
variations in the tail lengths, which subsequently impact gene transfection. Detailed information can 
be found in recent review articles [42, 45, 46]. Badea et al. have synthesized gemini surfactants 
(spacer length n = 2–16; alkyl chain m = 12 or 16) (Figure 1.5A) to deliver the pGTmCMV.IFN-GFP 
plasmid (coding for the interferon  (IFN) protein in murine keratinocytes (PAM 212) in vitro at 
various charge ratios of plasmid to gemini surfactant = 1:5, 1:10, 1:20, and 1:40. Additionally, the 
topical delivery of the same plasmid using liposomal and nanoemulsion systems (based on gemini 
surfactant 16-3-16) was investigated in vivo [47]. Their observation revealed that vectors with gemini 
surfactants (at a charge ratio, N+/P- of plasmid:gemini = 10:1 and a surfactant concentration of 1.5 
mM) possessing long alkyl tails (16-3-16) are more efficient with respect to IFNγ expression (1.63 
ng/5×104 cells) than those having short hydrocarbon tail (12-3-12, 1.1 ng/5×104 cells) in vitro. In 
further studies, Foldvari et al. have demonstrated the physicochemical (particle size, zeta potential) 
and structural features (effect of head group and tail lengths) of the 12-s-12 and 16-3-16 gemini 
surfactants necessary for cutaneous gene therapy [33]. It was found that the 12-s-12 series did not 
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exhibit any transfection efficiency without the presence of the helper lipid dioleoylphosphatidyl-
ethanolamine (DOPE). In the case of the 12-s-12 surfactants, increasing the spacer length 
substantially reduced the IFNγ expression level (from around 1200 pg/5x104 cells to around 500 
pg/5x104] even though the particle size and the zeta potentials were similar. In a direct comparison of 
12-3-12 and 16-3-16 (chemical structure in Figure 1.5A), both surfactants showed similar zeta 
potential value with a smaller particle size for 12-3-12 (140 nm) than 16-3-16 (210 nm) in a mixture 
of DNA-gemini-DOPE. The Small Angle X-ray Scattering (SAXS) studies revealed the presence of a 
complicated morphology of cubic packing arrangement with respect to the arrangement of surfactant 
and DOPE monomers, with both lamellar, and what was subsequently identified as (potentially) a 
cubic packing arrangement [33]. It was hypothesized that this ability to adopt multiple packing 
arrangements was responsible for the increase in transfection efficiencies observed by Badea et al. 
[47]. 
We have recently evaluated the delivery of pVGtelRL plasmid consisting of the green 
fluorescent protein (GFP) gene into human ovarian carcinoma cells (OVCAR-3) with a series of 
phytanyl substituted (Phy-3-m; m = 12, 16 and 18, Figure 1.5 B) and symmetric m-3-m (m = 12, 16 
and 18) type gemini surfactants [48]. The transfection results revealed that the phy-3-m compounds 
showed higher GFP expression (~10-15%) as compared to the 16-3-16 gemini surfactant (~5%) at a 
N+/P- charge ratio of 10:1. This was attributed to the higher degree of micellization of phy-m-3 and 
the formation of higher order structures (i.e. inverse hexagonal and/or cubic) upon complexation with 
DNA [48]. Higher degree of micellization was observed due to the increased tail-tail interactions 
between the hydrocarbon chains of the surfactant molecules (because of increased hydrophobicity). 
Noteworthy, a higher degree of micellization (α) signifies that the head group repulsion might play a 
crucial role in determining the structure of micelle aggregate during the self-assembly process [48, 
49]. A higher value of α, corresponds to greater dissociation of the counterions from the surface of 
the micelle, and indicates weaker ability of binding of the counterions to the micelles [50]. A cationic 
gemini surfactant with a higher α would be a better candidate to condense proteins or other 
polyelectrolytes, such as DNA, as anionic molecules may more easily be able to replace the counter 
ions at the surface of the micelle to form compact complexes of much smaller size [48]. Furthermore, 
phytanyl based gemini surfactants (phy-3-m, m = 12,16,18) along with DOPE (at molar ratio of 
DOPE:gemini = 1:1.5) were used to deliver the pVGtelRL vector (at charge ratio of DNA to gemini= 
1:2, 1:5, 1:10) in OVCAR-3 cells [34]. The EGFP expression (~15 %) was higher for long tails 
(m=16 or 18) as compared to the short tail (m = 12) gemini series (~9 %). Phytanyl substituted 
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compounds showed higher transfection efficiency (~ 9-15 % EGFP expression) than the symmetric 
16-3-16 (~5%) which was correlated with our previous findings [48]. These results were further 
confirmed by a SAXS study which revealed the presence of multiple phase [34]. It should be noted 
that the OVCAR-3 cells are difficult to transfect, for instance the commercial positive control, 
Lipofectamine 2000 also exhibited only ~10-15% of cells expressing GFP [48]. 
In another study, Donkuru et al. utilized the m-3-m, m-7-m, and m-7NH-m (m = 12, 16, and 
18) gemini surfactants to deliver a plasmid containing the luciferase gene (at N+/P- charge ratio of 
10:1) in PAM 212 and COS-7 (African Green monkey kidney fibroblast) cells [35]. It was found that 
the transfection efficiency increased with an increase in alkyl tail length (m = 12 < m =16 < m =18). 
This was attributed to the increased hydrophobicity caused by the increase in the tail length of the 
surfactants and consequently enhanced DNA compaction. These results are in good agreement with 
our previous findings in which phy-3-12 exhibited the lowest level of GFP expression in OVCAR-3 
cells [48].  
The m-2-m (m = 12, 14, 16) type gemini surfactant with a pEGFP-C1 plasmid (encoding 
GFP; N+/P- charge ratios of 2:1, 4:1 and 8:1) and a mixed helper lipid component comprised of 
DOPE and cholesterol (molar ratio of gemini:DOPE:cholesterol was 3:2:1) was used for gene 
transfection in human epithelial cervical carcinoma (HeLa) cells by Cardoso et al. [51]. It was found 
that increasing the alkyl tail length of the gemini from 12 to 16 (without helper lipid), resulted in an 
increase in transfection from 6.6 % to ~32.1% GFP, respectively. Incorporating the mixed helper 
lipid substantially enhanced the transfection efficiency of these systems; for instance, 12-2-12 and 
16-2-16 based vectors showed 45.7 % and 55 % GFP expression, respectively. It was hypothesized 
that the combined hydrophobic (increase in hydrocarbon tail provides better hydrophobic interaction) 
and electrostatic interaction (positively charged gemini and negatively charged DNA) were key 
factors for this enhanced transfection efficiency. It was further evident from video-enriched light 
microscopy analysis (VELM) and thermal analysis (DSC) data that both unilamellar and 
multilamellar vesicles of varying sizes were present for the m-2-m systems e.g. 16-2-16. In particular 
it was hypothesized that the 16-2-16 system may form two coexisting phases (one lamellar and a 
second, ambiguous phase), giving rise to the increase in transfection efficiency, consistent with 
previous results [33-38, 51].  
Cardoso et al. have also investigated a series of serine-based gemini surfactants with 
variations in the alkyl chain length and in the chemical nature of the linker group bridging the spacer 
to the head groups (amine, amide and ester) [52]. The gemini surfactants were mixed with the 
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pEGFP-C1 plasmid encoding GFP (N+/P- charge ratios ranging from 2:1 to 8:1), and with a mixed 
helper lipid component comprised of DOPE and cholesterol (molar ratio of DOPE: cholesterol = 
2:1). The gemini to helper lipid added in various mole ratios ranging from 1:1 to 1:4. For instance, 
the molar ratio between (12Ser)2N5: helper lipid = 1:4; and the (14Ser)2N, (16Ser)2N and (18Ser)2N: 
helper lipid=1:1. In the absence of helper lipids (N+/P- = 2:1), the transfection efficiency was 
increased while increasing the alkyl tail length from (12Ser)2N5 (~2% of cells expressing GFP) to 
(18Ser)2N5 (32% of cells expressing GFP). However, incorporating the helper lipid in these systems 
significantly enhanced the transfection efficiency, for instance, the maximum transfection efficiency 
was observed for (12Ser)2N5 (N+/P- = 1:1), (14Ser)2N5 (N+/P- = 4:1) , (16Ser)2N5 (N+/P- = 8:1) and 
(18Ser)2N5 (N+/P- = 2:1) were around 37%, 25%, 11% and 21% GFP, respectively. There were no 
clear trends observed relating variations in alkyl tail length and the transfection efficiency. It was 
found from a DNA protection experiment (DNA protection was expressed in terms of the level of 
intercalation of the PicoGreen dye; DNA complexed by surfactant is unable to intercalate the dye) 
that the (16Ser)2N5-based complexes showed the lowest protection of DNA (high concentration of 
intercalated dye), and exhibited lowest transfection efficiency. Conversely, the 12, 14 or 18 alkyl tail 
surfactants showed higher levels of DNA protection (low concentration of intercalated dye) in both 
the presence and absence of the helper lipid component. The zeta potential values were changed from 
negative to positive values at the highest N+/P- charge ratios (4/1 or 8/1) for the C12-based systems 
(in addition of helper lipid mixture). It was suggested that the addition of helper lipid changed the 
internal structure of the complexes and consequently increased the zeta potential. In case of the C18 
surfactant, which retains a negative zeta potential in the presence of the helper lipids, it is believed 
that the DOPE and cholesterol lipids remained at the surface level of the complex, with the 
combination of strong electrostatic and hydrophobic interactions between gemini and DNA 
preventing any internal rearrangement of the complexes. The lower transfection efficiency of the 
C18-based complexes was attributed to the lack of ability to adopt different morphologies by these 
systems. In support of this argument, it was observed that the C12-based system (both in presence or 
absence of helper lipid) showed the highest level of membrane (comprised of 1,2-dioleoyl-sn-
glycero-3-phosphocholine, DOPC) destabilization as compared to the C18-based surfactant, which 
may be indicative of an enhanced ability of the C12 surfactant to interact with cellular membranes, 
possibly due to the ability of the components of the complex to adopt different morphologies. Again, 
this interpretation is in good agreement with previous observations for other gemini surfactant 
systems. 
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Figure 1.5. A. Molecular structure of the m-s-m type gemini surfactants. The head group is 
composed of two positively charged nitrogen atoms, separated by a spacer of n = 3, 4, 6, 8, 10, 12, or 
16 carbon atoms and each containing two methyl groups. The tails consist of two saturated 12 or 16 
carbon atom chains (m = 12 or 16) [33, 47, 53, 54] B. Phytanyl substituted gemini surfactants (Phy-
3-m; m= 12, 16 and 18) [48] C. Molecular Structure of imidazolium gemini surfactants [1,2-
Bis(hexadecyl imidazol) alkane], (CmH2m+1Im)2Cn, where n = 2, 3, 4 [55], 5, or 12, and m= 10, 
12, 14 [55] or 16 [56]. D. (i) cationic gemini surfactants (S,S)-2,3-dimethoxy-1,4-bis(N-hexadecyl-
N,N-dimethylammonium butane bromide; (ii) stereoisomer (S,R)-2,3-dimethoxy-1,4-bis(N-
hexadecyl-N,N-dimethylammonium)butane bromide [57]. 
Zhou et al. have investigated DNA compaction and condensation induced by cationic 
imidazolium gemini surfactants ([Cn-4-Cnim]Br2, n = 10, 12, 14) (Figure 1.5 C) at various charge 
ratios (N+/P- ratios of 20:1, 10:1, 5:1, 3.3:1, 2.5:1, 2:1, 1.4:1, 1.25:1 and 1:1; originally expressed as 
P-/N+ ratios of 1: 0.05, 0.1, 0.2, 0.3, 0.4, 0.5, 0.7, 0.8, and 1) [55]. Their study revealed that gemini 
surfactants with longer tail lengths facilitated hydrophobic interactions between the surfactant and 
DNA, resulting in enhanced DNA condensation (Figure 1.6). Subsequently, the increased 
compaction of DNA was responsible for the higher transfection efficiency of these and similar 
complexes.  
In summary, the recent literature review clearly demonstrates that complexes containing 
gemini surfactants having longer alkyl tail lengths (m ≥ 12, 14, 16, 18) exhibit increased in vitro 
transfection relative to those with shorter tail length (m ≤ 10, 12).  
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Figure 1.6. (A) Schematic illustration of DNA compaction to multi-molecular DNA condensation 
progress with the increasing of [Cn-4-Cnim]Br2. (a) The free DNA strand with loose and flexible 
conformation. (b) Compacted DNA with minimum size. (c) Compacted DNA with slightly expanded 
size. (d) Multi-molecular DNA condensation. The purple “n”-shaped structures stand for the [Cn-4-
Cnim]Br2 molecules, the green string-like structures for DNA strands. (B) Schematic illustration of 
the three types of DNA and [Cn-4-Cnim]Br2 interactions, electrostatic interaction (a), hydrophobic 
interaction (b), and π-π interaction (c). The blue “Y” shaped structures with attached red lines for the 
zoom-in view of the double-stranded DNA. Adapted from the reference [55]. 
 
1.2.4. Effect of spacer length/group 
The composition and/or length of the spacer group in the region of the gemini surfactant head 
group has been shown to play a vital role in gene transfection. Zhi et al. have extensively reviewed 
the effect of spacer length, structure, and shape of the head group of various cationic lipids (including 
gemini surfactant), and their impact on gene transfection [58]. Briefly, the review examines cationic 
lipids possessing specific features in their head groups, including: amines and ammoniums 
(quaternary ammonium, primary, secondary and/or tertiary amine, polyamine lipids, linear-shaped 
polyamine compounds, globular and branched-shaped polyamines); guanidiniums; heterocyclic head 
groups; and some unusual head groups (cardiolipin analogues, nucleolipids, glycosylated cationic 
lipids, paramagnetic contrast agents or fluorophores). Varying the head group of the lipid/surfactant, 
one can design an efficient cationic lipid carrier to overcome the barriers of transfection efficiency 
both in vitro and in vivo [58].  
 Previous studies have shown efficient compaction of DNA for m-s-m type surfactants with 
spacer lengths of 2-12 methylene groups. When the gemini surfactant was combined with both 
plasmid DNA and the neutral lipid DOPE, the DNA was hypothesized to be compacted into a “ψ” 
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form with resulting complexes having high positive surface charge, resulting in increased 
transfection efficiency [47, 59]. In the “ψ” form, DNA molecules possess tightly packed, highly 
condensed structures which exhibit negative ellipticity in a circular dichroism (CD) spectrum [60]. 
The CD spectrum of the “ψ” form DNA shows the presence of a band at ~260 nm, indicative of the 
increased negative ellipticity. In the “ψ” form the base pairs in the double helix of the DNA remain 
in opposite orientation in comparison to the backbone of B or A form of DNA. It has been reported 
that cationic lipids can neutralize the negative charge of the DNA molecule and induce the “ψ” form, 
and the resulting lipid-DNA complex may form an inverted hexagonal phase in which DNA has a 
spatial organization and a fixed directionality [59]. Further enhancements in transfection were 
observed upon the introduction of a pH-sensitive secondary amine group within the spacer of the 
gemini surfactant. An approximately 9-fold increase in transfection was observed using 1,9-
bis(dodecyl)-1,1,9,9-tetramethyl-5-imino-1,9-nonanediammonium dibromide surfactant (12-7NH-12) 
compared to an unsubstituted gemini surfactant (12-7-12), and a 3-fold increase compared to the 
corresponding tertiary amine substituted compound. The pH-sensitive structural changes (pKa of the 
12-7NH-12 surfactant was observed to be 5.0 [35]) and an ability for the surfactant/lipid bilayer to 
adopt multiple phases (lamellar and some undefined phases) within the resulting complexes induced 
this increase in the transfection efficiency. Both effects were hypothesized to increase fusion between 
the nanoparticles and endosomal membranes, thereby facilitating DNA release inside the cell [36]. 
In another study, Misra et al. have reported the improved transfection efficiency in human 
embryonic kidney 293 cells (HEK293T), HeLa and human lung squamous cell carcinoma (H1299) 
cells using gemini cationic lipids possessing imidazolium head groups [1, 2-
bis(hexadecylimidazolium) alkanes; (C16Im)2Cnwhere Cn is the alkane spacer length (n = 2, 3, 5 or 
12) between the imidazolium head groups] [56]. Complexes were prepared in combination with 
DOPE and pEGFP-C3 plasmid DNA (N+/P- = 0.5:1 to 4:1) and it was observed that complexes 
[(C16Im)2Cn/DOPE)] (Figure 1.5 C) where the gemini lipid had a shorter spacer length between the 
two imidazolium head groups exhibited better transfection efficiency (maximum 80% GFP cells) 
than the commercially available Lipofectamine-2000 (~60% GFP cells) in presence of serum in all 
three cell types [56]. In addition, the same research group demonstrated that 16-s-16 cationic gemini 
surfactants (C16CsC16, where s = 2, 3, 5, or 12, Figure 1.5 A) in combination with DOPE and pEGFP-
C3 plasmid (N+/P- = 2:l to 12:1) showed enhanced transfection efficiencies not only in HEK293T but 
also in human lung carcinoma (H460), Chinese hamster ovary (CHO), HeLa, and human glioma 
(U343) cells again compared to Lipofectamine-2000 [53]. The most significant observed increase in 
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transfection were for surfactants having short spacer (s = 2 or 3) groups; approximately 80, 40, 50, 
12, 15 % GFP cells was observed for the s = 2, 3, 5 and 12, respectively in HEK293T cells in 
presence of serum and similar results were reported for s = 2 spacer in the H460, CHO, HeLa and 
U343 cell lines. The results were attributed to the formation of two coexisting lamellar structures in 
the lipoplexes [53]. Several studies have reported that the existence of lamellar, inverted hexagonal 
or cubic phase in cationic lipid-DNA complexes are responsible for better transfection efficiency 
after the endocytosis [30, 61-63].  
 
Figure 1.7. Molecular structures of cholesterol-based cationic gemini lipids A. hydroxyethyl spacer 
(R= -CH3 or-CH2CH2OH) [64]; B. oligo-oxyethylene spacer n = 1-4 [64]; C. oxyethylene-type 
spacers n= 1-3,5 [65].  
 
Misra et al. have investigated the cationic gemini surfactants based on cholesterol and 
possessing different positional combinations of hydroxyethyl (-CH2CH2OH) (Figure 1.7A) and oligo-
oxyethylene-(CH2CH2O)n- moieties (Figure 1.7B) in the spacer group, as well as alkyl (-CH3) and/or 
hydroxyethyl (-CH2CH2OH) moieties attached at the quaternary ammonium groups (Figure 1.7A and 
7B) [64]. In presence of serum, these gemini surfactants (in combination with DOPE at the molar 
ratio of 1:1) enhanced or sustained the same level of transfection activity in the HeLa cells as 
compared to the one carried out without serum. Increasing the spacer length of oligo-oxyethylene 
(Figure 1.7B) from 1 to 4 decreased the transfection efficiency, which was further reduced upon 
introduction of a hydroxyethyl moiety (-CH2CH2OH, Figure 1.7A) in the spacer [64]. Enhanced 
transfection efficiency (~ 65% GFP expressing cells in the absence of serum, increasing to ~90 % 
GFP expressing cells in the presence of serum) was observed for the oligo-oxyethylene-(CH2CH2O)n 
with n = 1, (CholHG-1ox) compared to a hydroxyethyl spacer (~75 % GFP expressing cells in 
presence of serum) (Figure 1.7A) or other long chain oligo-oxyethylene-(CH2CH2O)n with n = 2, 3 
and 4 (Figure 1.7B) in presence of serum, partly due to the presence of cholesterol moiety in their 
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structure. The significant differences in the transfection efficiency among all the gemini surfactants 
were explained on the basis of their biophysical characteristics. In the presence of 10% fetal bovine 
serum (FBS), the CholHG-1ox showed improved lipoplex formation (zeta potential ~18 mV at N+/P- 
= 0.5) compared to CholHG-3ox (zeta potential ~12 mV at N+/P- = 0.5). Under the same serum 
condition, a DNA release study (ethidium bromide re-intercalation assay) from the lipoplex revealed 
that CholHG-1ox released approximately 50% DNA in the release medium (sodium dodecyl sulfate 
(SDS): cationic lipid molar ratio of 2), whereas the other gemini surfactants released only 30% DNA. 
Noteworthy, the anionic surfactant SDS is well known to induce the DNA release from various 
lipoplexes [64]. The exact mechanism for the enhanced transfection efficiency of CholHG-1ox is not 
clear; however, it is hypothesized that a shorter length oxyethylene spacer group in addition to the 
presence of cholesterol moiety in the tail group of the surfactant might play a crucial role to induce 
better DNA compaction in the lipoplex compared to other surfactants studied. The Dynamic Light 
Scattering (DLS) data suggested that the aggregates size for CholHG-1ox were ~137 nm whereas 
CholHG-3ox showed larger aggregates of approximately 220 nm. Thus, CholHG-1ox system caused 
more compaction and formed smaller complexes than the CholHG-3ox. Moreover, it was 
hypothesized that the presence of the cholesterol moieties may have rendered better stability of the 
CholHG-1ox lipoplexes. Recent studies reveal that the presence of serum protein helps the formation 
of cholesterol domains which can interact with the cellular membrane through lipid raft/membrane 
sorting mechanism, and consequently enhances the transfection efficiency of the lipoplexes [66]. 
Lipid raft of a biological membrane are enriched with different types of lipids and proteins e.g. 
cholesterol, long-chain saturated sphingo and phosphatidylcholine lipids and specific proteins, which 
are associated with the cell signaling and trafficking process. With respect to the head group of the 
surfactants, the presence of the hydroxyl groups on the head group of the CholHG-1ox undergoes 
interactions with serum protein (FBS), and enhanced lipoplex association in presence of serum. A 
DNase stability assay revealed that CholHG-1ox based lipoplexes had increased stability against 
DNase I than CholHG-3ox (in presence of serum (FBS), which may also account for some of the 
observed increases in transfection efficiency, and ultimately the combination of some or all of the 
above factors might play a significant role in inducing better transfection efficiency for the CholHG-
1ox based lipoplexes.  
Similar results were observed for four novel cholesterol-based gemini surfactant differing in 
the length of oxyethylene-type spacers [−CH2−(CH2−O−CH2)n−CH2−] between each ammonium 
head group (Figure 1.7C) [65]. It was observed that the incorporation of an oxyethylene spacer 
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between the cationic ammonium head groups could significantly increase the transfection efficiency 
of the gemini surfactant as compared to their monomeric counterparts in HeLa cells [65]. In presence 
of 10% serum, the transfection efficiency for the short and longer spacer groups was ~75 % and ~20 
% GFP cells, respectively; signifies that the shorter spacer are more efficient than the longer spacer 
groups. Barran-Berdon et al. have reported similar experimental results with the gemini surfactant 
[bis(hexadecyl dimethyl ammonium) oxyethylene], labeled as (C16Am)2(C2O)s, (where the 
oxyethylene spacer length varied from s = 1, 2 or 3) in combination with the pEGFP-C3 plasmid (at 
various N+/P- ratios between 1:1, 1.5:1, 2:1, 2.5:1, 4:1) and the helper lipid DOPE. The transfection 
efficiency was determined in HEK293T, HeLa, CaCO-2 (human epithelial colorectal 
adenocarcinoma), Hep3B (human hepatoma) and MDA-MB231 (human breast cancer) cells in vitro 
[37]. In the presence of serum, it was observed that a short polyoxyethylene spacer (s = 1) showed 
the highest transfection efficiency (ranging from ~50-75% GFP positive cells) in all cell lines except 
the HEK293T cells at the effective N+/P- = 2:1 and a molar ratio of gemini to DOPE of 0.7:1. In 
HEK293T cells, a longer spacer (s = 3), showed highest transfection efficiency (~45 % GFP positive 
cells) hypothesized to be due to the orientation of the polyoxyethylene region that may have occurred 
in such a way that the spacing between two cationic head group become smaller, and favors the 
transfection into this specific cells. The exact reason(s) for these enhanced transfection efficiency is 
not clear: however, the presence of coexisting lamellar phases (determined from SAXS studies) and 
the synergistic interaction between the polyoxyethylene moiety and serum protein might have played 
a crucial role [37]. Their conclusions again point to the potential importance for the lipids and 
surfactants to adopt multiple packing arrangements within the particle structure. 
In further studies, Bajaj et al. [67], investigated the nature of the spacer between the head 
groups of thiocholesterol-derived gemini surfactants, having synthesized three gemini disulfide based 
surfactants with: 1) hydrophobic flexible polymethylene (−(CH2)5); 2) hydrophobic rigid aromatic 
(−C6H4−) spacer; and 3) hydrophilic flexible oligooxyethylene (−CH2−CH2−O−CH2 −CH2−) spacer 
segments (Figure 1.8). A clear dependence on surfactant structure as well as on cell type was 
observed. Lipid formulations containing gemini surfactants with either hydrophobic polymethylene 
(Figure 1.8-1) and hydrophilic flexible oligooxyethylene (Figure 1.8-3) spacers were found to be 
effective in HeLa cells, whereas those incorporating gemini surfactants with only the hydrophilic 
oligooxyethylene (Figure 1.8-3) spacer were found to be more effective in human fibrosarcoma cells 
(HT1080) [67]. In prostate cancer cells (PC3AR), the hydrophobic rigid aromatic spacer (Figure 1.8-
2) containing gemini was found to result in transfection efficiencies of up to 61% GFP expression. 
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Interestingly, this group of gemini surfactants was able to transfect the human keratinocyte cells 
(HaCat), which is believed to be “difficult to transfect” cells; although the actual reason for enhanced 
transfection with the novel disulfide possessing gemini lipids is not clear. 
 
Figure 1.8. Chemical structures of thiocholesterol-derived cationic gemini lipids having -(CH2)5- (1), 
-C6H4- (2), and -CH2-CH2-O-CH2-CH2- (3) spacer. Adapted from the reference [67]. 
 
The spacer length between the head groups in pyridinium-based gemini surfactants impacted 
the DNA binding capability, stability, cytotoxicity and transfection efficiency [68-72]. Pyridinium-
based surfactants along with the helper lipid DOPE (molar ratio of gemini:DOPE = 1:1) with pDNA 
(N+/P- = 1:2.5) and having a C4 spacer between the head groups exhibited the highest transfection 
efficiency compared with the shorter C3 or longer C5 spacers in COS-7 cells [68]. The specific 
reason for the changes in the transfection efficiency was again not clarified; however, Cryo-TEM 
imaging revealed a vesicular structure of the lipoplexes with size less than 200 nm. Additionally, 
surfactants having a C8 spacing (~100,000 relative luminescence units (RLU)/µg protein) showed 
lower transfection efficiency than a C2 spacing (~120,000 RLU/µg protein) in lung carcinoma cells 
(NCI-H23) with a gemini surfactant to cholesterol helper lipid (molar ratio 1:1) and N+/P- = 2:1 [69]. 
It is hypothesized that the pyridinium polar head groups are larger in size (relative to a quaternary 
ammonium group) and as a result a shorter spacer length might have bring the head groups closer 
than their desired (equilibrium) spacing, increasing charge density and therefore increasing 
electrostatic interactions with DNA and subsequently enhanced the DNA compaction [69]. 
Maslov et al. revealed that cationic liposomes composed of cholesterol, spermine-based 
polycationic gemini surfactant and DOPE (gemini: DOPE molar ratio 1:1) were able to deliver FITC 
labeled oligonucleotide (~70-274.5 mean fluorescenence, RFU), plasmids (~3.3-42 RFU), and 
siRNAs (~5-105 RFU) at the various charge ratio of gemini: pDNA = 2,4,6:1 into HEK293 cells with 
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significantly higher efficiency than that of Lipofectamine-2000 (~1.4-34 RFU) in presence of 10% 
FBS serum. A gemini surfactant containing two cholesterol units, carbamate linker and spacer of six 
methylene groups showed the best transfection efficiency in vitro compared to the other tested 
analogues [73]. 
In summary, the literature review indicates that gemini surfactants having shorter spacer 
lengths (s ≤ 4) OR longer spacer lengths (s > 10) exhibited better transfection efficiency than those 
with the intermediate spacer length. This was attributed to the fact that these features (s ≤ 4 or s > 10) 
may induce structural and packing parameter changes of the complexes (gemini-DNA), for instance, 
lamellar, inverted hexagonal or cubic phase. Another important aspect is the introduction of specific 
functional groups within the spacer and/or head group region (extensively review by Zhi et al. [58]). 
For instance, cholesterol, spermine, pH-sensitive amide group (NH), guanidiniums, cardiolipin 
analogues, nucleolipids, glycosylated cationic lipids, pyridinium, etc. can impact compaction and 
condensation with negatively charged DNA molecules. 
1.3. In vitro transfection efficiency  
In recent years, more than 250 different types of gemini surfactants have been synthesized 
and their in vitro transfection efficiency have been determined by various research groups [43, 67, 
73, 74]. The application of gemini surfactants for DNA transfection was extensively reviewed by 
Wettig et al; Bombelli et al., Donkuru et al. and Kumar et al. [24, 42, 45, 46]. Only recent additions 
to the body of in vitro studies will be presented here. 
Yang et al. utilized amino acid substituted (glycine or lysine; 12-7N(Gly)-12 or 12-7N(Lys)-12) and 
dipeptide substituted (glycine-lysine or lysine-lysine; 12-7 N(Lys-Lys)-12 or 12- 7N(Lys-Gly)-12) 
gemini compounds in the presence of helper lipid DOPE to prepare a lipoplex [75]. The gemini was 
combined with the DNA (encoding interferon gamma and GFP) (N+/P- = 10:1) to to transfect 
different epithelial cells, e.g., COS-7, PAM212 and cotton tail rabbit epithelial cells (Sf 1Ep). Results 
showed that the gene expression was substantially increased up to 72 h, and drastically declined by 
the 7th day. Overall, the glycine substituted gemini surfactant (12-7N(Gly)-12) exhibited higher gene 
expression (ranging from ~350-5000 pg IFN / 20000 cells at 72 h) in all three cell types.  
Mohammed-Saeid et al. have investigated the effect of lyophilization (sucrose and trehalose 
as stabilizer) on gene transfection with the gemini surfactant (12-7NH-12) along with DOPE [76]. 
The gemini to plasmid (encoding for the murine interferon-γ and green fluorescent proteins 
(pGThCMV.IFN-GFP)) at an N+/P- charge ratio of 10:1 was used to transfect COS-7 cells. Sucrose 
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and trehalose improved the stability of the lipoplex up to three months at 25ºC, and the transfection 
efficiency was enhanced by 2-3 magnitude higher than the fresh formulation (approximately 8.2±2.6 
ng of IFNγ/1.5×104 COS-7 cells without lyophilization). It was hypothesized that the 
lyophilzation/rehydration cycles changes the lipoplex morphology (inverted hexagonal phase) which 
ultimately enhanced the transfection efficiency [76].  
Perrone et al. synthesized a type of gemini surfactant containing melamine scaffolds 
connected by n-hexyl linker and functionalized with a 1-propylammonium polar head and a 
lipophilic chain having variable carbon length (from C8 to C16). GFP – expressing plasmid was used 
to transfect the adherent cell lines (A549 and U-87 MG), normal suspension cells (Bristol 8) and 
primary neuronal cells (DRG neurons) with. Significantly higher transfection efficiency was 
observed for the studied formulation and this was dependent on the gemini tail length. For instance, 
the C12 – tail surfactants showed significantly higher results (ranging from 45-80% GFP positive 
cells) than both C14 (15-20% GFP positive cells) and Lipofectamine 2000 (10-20% GFP positive 
cells) [77].  
Sharma et al. have synthesized a series of pyridinium gemini surfactants, among them the 
gemini surfactant consisting of 3-oxapentane-1,5-diyl hydrophilic spacer showed significantly higher 
transfection efficiency (~500,000 RLU/µg protein) compared to Lipofectamine (~300,000 RLU/µg 
protein) in NCI-H23 lung cancer cells in presence of DOPE (gemini:DOPE at molar ratio of 1:2) 
[78]. This was attributed not only to the chain length but also to the presence of counter ions in the 
head group.  
Donkuru et al. have introduced a a pH-sensitive spacer moiety in the gemini surfactant (1,9-
bis(alkyl)-1,1,9,9-tetramethy l-5-amino-1,9-nonane-diammonium dibromide surfactants, m-7NH-m, 
m = 12, 16, 18) to facilitate the transfection efficiency [35]. The surfactants with pH – sensitive 
spacer groups (m-7NH-m) at a N+/P- charge ratio of 10:1 showed higher transfection efficiency in 
murine PAM 212 keratinocytes (~2.5-3.5 ng of luciferase/5×104 cells) compared to the unsubstituted 
compounds (m-7-m, m-3-m series, ~0.5-1 ng of luciferase/5×104 cells ). This was attributed to the 
interactions between negatively charged phosphate groups of DNA and the (–NH–) groups of m-
7NH-m gemini surfactants as well as trimethylene spacing between nitrogen centers and the 
polymorphic changes induced by acidic pH, better transfection results were obtained. Consequently, 
improved endosomal escape of the plasmid DNA occurred. 
Maslov et al. synthesized gemini surfactant with polycationic lipids which consists of two 
cholesterol units, carbamate linker and spacer of 4 or 6 methylene groups, Figure 1.9. In presence of 
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DOPE, the transfection efficiency of FITC-labeled oligonucleotide, plasmid DNA and siRNA was 
evaluated in HEK293 cells. Their study showed substantially higher transfection efficiency than 
Lipofectamine 2000. The linker type, spacer length and the amount of cholesterol residues played a 
significant role in the results. The gemini surfactant containing two cholesterol units, carbamate 
linker and spacer of six methylene groups (with the 2X3-DOPE liposome, Figure 1.9) demonstrated 
the best in vitro transfection results among other analogues tested [73]. Additionally, we have 
mentioned in earlier section (‘effect of spacer length/group’) that gemini/DOPE system showed 
better transfection efficiency in a recent study compared with the Lipofectamine 2000 in HEK293T, 
HeLa and H1299 cell lines [56]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.9. Chemical structures of cholesterol based polycationic amphiphiles. Adapted from the 
reference [73]. 
 
In a recent study it was observed that using pyridinium gemini surfactants and cationic lipid 
mixtures (cholesterol, DOTAP and DOPE) (molar ratio of 1:2) along with plasmid DNA (gWiz Luc 
and gWiz GFP plasmid DNA) enhanced the transfection efficiency (~80000 RLU/µg of protein) in 
NCI-H23 cancer cells (in comparing with Lipofectamin-2000 (~20000 RLU/µg of protein)) [79]. 
This was obtained due to the blending of gemini surfactant into helper lipids, which causes 
fluidization of the supramolecular lipid bilayers.  
Based on our previous review [42] and the current literature assessment, overall, there are no 
direct correlations observed between the different gemini surfactants and the transfection efficiency. 
Thus, multiple factors can be considered to interplay a pivotal role in these observed lack of 
correlations. For instance, variety of lipoplex formulations demonstrated by different research 
groups, use of varied vectors and co-lipids, lack of understanding of the lipoplexes internal 
A. 
B. 
2X1, X= C(O), n=4 
2X2, X= C(O)NH, n=4 
2X3, X= C(O)NH, n=6 
X1, X= C(O), n=4 
X2, X= C(O)NH, n=4 
X3, X= C(O)NH, n=6 
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structures, diverse cell lines, transfection efficiency determination method, choice of internal 
standard and presentation of the results [24, 42]. These are some of considerable factors to be 
addressed in near future to better understand the transfection efficiency governed by the cationic 
gemini based lipoplexes. 
1.4. In vivo transfection efficiency  
 Intraperitoneal, intramuscular or subcutaneous injection strategies are well known for in vivo 
delivery of lipoplex [80]. Several studies showed topical application of lipoplexes containing gemini 
surfactant [81-83], in vivo ocular delivery for the treatment of glaucoma [84] and suppression of the 
B16 melanoma metastasis [85]. Badea et al. have shown the 16-3-16 gemini surfactant along with 
pGTm·CMV·IFN-GFP plasmid coding for interferon gamma (IFN-γ) and GFP for topical application 
for the treatment of localized scleroderma in normal, knock out and diseased animals [47, 81, 82]. 
Gemini–DNA formulations (nanoparticle and nanoemulsion) showed 3–5 fold increase in IFN-γ 
expression in the skin compared to the treatment with naked DNA, and 4–6 fold increase compared 
to the cholesteryl 3b-(-N-[dimethylaminoethyl] carbamate)[Dc-chol]–DNA complex [47]. 
In another study, Badea et al. have investigated cutaneous gene therapy with the gemini 
nanoparticles (16-3-16) as a topical formulation in IFN-γ deficient mouse model. Their results 
revealed significantly higher levels of IFN-γ in the skin (0.480 ng/cm2) relative to treatment with 
naked DNA (0.167 ng/cm2). No skin irritation was observed with the gemini based nanoparticle 
formulation compared to cationic lipid cholesteryl 3b-(-N-[dimethylaminoethyl] carbamate) [Dc-
chol] (NPDc-DNA) nanoparticle [81].  
Recently, the IFN-γ gene was used in Tsk/+ (tight-skin scleroderma) mouse model. The non-
invasive topical nanoparticle formulation with gemini 16-3-16, in the treatment period of 20 days 
(once a day), resulted in a reduction of skin thickness. The DNA microarray, RT-PCR and 
histopathological results suggested that the IFN-γ induced inhibition of collagen production in the 
dermis [82]. 
Markov et al. have investigated the potential to study the antitumor effect (the suppression of 
B16 melanoma metastases) of gemini amphiphiles based on cholesterol (2X3, Figure 1.18) and long-
chain hydrocarbon substituent (2D3) linked with spermine; along with the helper lipid DOPE and 
pEGFP-C2 plasmid DNA, in vivo [85]. The liposomes with 2X3-DOPE or 2D3-DOPE showed 
enhanced transfection efficiency in B16 (C57Bl/6J-derived melanoma) cells, and the results were 
substantially higher than the gold standard transfecting agent Lipofectamine 2000. In the antitumor 
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model of murine B16 melanoma, 2X3-DOPE and 2D3-DOPE showed approximately 3-5 fold 
suppression of the metastasis, in vivo. It was observed that the 2D3-DOPE was efficient over the 
2X3-DOPE liposomes in vivo. The exact reason for the enhanced gene transfection (both in vitro and 
in vivo) is not clear, notwithstanding, the endocytosis (in the dendritic cells) of these cationic gemini 
liposomes is believed to be mediated by the clathrine or caveolae pathway. This study is an indicative 
for the development of the antitumor dendritic cell based vaccine. 
Alqawlaq et al. have used gemini surfactant (12-7NH-12) along with the helper lipid DOPE 
or helper lipid vesicle DOPE:DPPC system; and the Cy5 labeled pCMV6-GFP plasmid (at various 
charge ratio of gemini to DNA = 5, 7.5, 10, 12.5, and 15 :1 to treat glaucoma in vitro and in vivo 
[84]. After intravitreal administration of the gemini-DOPE-DNA, nanoparticles were localized in the 
nerve fiber layer of the retina. However, the topical administration was not as effective as the 
intravitreal in which the nanoparticles were localized within the limbus, iris and conjunctiva. It was 
reported that the nanoparticles prepared with gemini-DOPE-DPPC can induce coexisting lamellar 
and inverted hexagonal phase in lower pH (endosome or lysosome), these features are important for 
better gene transfection and release of DNA into the cytosol [33, 84]. Overall, this study 
demonstrates the applications of gemini-based lipoplexes for the treatment of glaucoma by 
intravitreal and topical ocular gene therapy.  
1.5. Characterization of surfactant-lipid-DNA interactions  
Transfection efficiency of cationic lipid-based vectors can be improved by incorporating 
various types of helper lipids in the system [86-96]. Gemini surfactants alone or in a mixture with 
helper lipids have showed enhanced transfection efficiency; however, the interaction mechanism(s) 
of cationic gemini surfactants (and/or helper lipids) with DNA remains mostly undefined. Among the 
various approaches, Langmuir Blodgett monolayer studies, atomic force microscopy (AFM) studies, 
fluorescence microscopy, zeta potential, particle size measurement, transmission electron 
microscopy, U.V. spectroscopy, thermodynamic binding studies, small-angle x-ray scattering 
(SAXS), and differential scanning calorimetry (DSC) studies have been carried out to study the 
complexation/condensation behavior of gemini surfactants-DNA, and subsequent gene expression. 
Among these techniques, we have presented two relevant approaches to our current thesis in the 
following sections. We will focus on some of the important insights gained from the use of these 
methods, the implication of these results on our understanding of the interactions between cationic 
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lipids or surfactants and DNA, and the implication of these interactions on the mechanism(s) 
involved in transfection. 
1.5.1. Langmuir Blodgett (LB) monolayer studies 
 The Langmuir-Blodgett (LB) monolayer technique is a relatively new approach towards 
understanding the interactions occurring in mixed surfactant/lipid/DNA complexes [97-102]. A 
Langmuir monolayer can be used as a model interface that allows the study of film chemistry and 
film structure with changes in either film compression or changes in sub-phase composition, pH, 
temperature etc. [103]. This could incorporate either a cell membrane model (this will be further 
discussed in the section 1.6) using the gemini surfactant [104-112] or the interaction between DNA 
and cationic lipid/ gemini surfactant at the air water interface [54]. The Langmuir trough is often 
coupled with Brewster angle microscopy (BAM) to determine the topography and domains of the 
floating monolayer at different phases. When p-polarized light shines incident to the air-water 
interface at or near 53o (Brewster angle), no light is reflected. However, if a monolayer is spread on 
the surface, this changes the local refractive index and causes a small amount of light to be reflected 
and subsequently an image of the monolayer can be collected through a microscope objective by a 
CCD camera [113]. Thus, the image is obtained based on the differences between the refractive index 
of the pure surface and the surface with the monolayer. This technique provides information 
concerning the homogeneity of the monolayer, domain formation, phase transitions and adsorption of 
material from the aqueous phase. 
To determine the surface pressure, the monolayer is compressed with the barriers present in 
the trough, this provides an isotherm of surface pressure as a function of mean molecular area (π-A) 
for the spread compounds. Surface pressure is the difference between the surface tension of pure sub-
phase (γo) and the monolayer-covered sub-phase (γ). At 20°C pure water possess the surface pressure 
of about 72 mN/m. Figure 1.10 depicts an example of an ideal isotherm for a Langmuir monolayer 
[113]. As the surface pressure (π) of the two-dimensional monolayer increases, the molecules 
comprising the monolayer undergo different phase transitions and the molecules are packed more 
tightly with increasing surface pressure; i.e., in each phase, the molecules are found in different 
orientations. Thus, the theoretical isotherm (Figure 1.10) can be broken down into gaseous (G), 
liquid expanded (LE), coexisting LE and liquid condensed (LC), LC state, and solid-like (S) states or 
phases. In the G-phase, surfactant molecules remain far apart (Figure 1.10B), and consequently no 
interaction is observed. Increasing the surface pressure (by the compression of barriers) decreases the 
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area per unit molecule. As the molecules comprising the monolayer are forced closer to one another, 
the liquid expanded (LE) phase can be observed. Further compression of the monolayer exhibits a 
steeper rise in surface pressure at slightly lower areas. This phase corresponds to the LC phase where 
molecules are closely packed compared with the LE phase (Figure 1.10B). Finally the monolayer 
reaches the S phase, where a very steep linear isotherm is obtained at low mean molecular areas; 
corresponding to a higher density of the molecules with low compressibility in the monolayer. 
Further compression of the monolayer causes monolayer collapse. The minimum cross sectional area 
(A0) is obtained by extrapolating the isotherm at the steepest slope prior to collapse back to zero 
surface pressure (Figure 1.10). In practice, experimental monolayers may not exhibit all these phases 
due to the narrow ranges of temperature and surface pressure available.  
 
 
 
 
 
 
 
 
 
Figure 1.10. A. Theoretical π-A isotherm obtained by compressing an insoluble lipid monolayer 
formed at an air-water interface. Adapted from reference [113, 114]. B. Lipid packing at the various 
phases of monolayer (at gaseous phase molecules may be orientated flat on the interface (i), or their 
tails may remain out into the non-aqueous phase (ii and iii). Adapted from reference with permission 
[115].  
 
Dupuy et al. have studied the surface properties of novel fluorinated gemini surfactants with 
a diamino- diethyl-oxide spacer and carboxylic acid or ester polar head groups [116]. Figure 1.11a 
shows the π–A isotherm for the interaction of a gemini surfactant containing an ester-based head 
group (Figure 1.12A) with DNA, the single stranded DNA (ss-DNA) concentrations were 0.1 mg/L 
and 1 mg/L at pH 7.4. When the ssDNA was added to the sub-phase, it was observed that the 
molecular area at the lift-off (A0) remains constant, but the compressibility modulus decreased from 
92 to 88 mN/m. Additionally, molecular area at collapse was 67 Å2 and 73 Å2 for the 1 mg/L as 
compared to 0.1 mg/L, respectively.  
A B 
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The changes in surface tension with respect to the area of the surface associated with a liquid 
film can be denoted as interfacial elasticity. For a Langmuir monolayer equilibrium elasticity is 
related to the compressibility of the monolayer [117]. Compressibility is indicated by the equation, 
𝐶 = −
1
𝐴
(
𝑑𝐴
𝑑𝜋
)
𝑇
 Equation 1.5.1-1 
where, A is the area per molecule at surface pressure π [117, 118]. The reciprocal of compressibility 
is denoted as compressibility modulus (Cs-1). Cs-1 provides information on the phase transition(s) of a 
Langmuir monolayer, for instance, the more sharp the phase transition, the higher is the differential 
dπ/dA and stiffer the monolayer [104, 117, 119]. In contrast, carboxylic acid head groups (Figure 
1.12B, Figure 1.10b) did not result in any significant interactions with ssDNA as observed from the 
similar compression isotherm curves. This was attributed to the electrostatic repulsions between 
carboxylate groups and DNA (Figure 1.13). These results signifies that the monolayer characteristics 
depend on the hydrophobic chain length, the polar-head, the pH of the sub-phase and the flexibility 
of the spacer. Figure 1.13 shows that the presence of ssDNA in the sub-phase seems to show a low 
interaction between the surfactants and the oligonucleotide. This study provides a platform to 
understand the interaction of gemini surfactant with DNA at the air/water interface using Langmuir 
monolayer technique. 
 
Figure 1.11. π-A isotherms of gemini surfactant with ester polar head groups (a) carboxylic acid 
head groups (b) with different concentrations of DNA in the sub-phase. Reproduced with permission 
[116]. 
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Figure 1.12. Chemical structure of the new fluorinated gemini surfactants. A. diester type gemini 
surfactant, B. diacids type gemini surfactants [116]. 
 
Castano et al. synthesized a derivative of cholesterol with guanidinium cationic head groups 
(bis(guanidinium)-tris(2-aminoethyl)amine-cholesterol, BGTC) and examined mixed monolayers of 
BGTC and DOPE with DNA to investigate the interactions between BGTC-DOPE and DNA in order 
to tailor an efficient gene therapy vector [120]. Figure 1.14 shows the DNA interactions with 
BGTC/DOPE (molar ratio 3:2) at charge ratio of BGTC:DNA = 1:5 at a surface pressure of 20 
mN/m, and beyond the collapse pressure (surface pressure > 46 mN/m). It was hypothesized that due 
to the interactions of BGTC with DNA (in the sub-phase), the BGTC molecules remain in the layer 
facing towards the aqueous phase, in contrast, DOPE flip-flops (polar head group facing outside (air) 
and the alkyl tail resides towards the subphase (water), in Figure 1.14B the top DOPE layer) beyond 
compression to form a top layer. Polarization modulated infrared reflection absorption spectroscopy 
(PM-IRRAS) studies revealed that due to the adsorption of DNA under the BGTC monolayer, the 
intensity of the main band of the DNA phosphate group (1220 cm-1) was increased. It was suggested 
that the BGTC molecules are stabilized by the DNA layer, and could not flip-flop like DOPE. This 
study signifies a systematic approach to understand the cationic lipid based gene delivery system and 
helps to explain the improved transfection efficiency both in vitro and in vivo. 
Chen et al. conducted Langmuir monolayer studies with the cationic gemini surfactants, 
[C18H37(CH3)2N+-(CH2)s-N+(CH3)2C18H37],2Br−(18-s-18 with s = 3, 4, 6, 8, 10 and 12) (Figure 
1.5A) in presence of ds-DNA or ss-DNA at the air/water interface [54]. It was observed from the 
π−A isotherms along with FTIR, IRRAS, AFM and CD measurements, that for s ≤ 6, a fibril 
structure was formed for the gemini/ds-DNA complex monolayer. For s > 6 the fibril structure 
collapsed to form a platform structure (Figure 1.15). For s ≤ 6, the DNA remained intact in the 
complex; therefore, DNA undergoes a transition into the preferable ψ-phase with a supramolecular 
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chiral order. This has been suggested to be important for efficient gene transfection [54] because in a 
ψ-phase, DNA molecules possess tightly packed highly condensed structures [60]. 
 
Figure 1.13. Schematic representation of monolayers of diester containing gemini surfactant 
compressed on an aqueous sub-phase with (B) and without DNA (A). A. at low surface pressure 
(small surface density of the molecules), ethyleneoxide moiety reside towards the subphase and 
intermolecular H-bond occurs in the NH group and no interaction with ssDNA. B. at higher surface 
pressure, the polar head group undergoes transition from an extended ethyleneoxide moiety to a U-
shape and interacts with the negatively charged ssDNA molecule. Adapted from the reference with 
permission [116]. 
 
 
Figure 1.14. Scheme of the DNA (~200 base pairs) interactions with BGTC/DOPE. (A) At 20 
mN/m, formation of an incomplete DNA layer (≈7 Å thick) under the BGTC/DOPE monolayer (≈19 
Å thick). (B) Beyond the collapse pressure, formation of an asymmetric lipid bilayer (≈50 Å thick); 
DOPE on the top flip-flops to create a bilayer in which the polar head resides outward (air) and the 
alkyl tail toward the BGTC alkyl tail, and BGTC in contact with an organized DNA layer (≈27 Å 
thick). Adapted from reference [120]. 
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Figure 1.15. Schematic illustration of the monolayer of (A) gemini/ds-DNA complex; fibril (top) and 
platform structure (bottom) formation or (B) gemini/ss-DNA complex; fibril structure formation with 
the conservation of complex monolayer. A. the ds-DNA remains in the double-stranded helical 
conformation. For s ≤ 6 (top), at low surface pressure the gemini/ds-DNA complex is formed 
laterally and the fibril aggregate is achieved with the 2-7 nm height; at s > 6 (bottom), the complex 
formation occurs laterally and platform structure is achieved. Adapted from reference [54]. 
 
1.5.2. AFM studies 
AFM is a widely used technique to investigate the interaction of gemini surfactants with 
other helper lipids or DNA [33, 34, 54, 121-125]. AFM studies were carried out to characterize the 
gemini surfactant – DNA monolayers (using 12-s-12 surfactants (s= 3, 4, 6, 8, 10, and 12) [125] and 
a series of asymmetric (m-s-n, m≠n) surfactants deposited from Langmuir films onto mica [126]. The 
formation of complex monolayers between gemini surfactants and DNA at the air-water interface 
was systematically investigated. The spacer length of the gemini surfactant had profound effect on 
the surface properties [125]. For surfactants with s = 6, electrostatic interactions between the 
phosphate groups of DNA and gemini led to a conformational change for the gemini compounds, 
resulting in the maximum extrapolated area (Ae) in presence of DNA in the subphase; whereas at s = 
10, the maximum in the Gibbs area was observed in absence of DNA (surface tension measurement). 
Minimum surface area occupied by a surfactant molecule at the air/water interface can be determined 
from the concentration dependence of the surface tension using the Gibbs equation. The Gibbs 
surface excess concentration is derived from the equation: 
𝛤 = −
1
2.303 𝑅𝑇
(
𝑑𝛾
𝑑 log 𝐶
)
𝑇
  Equation 1.5.2-1 
where, dγ = change in surface tension, C = molar concentration of surfactant, R= ideal gas constant 
and T = absolute temperature. Using the equation 1.5.2-1 one can determine the surface area 
occupied by the surfactant molecules (Gibbs area) by the equation: 
𝑎 = 1/(𝑁𝐴𝛤)    Equation 1.5.2-2 
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where, 𝑁𝐴 is the Avogadro’s number [127]. The electrostatic interaction was further evident from the 
AFM topography which showed the presence of fiber like structures, and the thickness of the fibers 
were correlated with the spacer length of the gemini surfactants [125]. The asymmetric gemini 
surfactants also showed similar results. For instance, increase in the asymmetry of the alkyl tail 
increased the hydrophobicity and provided better condensation of DNA, and AFM topography 
showed an increase in the width of the fibrils [126]. Noteworthy, for compounds with s > 6, the 
compressed monolayer become more hydrophobic, resulting in the spacer group adopting a “U-
shape” conformation which is an indication of bola amphiphile monolayers. This gemini surfactant 
tends to form a vertical wicket like conformation at the air-water interface like the other bola form 
quaternary ammonium surfactants [125].  
The condensation effect of T4 DNA with the 12-3-12 gemini surfactant was observed using 
AFM microscopy and fluorescent microscopy (FM) was investigated by Miyazawa et al. [124]. It 
was found that upon increasing the surfactant concentration from 0 µM to 10 µM, DNA (0.1 µM) 
exhibited coil to partially folded to folded structure. A ‘rings-on-a-string’ structure or a network 
structure composed of many fused rings was observed with the gemini concentration of 0.2 µM and 1 
µM, respectively. Specifically, many rings were observed and they were interconnected by elongated 
coil parts along a single DNA molecule (Figure 1.16). This study signifies that the electrostatic 
interactions between gemini surfactants and DNA induces condensation in the DNA molecule. It is 
hypothesized that the relatively smaller head group area of the 12-3-12 surfactant may lead to higher 
values of packing parameter indicative of the spherical structures, and the DNA molecule can be 
packed inside this surfactant collapse part and consequently forms the ‘rings-on-a-string’ structure 
[124]. Interestingly, studies have shown that gemini surfactant (12-3-12) can induce better 
transfection efficiency compared with other gemini surfactant 12-m-12, m=4, 6, 8, 10, 12, 16 in 
PAM212 cells [33]. Thus, the AFM study supports the transfection results of the 12-3-12 gemini 
surfactant. 
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Figure 1.16. FM top and AFM middle images and schematic representations (bottom) of partially 
folded and folded DNA. The partially folded (A) rings-on-a-string structure in the AFM image. The 
folded (B) network structure composed of many fused rings in the AFM image. Reproduced with 
permission [124]. 
 
Foldvari et al. have utilized AFM to investigate the pGTmCMV.IFN-GFP plasmid /gemini 
surfactant (spacer n = 3–16; chain m = 12 or 16) complexes (1 : 10 charge ratio), in the presence or 
absence of DOPE [33]. In the absence of DOPE, a ‘beads-on-a-string’ structure was observed for the 
16-3-16 surfactant. Interestingly, at 30 second incubation the ‘beads-on-a-string’ structure (Figure 
1.17A) was formed; while increasing the incubation time to 15 min, formed more compact particles 
(Figure 1.17B) with a particle size of around 220 nm (determined from accompanying light scattering 
results). Conversely, introducing DOPE in the system resulted in substantial changes in the 
morphology of the complexes, for instance, both 12-3-12 and 16-3-16 exhibited clear vesicle 
formation. These findings were further confirmed by a SAXS study in which no polymorphic 
structures were observed for the gemini – DNA systems in the absence of DOPE [33]. Addition of 
DOPE to the gemini surfactant – plasmid complexes, for both 12-3-12 and 16-3-16 resulted in a 
lamellar morphology along with the presence of additional phases, and showed better transfection 
efficiency in PAM 212 keratinocytes in vitro over the system without DOPE. Hence, studying the 
morphology of the gemini based lipoplex with AFM, provided an insight as to how this could be 
correlated with the particles size and SAXS results; and ultimately to interpret the transfection 
efficiency results.  
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Figure 1.17. AFM images showing plasmid DNA compaction by the gemini surfactants on freshly 
cleaved mica surface (bar represents 400 nm). (A) plasmid-gemini complex after a 30-second 
incubation; (B) plasmid-gemini complex after a 15-minute incubation Adapted from reference [33]. 
 
Figure 1.18. AFM images of the phy-3-12 containing complexes at different charge ratio of (a) 2:1 
fibril structure; and (b) 10:1 compacted structure. Reproduced with permission [34]. 
Our recent study with phytanyl modified gemini surfactants (phy-3-m and phy-7NH-m, m = 
12, 16, 18) along with helper lipid DOPE and pVGtelRL plasmid, exhibited improved transfection 
efficiency in OVCAR-3 cells [34]. The highest transfection efficiency was obtained at an N+/P- 
charge ratio of 5:1. The AFM study revealed that the phy-3-12 complexes at an N+/P- = 2:1 exhibit a 
large number of fibrils combined with larger aggregates (Figure 1.18). However, fibril formation was 
drastically decreased at an N+/P- = 10:1, and tightly compacted particles were formed. This was also 
evident from particle size analysis where particle sizes of 1220 nm and 188 nm, were observed for 
N+/P- = 2:1 and 10:1, respectively. Thus, AFM along with particle size measurement and SAXS 
study provided a better understanding of the interaction mechanism of lipoplex; and helped in 
correlating the enhanced transfection efficiency of gemini based lipoplexes with a better 
understanding of the morphology of the particle formation (larger aggregate or tightly condensed 
complex formation) [34].  
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1.6. Cell membrane model system 
The biological membrane is a major component of living cells, and plays a significant role in 
most of the cellular phenomena. The following sections will describe the background of the proposed 
model membrane study. In the following sections we have presented various components of cell 
membranes and the importance model membrane system to study the interactions between the 
cationic lipoplex based and model membrane components. 
1.6.1. Lipid raft formation in a biological membrane 
A brief historical background of model membrane system development was reviewed by 
Sezgin and Schwille (2012) [128]. The liposome was discovered in 1964 [129] which led to the 
establishment of the Fluid mosaic model for the biological membrane by Singer and Nicolson in 
1975. According to the fluid mosaic model it is believed that membrane proteins are like icebergs 
floating in a sea of lipids [130]. Recently, researchers have proposed the presence of ‘rafts’ and 
“caveole” at the cell surface [131-133]. According to this model, instead of being a random ocean of 
lipids, plasma membranes possess a certain lipid structure within this ocean of lipids. The lipid 
“structures” within the membrane ocean are called lipid rafts (Figure 1.19) [134, 135]. Lipid rafts 
(sizes ~10-200 nm) are enriched with cholesterol, long-chain saturated sphingolipids and 
phosphatidylcholine (PC) and specific proteins. These are associated with the cell signaling, 
membrane trafficking, endocytosis and are utilized by some viruses for budding [131, 135, 136]. It 
has been reported that sphingolipid/sterol assembly in lipid rafts can be modulated by 
glycosylphosphatidylinositol (GPI)-anchored proteins, certain transmembrane proteins, acylated 
cytosolic effectors, and cortical actin [135]. Lipid based formulations (lipoplexes) might influence 
the lipid rafts of cellular membranes, which in turn results in better endocytosis and endosomal 
escape of the lipoplex. There are several review articles published in the research area of lipid rafts 
[135, 137-139], and a detailed review of this broad field is beyond the scope of this thesis. 
Additionally, the outer leaflet of plasma membrane contains more sphingomyelin, 
phosphatidylcholine and cholesterol whereas the inner leaflet contains more phosphatidylserine and 
phosphatidylinositol [140]. There have been numerous review article published in the lipid 
composition of plasma membrane, lipids biosynthesis and lipid distribution at the different stages of 
endosome maturation [140-147]. The different endocytosis pathways and how the lipid based drug or 
gene delivery system may be uptake and released from the endocytosis process have been 
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extensively reviewed by several researches [21, 148-152]. Readers are suggested to read above 
mentioned articles for better understanding of this broad research area.  
 
 
Figure 1.19 (A) Singer and Nicolson’s fluid mosaic model of the membrane; (B) lipid raft model of 
the membrane; (C) lipid raft structure in the membrane (blue bilayers) showing inserted 
transmembrane proteins (TM1, TM2); glycosylphosphatidylinositol anchored proteins; dually 
acylated proteins (Acyl); and phospholipids (PC), phosphatidylcholine (PE), 
phosphatidylethanolamine; PS, phosphatidylserine; PI = phosphatidylinositol; SPM = 
sphingomyelin; Chol = cholesterol; Gang = gangliosides (Figures are adopted from ref. [134] and 
[153]). 
1.6.2a. Membrane lipid composition 
Theoretically, the cellular membrane lipidome is composed of glycerophospholipids (9600 
species), sphingolipids (more than 100,000 species), mono-, di-, or triglycerides variants (thousands) 
as well as fatty-acid and sterol-based structures (numerous) [154]. Cellular membrane lipids (Figure 
1.20 and 1.21) are divided into three distinct groups such as phospholipids (glycerol-based lipids, 40-
60 mol % of the total lipid fraction [114]), ceramide-based sphingolipids, and sterols. Phospholipids 
are subdivided into several groups according to their hydrophilic groups e.g. phosphatidylcholine 
(PC), phosphatidylethanolamine (PE), phosphatidylserine, phosphatidylinositol, and cardiolipin. The 
first three mentioned lipids are the principle lipids in the cellular membrane. Sphingolipids possess 
sphingoid base as a backbone; these lipids are responsible for the hydrophobicity of the core of the 
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lipid bilayer. Cholesterol (30-50 mol % of the total lipid fraction) is responsible for the fluidity and 
packing of the lipid membrane [147, 155]. 
 
Figure 1.20. Modern view of biological membranes (adapted from the ref. [114]).The illustration 
shows the lateral heterogeneities, cluster and domain formation within the membrane plane. The 
‘green’ color lipids forms the membrane bilayers, the ‘red’ color are the integral proteins, ‘yellow’ 
color are different domain formation.  
 
 
Figure 1.21. Chemical structure of some lipids present in biological membrane: A. 
Phosphatidylcholine (Glycerophospholipid), B. Sphingomyelin (sphingolipids), C. 
Glycosphingolipids (sphingolipids), D. Cholesterol (sterols). 
1.6.2b. Model endosomal membranes 
One method which can be used to investigate the interaction of different systems with 
cellular and endosomal membranes is by using model membranes. The real cell membrane is a 
bilayer formed by phospholipids molecules, in which sterols and proteins are embedded [156]. Model 
cell membranes are systems in which their lipid organization mimics the arrangement of lipids in 
natural cell membranes [106]. A mixture of different lipids like cholesterol, dipalmitoyl 
phosphatidylcholine (DPPC), dioleoyl phosphatidylcholine (DOPC) and 1-palmitoyl-2-
oleoylphosphatidylcholine (POPC) are used to constitute these model membranes. The composition 
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of different membranes inside the cell varies depending on the type of cell organelle and type of 
tissue [157]. Based on our literature survey, the exact composition of the endosomal membrane is not 
precisely defied. In mammalian liver, the plasma membrane, lysosomal membranes and nuclear 
membrane contains cholesterol at around 19.5%, 14% and 10% of total lipids, respectively [158]. 
Some molar ratios between cholesterol/phospholipid-p in human erythrocytes, thymocytes and 
lymphocytes are mentioned as 0.81, 0.75 and 0.69, respectively [158]. Therefore, for a normal 
plasma membrane the amount of cholesterol in the cell varies from 30% to 50% [147, 159]. Van 
Meer et al. have suggested that the early and late endosomes may have a cholesterol content of lower 
than 30 % or ~25-30% [147, 160]. Additionally, some recent Langmuir monolayer studies have 
utilized 30% cholesterol as a model mammalian cell membrane along with the DPPC lipid (70%) 
[156, 161]. Therefore, in our current study we have reduced the cholesterol concentration about 5% 
to mimic the endosomal membrane. To investigate the effect of our gemini based lipoplexes, a model 
membrane of DPPC and cholesterol with a molar ratio DPPC/cholesterol = 75/25 % will be used in 
our experiment to simulate the endosomal membrane. 
1.6.3. Types of model membranes 
In a model membrane system lipid organization mimics the arrangement of natural biological 
cell membrane. There are various types of model membrane systems including the Langmuir 
monolayer, supported lipid bilayers (SLB), bimolecular lipid membranes (BLM), and lipid bilayers 
(vesicles or liposomes) [106, 128, 153, 162]. The following sections will briefly describe the feature 
of these model membrane systems.  
1.6.3a. Supported Lipid Bilayers (SLB) 
SLBs are a model membrane system in which the lipid bilayers are formed on a solid 
support, mainly silicon or mica. In this model, the lipid monolayer exhibits specific characteristics 
such as the first layer of lipids polar head group remains at the support (mica/silicon), and the 
hydrophobic tails are in contact with the lipid chains of the second monolayer. SLBs possess a 
planner structure, and remain intact while subjected to high flow rate or vibration due to the coupling 
with underlying solid substrates. Therefore, SLBs are easy to produce, and exhibit higher stability 
than bimolecular lipid membranes [106, 114].  
1.6.3b. Lipid monolayers: a Langmuir-Blodgett study 
The simplest model by which to study the biological membrane is the lipid monolayer 
system. In chapter I we have introduced the Langmuir-Blodgett system. A lipid monolayer can be 
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formed by spreading amphiphilic molecules on a sub-phase of water or different buffer systems using 
a Langmuir trough. By this technique temperature, surface pressure and sub-phase composition can 
be controlled to mimic a biological membrane [105]. It is believed that the surface pressure of 
biological cell membrane ranges from 30-35 mN/m [153, 163, 164], these surface pressures are 
readily accessible using the Langmuir method. The preparation of Langmuir monolayers will be 
discussed in the section 3.2.3. 
1.6.3c. Liposomes/Lipid vesicles 
A liposome is one of the model membrane systems having a lipid bilayer that surrounds a 
small internal aqueous compartment (Figure 1.22) [165, 166]. Liposomal model membrane systems 
are widely used because they mimic the organization of a biological membrane. There are three types 
of unilammelar system such as small unilammelar vesicle (SUV, 20-50 nm), large unilammelar 
vesicle (LUV, 50-100 nm), or giant unilammelar vesicle (GUV,10-100 μm) [106].  
 
 
 
 
 
 
 
 
 
 
 
Figure 1.22. Illustration of the liposomal vesicles having phospholipids bilayer. Adapted from the 
reference [166]. 
1.6.4. Lipids and gemini surfactants used in the current project 
1.6.4a. 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC)  
DPPC (Figure 1.23), a zwitterionic saturated phospholipid, consists of a polar head group 
(phosphate group and a choline), and non polar tail group of two fatty acid chains. DPPC is the most 
abundant lipid (30–45%) found in the lung, and forms stable monolayers in alveoli [167]. It can 
reduce the surface tension of water against air to approximately 3 mN/m, and maintains alveoli 
function during breathing. Therefore, DPPC is often denoted as lung surfactant [167, 168]. DPPC is a 
widely used lipid to study model biological membranes [169-183]. There have been few published 
articles which evaluated the effect of different types of gemini surfactant on DPPC model membrane 
[57, 184-188]. These studies provides an insight to use the DPPC as a major phospholipid component 
Phospholipid 
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Hydrophobi
c tails 
Hydrophilic 
head 
Water 
Water 
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of model biological membrane in the Langmuir monolayer studies. Additionally, DPPC monolayer is 
easy to produce and already been well characterized in the literature as a model membrane.  
 
Figure 1.23. Chemical structure of 1,2-dihexadecanoyl-sn-glycero-3-phosphocholine (DPPC). 
1.6.4b. 1-palmitoyl-2-oleoylphosphatidylcholine (POPC) 
Tumor cell membranes are comprised of more unsaturated lipids (such as POPC) , whereas 
normal cells contain a higher amount of cholesterol and saturated phospholipids [189]. An extensive 
review has been published examining the biophysical changes with respect to cellular membrane 
composition, specifically for membranes in drug resistant cells [190]. Discussing all the features of 
cancer cell membranes is beyond the scope of this thesis. Readers are suggested to read the review by 
Nagoya (1993), for a detailed overview of cellular lipid composition of cancer cells [191]. In addition 
to cancer, alteration of cell membrane lipid composition may occur in other disease conditions such 
as diabetes, and cardiovascular disorders such as hypertension, atherosclerosis, coronary heart 
disease, sudden cardiac death, aneurism, and thrombosis. Therefore, biophysical investigations of 
lipid membrane structure, in order to understand the interaction of drugs or drug delivery systems 
with specific cell membrane lipids may provide insight with respect to cellular uptake mechanisms of 
such delivery systems [106].  
POPC (Figure 1.24) is another most abundant phospholipids in cell membranes. POPC 
provides a good model to study the fluidic nature of the cancer cell membrane using the Langmuir 
technique. POPC has been reported to be more abundant lipid in leukemic cancer cell membranes 
than other cancers; and Wnetrzak el al. have studied a POPC/cholesterol monolayer as a model 
cancer cell membrane (leukemia) [180]. There have been few published articles which have used 
different gemini surfactant along with POPC monolayer system [192]. This study provides an insight 
to use the POPC as a model membrane component to investigate the interactions with the gemini-
based lipoplexes in a Langmuir monolayer studies.  
 
Figure 1.24. Chemical structure of 1-palmitoyl-2-oleoylphosphatidylcholine (POPC). 
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1.6.4c. Cholesterol 
Cholesterol (Figure 1.25) is a vital component of mammalian cell membranes since it 
maintains membrane fluidity, and has significant role in lipid rafts [193]. Heczkova and Slott have 
synthesized new ether analogues of the phosphatidylcholine and lyso-phosphatidylcholine which 
possess properties of an anti-tumor agents. It was revealed that the ether lipids were strongly 
associated with the cholesterol– sphingomyelin domains (lipid rafts) of the plasma membrane due to 
the hydrophobic nature of the lipids, and stabilized the lipid rafts against the temperature induced 
melting. Thus, this study indicates that the anti-tumor agents can modulate the cholesterol portion of 
lipid raft [194]. Therefore, it is important to study cholesterol based model membrane system to have 
better understanding of the lipid raft. There have been several published articles which have reported 
different studies using cholesterol as a model membrane component. These include the comparative 
study between the Langmuir monolayer of the mixed DPPC-cholesterol system and the physical 
stability (particle size, polydispersity) of DPPC-cholesterol liposomes [182], 1,2-dimyristoyl-sn-
glycero-3-phosphocholine (DMPC)-cholesterol monolayer [195], glycolipid–cholesterol monolayers 
[196], a lipid raft model of N-palmitoyl-D-erythro-sphingosylphosphorylcholine (PSM), 1,2-
dioleoyl-sn-glycero-3-phosphocholine (DOPC), and cholesterol [197].These studies signifies the use 
of cholesterol as a model biological membrane component for the Langmuir monolayer study. In our 
current study, we have used cholesterol along with DPPC to mimic the model endosomal membrane.  
 
Figure 1.25. Chemical structure of cholesterol. 
1.6.4d. 1,2-Dioleoyl-sn-glycero-3-phosphatidylethanolyamine(DOPE) 
The transfection efficiency of cationic lipid based vectors can be improved by incorporating 
helper lipids in the system. One example includes the use of dioleoyl-phosphatidylethanolamine 
(DOPE, Figure 1.26) to increase transfection efficiency [86, 87]. In our current study we have used 
DOPE as a helper lipid in the formulation of our cationic gemini surfactant based transfection 
vectors. DOPE, as a helper lipid, is thought to increase transfection efficiency by formation of mixed 
aggregates with high (greater than unity) packing parameters. This leads to a transition from micelle-
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forming systems towards vesicles, and subsequently towards the formation of inverted hexagonal or 
cubic phases [198]. In addition, the fluidity of cellular membranes can be increased by incorporation 
of DOPE, which may further enhance transfection efficiency. 
The co-existence of lamellar [32] and inverted hexagonal [31] structures as an important 
property for cationic lipid/DNA lipoplexes was first introduced by Safiniya’s group [31, 32]. The 
inverted hexagonal phase of a lipoplex has been demonstrated to be preferable over the lamellar 
phase in terms of efficient gene transfection due to enhanced endosomal membrane fusion and 
release of the lipoplexes into the cytoplasm (this phenomena has been described in the section 
1.2). Figure 1.27 depicts the conversion of lamellar to inverted hexagonal structure of lipoplexes. 
Lamellar lipoplexes generally bind with anionic lipids of cellular membranes and increase the 
packing parameter of the cationic surfactant which allows the formation of inverted hexagonal or 
cubic structures (Figure 1.27). However, these non-lamellar structures are not favorable for 
binding DNA; instead they are favorable for releasing DNA after cellular internalization. In this 
context some helper lipids are used in combination with the gemini surfactants; e.g. DOPE to aid 
in the formation of non-lamellar structures.  
 
Figure 1.26. Chemical structure of 1,2-Dioleoyl-sn-glycero-3-phosphatidylethanolyamine (DOPE). 
 
Figure 1.27. Schematic representation of the lamellar phase to the columnar inverted hexagonal 
phase of cationic lipid-DNA complexes. A. the cationic lipid-DNA complex in a lamellar phase. 
The DNA molecules reside between the lipid bilayers (in water) and are separated by a distance 
dDNA. B. addition of the helper lipid DOPE with the DOTAP induces the phase transition from 
lamellar to inverted hexagonal phase in which the polar head group of the lipids are facing 
towards the DNA and the hydrophobic tails outward. Adapted from the reference [31]. 
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1.6.4e. Cationic gemini surfactant used in the current project 
The cellular uptake mechanism of a cationic lipid based nanoparticles can be governed by 
cell-type and nanoparticle properties, e.g. lipid raft-mediated uptake, macropinocytosis, clathrin and 
caveolae-dependent endocytosis [199]. Keeping this in mind, a novel class of pH sensitive gemini 
surfactant, m-7NH-m, m = 12, 16, 18 were synthesized (Figure 3.9) [200, 201]. In addition, 16-7NH-
16 possess low CMC value as well its pKa value is 5.04 ± 0.3 [35]. This could provide better 
endosomal escape since the endosomal pH is around 5-6. The pH of the lysosome is around 4-5, 
which is more acidic compared to early endosomes [23]. Thus, the presence or absence of pH 
sensitive group (m-7-m) exhibits better structural activity relationship clues. As such, in this project 
we have used the gemini 16-7-16 and 16-7NH-16 surfactants (Figure 1.28) which have shown 
improved transfection efficiency in our previous study [35].  
 
Figure 1.28. Typical gemini surfactant structures with a methylated spacer 16-7-16 and an amino-
substituted spacer 16-7NH-16. 
1.7. Summary  
Overall, this literature review reveals that studying the interaction behavior of gemini 
surfactant with DNA in a lipoplex can aid in understanding the mechanism(s) involved in the 
condensation of DNA and the subsequent release of incorporated DNA from the lipoplex into the 
cytoplasm through endosomal escape. It is evident that the conformational changes in the lipoplex 
morphology will eventually facilitate enhanced cell penetration as well as transfection of the gene. In 
another aspect, in order to overcome the cellular barriers of a lipoplex, we need to understand how 
DNA influences the arrangement of vector components (lipids, surfactants, polymer etc.) during the 
complexion of DNA; as well as how these components interact with biological membranes. 
Moreover, ultimate usefulness of non-viral gene delivery systems will depend on the rate, extent and 
duration of transfection, the ability of the gene delivery systems to specifically interact with target 
cells in vitro as well as in vivo. Having been aware of the aforementioned features of a cationic 
lipoplex one can design an efficient non-viral gene delivery vector including gemini surfactant with 
appropriate modifications. 
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This chapter has demonstrated the impact of a wide number of variations within the structure 
of the gemini surfactant upon transfection efficiencies, and has identified a number of key features 
important for transfection, including structural polymorphism and stimuli responsive functional 
groups. Understanding of membrane fusion events, and overall a better understanding of the 
interaction of complexes with cellular membranes, and the eventual fate of complexes within the 
cytoplasm will continue to be critical for further optimization of these vectors. Studies should be 
carried out to locate/track the nanoparticles in the cell surface (membrane), cytoplasm or in the 
nucleus; allowing for correlation of the transfection efficiency results with the exact number of 
particles been taken up by a specific cells. Next generation gene transfection vectors could include 
gemini surfactant coupled with surface modification of the liposome for targeting, additional 
environmentally responsive stimulus, or the formation of other “smart” vectors to deliver the DNA 
cargo to the nucleus. 
Moreover, the chemical nature of the transfection agent, the structure of the delivery system, 
cell types and transfection efficiency yet to be optimized for the gemini based gene delivery system. 
Next generation gene delivery method might include the cationic gemini surfactant along with the 
surface modification of liposome, utilizing the targeting ligands on them, using smart biomaterial 
(pH sensitive) and formation of different combination of smart biomaterial-gemini-DNA to deliver 
the DNA cargo to the nucleus. Keeping these important factors in mind we have designed the current 
project which will be discussed in chapter IV, and the interaction of novel gene transfection system 
on the model biological membrane in chapter V.  
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Chapter II 
2.1 Objectives and Hypothesis 
2.1.1 Hypothesis statement 
We hypothesize that the interactions of the novel gene therapy formulations consists of 
gemini surfactant, DOPE and DNA may disrupt and destabilize the model endosomal membrane.  
2.1.2 Overview of proposed project/rationale 
Multicomponent lipid membranes form the majority of membrane barriers in living 
organisms, and their function is highly dependent on membrane composition. It is known that 
domains high in the concentration of a particular lipid component are formed in cellular membranes 
under specific conditions (e.g. lipid raft domains in endocytosis) and that these domains can be 
modified by lipid-based drug delivery systems [149]. On the other hand, major barriers faced by the 
non-viral transfection vectors to deliver DNA in gene therapy applications includes a lack of 
understanding of how DNA influences the arrangement of vector components (lipid, surfactants or 
polymers) during the complexation of DNA; as well as how they interact with biological membranes. 
Brewster’s Angle Microscopy (BAM), Polarization Modulated Infrared Reflectance Absorption 
Spectroscopy (PM-IRRAS), Atomic Force Microscopy (AFM) and Kelvin probe force microscopy 
(KPFM) can be used to characterize the arrangement of the gemini surfactants and phospholipids that 
make up the transfection vector (both in the presence and absence of DNA) as well as the effect of 
these components on model biological membranes.  
2.1.3 Objective / Short term goals 
Characterization of gemini phospholipids transfection formulations in the presence and absence of 
DNA using BAM, PM-IRRAS, AFM and KPFM. 
2.1.4 Long term goals 
Characterization of model biological membranes 
a. DPPC-Cholesterol or POPC-Cholesterol model membrane. 
b. Model Membrane (DPPC-Cholesterol or POPC-Cholesterol) with gemini 
surfactants/phospholipids (16-7-16, 16-7NH-16 with DOPE or without DOPE). 
c. Model Membrane with gemini surfactants/phospholipids/DNA system. 
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Chapter III 
Material and Methods 
3.1 Materials 
Gemini surfactants 16-7-16 and 16-7NH-16 were synthesized in our laboratory according to 
procedures previously reported in the literature [35, 201, 202].. The degree of purity was determined 
by using NMR and surface tension measurements [200]. DOPE (1,2-dioleoyl-sn-glycero-3-
phosphoethanolamine), 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC) and cholesterol was 
purchased from Avanti Polar Lipids (Alabaster, USA). Double-stranded salmon sperm DNA was 
from Sigma-Aldrich, USA and was used without further purification. Sodium acetate was obtained 
from OmniPur (Darmstadt, Germany), acetic acid from Fischer Scientific (Ottawa, Canada). 
Chloroform, Sodium dihydrogen phosphate monohydrate and disodium phosphate heptahydrate were 
obtained from Sigma-Aldrich (Steinheim, Germany). Sodium acetate, acetic acid, and sodium 
bicarbonate were purchased from Sigma-Aldrich (Oakville, Ontario). In this investigation, deionized 
Millipore-Q water (18 mΩ cm and 72.6 mN/m at 20°C) was used. 
3.2 Methods 
3.2.1 Experimental procedures / Techniques 
3.2.2 Characterization of gemini-DOPE-DNA nanoparticles 
The gemini formulation used in the current project showed better transfection efficiency in 
PAM 212 keratinocyte cells and COS-7 cells [35], in vitro. However, our literature survey revealed 
that there is no report about the presence of specific types of lipids in ovarian cancer cells. Springer 
et al (2003) has characterized some plasma proteins in ovarian cancer cells [203], but they are not 
useful to study as model membrane system. As such, our current project aimed to evaluate DPPC-
cholesterol based model membrane system to mimic a normal cell membrane or endosomal cell 
membrane. Additionally, the POPC-cholesterol system may be implemented to represent the model 
cancer (leukemia) cell membrane [180]. 
In our previous study we have synthesized, and characterized the gemini 16-7-16 and 16-
7NH-16 along with helper lipid DOPE with or without the presence of DNA [35, 200]. This system 
showed smaller particle size with a positive zeta potential value, and improved transfection 
efficiency in PAM 212 and COS-7 cell line [35]. In our current project, we have used the gemini-
DOPE system with or without the presence of DNA as a lipoplex combination to observe the 
interaction with model membrane systems.  
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3.2.3. Preparation of a Langmuir-Blodgett monolayer 
We have already introduced the Langmuir-Blodgett monolayer system in chapter I, section 
1.5.1. The preparation of the Langmuir monolayer is described in the following section 3.2.4. In 
addition to the LB technique, Brewster angle microscopy (BAM) is commonly used to determine the 
thickness and topography of the LB monolayer [113].  
3.2.4. Monolayer formation and surface pressure measurements  
Surfactant, lipid, and mixtures were dissolved in chloroform obtained at a concentration of 
2.5 mmol/L. The mixtures of DOPE and gemini surfactants were prepared at a mole ratio of 3:2. 
DNA stock solution was prepared by dissolving DNA in Millipore-Q water for a stock concentration 
of 4 mg/L. The concentration of DNA and buffer used on the trough was 0.004 mg/mL [54]. Buffer 
solutions at pH = 4, 7, and 9 were prepared using acetate buffer (using 1% acetic acid), phosphate 
buffered saline (using Na2HPO4) and sodium bicarbonate (using NaHCO3), respectively at 10 mM/L. 
The experiment was performed on a large (14.5 cm by 53 cm) Langmuir-Blodgett trough (KSV 
Instruments, Helsinki, Finland), with surface pressure monitored using the Wilhelmy plate method. 
Compressions of the monolayers on the trough were carried out at a rate of 15 mm/min. A volume of 
20 µL of surfactant and/or lipid solution was placed onto the surface of the subphase using a micro-
syringe (GASTIGHT®, Hamilton-Bonaduz, Schweiz, Switzerland). For experiments that involved 
only buffer subphase, the monolayer was allowed to equilibrate for 10 minutes. For experiments 
involving DNA and buffer, the sub-phase was given 60 minutes to equilibrate with DNA prior to 
adding surfactant. The monolayer was then allowed to equilibrate for 30 minutes on the DNA and 
buffer subphase before the isotherms were collected. Isotherms and BAM images of the following 
samples with or without DNA were collected: 16-7-16, 16-7NH-16, DOPE, DOPE and 16-7-16, 
DOPE and 16-7NH-16.  
For the model membrane studies, the different buffer solutions (pH 4, 7 and 9) were spread as 
sub-phase in the Langmuir trough. Then a volume of 20 µL of surfactant and/or lipid solution was 
injected into the sub-phase using a micro-syringe (GASTIGHT®, Hamilton-Bonaduz, Schweiz, 
Switzerland). The injected samples were mixed with the sub-phase with the help of a glass rod and 
kept for 10 min to evaporate the solvent. However, for experiments involving DNA, the DNA 
solution was placed as a sub-phase in the though, and allowed 30 minutes to equilibrate prior to 
adding surfactant systems. Then, the gemini surfactant-DOPE systems were injected in the subphase, 
mixed with a glass rod, allowed 15 min for equilibration. Finally, DPPC: cholesterol = 75%:25% (the 
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experimental concentration is 2.5 mM in which DPPC and cholesterol possess 1.875 mM and 0.625 
mM, respectively) model membrane was spread on the DNA subphase. This monolayer was allowed 
to equilibrate for another 15 minutes on the DNA sub-phase before the isotherms were collected. 
Finally, the barriers were compressed at a rate of 15 mm/min to obtain the isotherm. 
3.2.5. Brewster angle microscopy (BAM) 
The Langmuir balance described in section 3.2.4 is equipped with a Brewster angle 
microscope (BAM) (KSV Instruments, Helsinki, Finland) which was used to visualize the 
morphology of the studied monolayers at the air–water interface. A standard He-Ne laser was used as 
a light source with the power of 50 mW, wave length of 658 nm and the spatial resolution of the 
device was 2 µm. Briefly the p-polarized light at 658 nm wave number was reflected at the air/water 
interface at the Brewster angle (53.1°) to an embedded CCD camera. During the compression of the 
monolayer, the images were collected at least every 0.2 mN/m surface pressure changes; and the 
images were processed by the ‘ACCURION Image 1.1.2’ software. The software automatically pings 
the surface pressure and mean molecular area at which the images were collected; consequently 
BAM images were presented according to the surface pressure values in the current studies.  
3.2.6. Atomic Force Microscopy 
Atomic Force Microscopy (AFM) was used to determine the nanoscale structure of a selected 
subset of the monolayers. The monolayers were deposited onto a solid, atomically flat substrate. In 
the current experiment, the standard Langmuir-Blodgett deposition onto freshly cleaved mica slides 
was used. Briefly, 15 µL of gemini surfactants and/or gemini-DOPE (stock solution of 1 mg/mL in 
chloroform) was spread onto the subphase containing buffer pH 4 (with DNA if applicable) in a 
small (approximately 15cm x 7cm) Langmuir trough (KSV Nima). The solvent was allowed to 
evaporate for 10 minutes, afterwards, the monolayer were compressed to reach and maintained the 
target pressure (15, 25 or 35 mN/m). The mica substrate (slide) was drawn up through the monolayer 
at a speed of 10 mm/min. The finished samples were allowed to dry overnight in a desiccator before 
imaging. AFM images were obtained with an AIST-NT Smart SPM loaded with a MikroMasch 
HQ:NSC15//Pt-15 cantilever tip (resonant frequency approximately 325 kHz). Height and phase 
images were obtained in AC mode. 
 Additionally, the Kelvin probe force microscopy (KPFM) technique was used to obtain the 
images of the contact surface potential difference (CPD) (between the tip and sample) in amplitude 
modulation (AM) mode. In the KPFM technique, a bias voltage is applied to the sample, and an 
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additional AC voltage is applied to the tip to generate a vibrating capacitor system; the bias voltage is 
chosen to compensate for the signal arising from the electric surface potential, and thus the image of 
the CPD is obtained [204, 205]. The AFM and KPFM images were obtained in one step, with two 
sweeps per line (one for AFM, the second for KPFM). The AFM and KPFM data were processed 
with the program IAPro from AIST-NT, by first fitting each line to a horizontal polynomial of degree 
2 (quadratic), and polynomial levelling, if required, to achieve a flat image. Cross sections are 
obtained by first smoothing the image with a Gaussian filter ( = 1 pixel), for clarity. 
3.2.7. PM-IRRAS 
Polarization modulation Infrared reflection absorption spectroscopy (PM-IRRAS) is another 
technique used to determine the conformation, interaction and orientation of molecules in a 
Langmuir monolayer [120]. Dluhy and Conell (1985), obtained the first IRRAS spectra from fatty 
acids and phospholid Langmuir films [206, 207]. Blaudez et al (1993), reported the complete mid 
infrared monolayer spectra of deutorated arachidic acid on a water sub-phase using the polarization 
modulated IRRAS system [208]. There are several review articles published on this subject area that 
readers are referred to for more detailed information [209-212]. In the PM-IRRAS system, a 
goniometer holds two units, a spectrometer and polarization modulation unit in one arm and an 
MCT-detector on the other arm. Briefly, parallel (p)-polarized light or perpendicular (s)-polarized 
light passes through the monolayer formed on the Langmuir trough. These signals are processed by 
the detector unit and reflectance spectrum is observed [213]. The spectrometer and PM-unit are 
operated at different frequencies, thus, allowing separation of the two signals at the detector. 
Interference from water or CO2 is removed by the polarization modulation method.  
3.2.7 (a) Monolayer characterization by PM-IRRAS  
In the current study, the PM-IRRAS measurements were carried out on a KSV NIMA PM-
IRRAS instrument (KSV Instruments Ltd, Helsinki, Finland). The incident light angle beam was set 
at 76°. Initially, different buffer solutions (pH 4, 7 and 9) were spread on the medium Langmuir 
trough and the background spectrum was collected. The surfactant and DOPE mixture was prepared 
according to the procedure mentioned in section 3.2.4. Then, 12 µL of this chloroform solution was 
spread over the sub-phase (buffer pH = 4, 7, 9 with or without DNA) on the medium Langmuir 
trough to obtain an initial surface pressure of around 10 mN/m. For the PM-IRRAS measurements of 
the model membrane, after collecting the background spectrum of the buffer (pH 4, 7 and 9); 20 µL 
of the gemini surfactant/DOPE systems were injected in the subphase, mixed with a pipette, allowed 
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10 min for equilibration. However, for experiments involving DNA, the DNA solution was placed as 
a sub-phase in the trough, and allowed 5 minutes to equilibrate prior to adding surfactant systems. 
Finally, 12 µL of the DPPC: cholesterol = 75%:25% (the experimental concentration is 2.5 mM in 
which DPPC and cholesterol possess 1.875 mM and 0.625 mM, respectively) model membrane was 
spread on the DNA subphase. The monolayer was allowed to equilibrate for another 10 minutes on 
the DNA sub-phase.  
The monolayer was compressed (5 mm/min) to surface pressures of 30 mN/m, 35 mN/m and 
the maximum compression of the barrier; PM-IRRAS spectra were collected at each surface 
pressure. The spectra was collected in the range of 800-4000 cm-1 and the resolution was 8 cm-1. In a 
PM-IRRAS instrument, the polarization modulation unit modulates the signal reflected from the 
surface at 74 kHz between s- and p-polarization. The difference between the two polarizations 
provides the spectrum containing surface specific information, and the sum provides the reference 
spectrum [214].  
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Chapter IV 
 
Characterization of Gemini surfactant and DNA monolayers at the air/buffer 
interface using Brewster angle microscopy 
 
4.1. Analysis of the  - A isotherms 
The compressibility modulus (Cs-1) was calculated from the compression isotherm according 
to the equation:  
Cs-1 = −A(∂π/∂A)T Equation 4.1 
where, A is the molecular area at a given surface pressure, π. The molecular area at collapse (Ac) and 
collapse pressure (πc) were directly determined from the compression isotherms. According to Davis 
and Rideal [118, 215], the compressibility modulus is used to determine the phases of the monolayer; 
for instance, for the liquid-expanded phase (LE) Cs−1 = 12.5–50 mN/m, liquid phase (LE-LC) Cs−1 = 
50–100 mN/m, liquid-condensed (LC) Cs−1 = 100–250 mN/m and solid (S) for Cs−1 > 250 mN/m. The 
higher the Cs−1 values, the less elastic the monolayer is. Apart from this, several other parameters are 
determined directly from the isotherm. For instance, the liftoff area (AL) is the molecular area where 
the isotherm rising just emerges from the baseline, and provides useful insight about the molecular 
orientation at the onset of intermolecular contact in the gas –liquid phase region [216]. At the gas–
liquid transition phase, liftoff occurs at larger molecular areas until all the molecules are compressed 
into a liquid phase. Fahey and Small have suggested that the liftoff from the base line is best 
estimated by eye since it is not always possible to get a sharp break from the base line [216]. The 
limiting area or minimum cross sectional area (A∞) is obtained by extrapolating the isotherm at the 
steepest slope prior to collapse back to zero surface pressure. The smaller the value of limiting area, 
more closely packed the monolayer is [119, 216]. The collapse pressure (πc) is determined from the 
‘y’-axis value of the isotherm at which the maximum surface pressure occurs; and the corresponding 
‘x’-axis value represents the molecular area at the collapse of the monolayer (Ac). The higher the 
surface pressure value at collapse, more stable the monolayer is [113].  
4.2 Results and Discussion 
4.2.1 Compression isotherms of the pure component films 
The Langmuir monolayer studies of the pure gemini surfactants were carried out at pH 4, 7, 
and 9 buffers (Table 4.1, Figure 4.1). From Table 4.1 and Figure 4.1A, at pH 4 we see that 16-7-16 
possesses a higher initial surface pressure (~5 mN/m) and the isotherm started rising at a higher 
49 
 
 
molecular area (250 Å2). The monolayer underwent a gas (G) to liquid expanded (LE) phase 
transition in the region of ~5-23 mN/m surface pressure followed by a plateau in surface pressure at 
around ~23 mN/m. The exact reason for this expanded monolayer is not clearly understood; 
however, the intermolecular forces (hydrophobic interaction) between the alkyl tail groups of two 
adjacent 16-7-16 molecules may be responsible. The probable mechanism(s) will be discussed in the 
following sections. For 16-7-16, the isotherm shows an initial higher surface pressure of ~5 mN/m 
which indicates that the isotherm started rising at a higher molecular area (lift off area) compared to 
the base line. This further indicates that the interaction between two adjacent 16-7-16 molecules 
occurred right after the monolayer was spread on the subphase, even without starting the 
compression of the monolayer. At the gas phase, the molecules were lying flat on the air/buffer 
interface (see for example Figure 1.10 B(i)), and provided much larger area, and better hydrophobic 
interaction between alkyl tails of two adjacent 16-7-16 molecules. Chen et al. have shown that 18-s-
18, s = 6, 8, 10, 12 surfactant also showed higher lift off areas, attributed to the fact that these 
molecules were lying flat on the water surface compared to ones with smaller spacer length (s < 6) 
[119]. This is in agreement with results obtained for the 18-Ar-18 surfactant, which showed a liftoff 
area of approximately 245 Å2 at 25°C [217]. Due to the smaller spacer group, the steric hindrance 
between the two alkyl chains of gemini surfactants would affect their rotation around C-C bonds of 
the spacer. This phenomena disappears when the spacer length increases. Thus, if the spacer is made 
more rigid, there is a higher chance that the alkyl tail of the surfactant may remain slightly tilted as 
opposed to directly lying flat on the surface. This could result in a smaller liftoff area for such a 
surfactant, as the molecule would now occupy a smaller area on the surface [119]. This phenomena is 
schematically presented in the Appendix (Figure A4.1). At low pH, 16-7-16 possesses two positive 
charges, which may have strong interactions with the buffer subphase (water molecules and the 
acetate buffer components). Additionally, after compressing the monolayer, it reaches a saturation 
point (at a surface pressure ~23 mN/m) which is an indication of continuous micelle formation. More 
16-7-16 molecules are squeezed out from the monolayer to the buffer subphase, where they can form 
micelles. Thus, there was no further increase in the surface pressure, instead a plateau was observed. 
Interestingly, the CMC value of 16-7-16 is much smaller than 16-7NH-16, which favors micelle 
formation (16 ± 9 x 10-6 M vs 150 ± 50 x 10-6 M, respectively) [35]. Consistent with this explanation, 
Chen et al. reported for the 12-6-12 surfactant that there was no surface pressure increase at the 
air/water interface during the compression of the monolayer. This was attributed to the dissolution of 
the surfactant in the aqueous medium [125]. In our case, the observed plateau at pH 4 was absent at 
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higher pHs (7 or 9) indicating the importance of buffer components as well as the solubility on the 
monolayer behavior. Overall, the buffer component may play a crucial role in determining the trend 
(relatively condensed or expanded) of the isotherm at different pHs. A similar effect was observed 
for the 18-2-18 gemini surfactant on an aqueous subphase containing anions of the Hofmeister series 
or different divalent cations by Alejo et al [218]. Their study revealed that the presence of specific 
ions in the subphase may induce changes in the monolayer in the form of condensation or expansion. 
Further investigation is needed to properly understand the effect of buffer components on the nature 
of the isotherm of the 16-7-16 surfactant. It is important to mention that 16-7-16 monolayer mainly 
remained in the G-LE or LE phase. Several studies have demonstrated similar results in which the 
monolayer remains in the LE phase. For instance, both 18-3-18 [219] and 18-2-18 [218] showed only 
the LE phase before collapse at air/water interface, which implies that there was no appearance of 
phase condensation. 
 
Table 4.1: Monolayer properties for the 16-7-16 and 16-7NH-16 surfactants, and DOPE at pH 4, 7, 
and 9 at the air/buffer interface. 
System pH AL (Å2) Ac (Å2) A∞ (Å2)  πc (mN/m) Cs-1 
 *4 - 17 -  23.1 34.6 
16-7-16 7 111.6 35 66.4  36.5 57.7 
 9 - 32.4 183.6  31.7 51.7 
 4 218.8 35.7 74.1  39.4 47.5 
16-7NH-16 7 139.9 53.1 88.6  40.1 77.9 
 9 163 70.1 112.0  35.9 76.0 
 4 173 35.2 127  40.9 56.7 
DOPE 7 125.3 38.7 79.2  41.6 74.6 
 9 118 56.2 84.0  46.3 123.5 
Parameters obtained from the π-A isotherms are liftoff area, AL; molecular area at collapse, Ac; 
collapse pressure, πc; minimum cross sectional area or limiting area, A and maximum 
compressibility modulus, Cs-1.* At pH 4 the isotherm reaches a plateau after around 17 mN/m surface 
pressure, therefore, it was not possible to get AL, Ac, A∞ or π c values accurately.  
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Figure 4.1. Comparison of π -A isotherm (A, C, and E) and compressibility modulus as a function of 
surface pressure (B, D, and F) for the gemini surfactant monolayers at pH 4 (A, B), pH 7 (C, D) and 
pH 9 (E, F) at 25°C. 
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On the other hand, 16-7NH-16 undergoes a gas to liquid expanded phase transition at a 
molecular area of ~218.8 Å2 (Table 1 and Figure 4.1A). While further compressing the monolayer, 
16-7NH-16 showed several phase transitions and reaches a maximum surface pressure of ~40 mN/m. 
We believe that 16-7NH-16 is protonated at pH 4, and contains three positive charges. This likely 
results in increased rigidity in the surfactant and forces the monolayer to adopt higher order phases 
i.e (LE, LC, etc.) reaching a surface pressure of 40 mN/m at collapse. Detailed explanation of this 
isotherm is mentioned in the following paragraph with compressibility modulus analysis.  
As mentioned earlier the G and LE phases correspond to the Cs-1 = ≤12.5, and 12.5-50 mN/m, 
respectively. As is observed from Figure 4.1B and 4.2A at pH 4, the 16-7-16 undergoes transition 
from a G to LE phase at around ~5-12 mN/m. Before the plateau of the isotherm, the monolayer 
reaches a LE phase (region A, Figure 4.2A). Then the monolayer returns to the gas phase and 
remains in gas phase until the maximum compression (region B, Figure 4.2A). Thus, 16-7-16 
remains in G or G-LE phase. In contrast, from Figure 4.1B, it is observed that 16-7NH-16 exhibited 
distinct phase changes at various mean molecular area as well as surface pressure. To illustrate these 
phase changes more clearly, we can plot both compressibility modulus and surface pressure as a 
function of mean molecular area (Figure 4.2B), allowing a direct comparison between the two plots. 
We can divide the plot into 3 distinct regions, corresponding to different phases and phase transitions 
within the monolayer. In region A, the monolayer undergoes a G to LE phase with a maximum Cs-1 
value of 36 mN/m at surface pressure around ~13 mN/m and molecular area of 131 Å2. Afterwards, 
the compressibility modulus plot shows two distinct phase transition regions. For instance, at region 
B and region C shows the presence of LE→G and G→LE phase transitions, respectively. 
Additionally, comparing the 16-7-16 with 16-7NH-16 at pH 4 (in both Figures 4.1B and 4.2), both 
surfactants show similar phase transition up to the surface pressure of ~21 mN/m. Afterwards, the Cs-
1 values for 16-7NH-16 increases with the increase in surface pressure and reaches a maximum 
surface pressure of 39.4 mN/m. However, 16-7-16 did not show this change in the surface pressure in 
the isotherm rather formed a plateau (Figure 4.1A and B). This result is consistent with the 
previously published results of 18-2-18 [218]. Overall, the results from the Figure 4.2 reveal that we 
cannot identify the phases accurately by relying only on the surface pressure isotherm. Based on a 
more detailed analysis of the compressibility modulus, it is apparent that there are alternative 
assignments of phases and transitions. 
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Figure 4.2. Surface pressure and compressibility modulus plotted as a function of mean molecular 
area of 16-7-16 (A) and 16-7NH-16 (B) monolayers at pH 4. The blue continuous line represents 
surface pressures and black line represent values of the compressibility modulus of both surfactants, 
respectively. The three regions of phase changes are indicated with A, B and C. 
Precisely, from the Figure 4.2B it is observed that while compressing the 16-7NH-16 
monolayer, it reaches a first maximum value of compressibility modulus (36 mN/m), and drops to a 
lower value afterwards (5 mN/m). This drop could be influenced by the negatively charged acetate 
(buffer component) which may have incorporated in between the 16-7NH-16 molecules to minimize 
the electrostatic repulsions (the phenomenon is schematically presented in the Appendix Figure 
A4.2). Until, a saturation point reaches between the charge neutralization by buffer component, the 
monolayer continues to change from LE → G phase, seen in region B of Figure 4.2B. At this point, a 
minimum in the compressibility modulus plot is observed. Due to the reduced repulsive forces 
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brought about by neutralization of the head group charge by the presence of the acetate ions 
(CH3COO-) the 16-7NH-16 molecules are able to come closer to one another. This gives rise to the 
further increase in surface pressure and compressibility modulus shown in region C of Figure 4.2B. 
While this explanation can explain the features observed in the isotherm for 16-7NH-16 at pH 4, it is 
possible that the neutralization of head group charge is not complete. As such there is sufficient 
repulsion to keep the 16-7NH-16 monolayer from entering more compressed states, such as the LC 
or S phases. The same phenomena would not occur at higher pH values, or for the 16-7-16 surfactant, 
where the possibility of a third positive charge in the head group is not possible. Additionally, higher 
aqueous solubility of the 16-7-16 over 16-7NH-16 may also play a vital role in determining the 
isotherm behavior of the monolayers.  
As can be seen from Table 4.1 and Figure 4.1C, 16-7-16 has a small liftoff area of ~ 111 Å2 
at pH 7, and an area at collapse (Ac) of 35 Å2 at a collapse pressure of 36.5 mN/m. The monolayer 
undergoes G to LE phase transition at ~5 mN/m and remains in the LE phase until undergoing an 
LE-LC phase transition prior to collapse. The minimum cross sectional area (A∞) is approximately 
66.4 Å2. This signifies a relatively condensed monolayer prior to collapse as compared to 183.6 Å2, 
at pH 9. A∞ is obtained by extrapolating the isotherm at the steepest slope prior to collapse back to 
zero surface pressure. This provides the cross sectional area of a hydrocarbon chain regardless of 
whether or not the compressed monolayer consists of close-packed vertically orientated chains. The 
smaller the value, the more closely packed the monolayer is [119]. At pH 9, the isotherm started 
rising at high molecular area, and then underwent a G to LE phase transition and remained mostly in 
the LE phase. At pH 9, the monolayer is more expanded than at pH 7. Several researchers have also 
reported similar expanded isotherms for the 18-s-18, s = 3,4,6,8,10,12 [54, 119]; 12-s-12, s = 
3,4,6,8,10,12 [125]; 18-Ar-18 [217], gemini amphiphilic pseudopeptides [104], pH sensitive gemini 
amphiphiles of N,N0-dialkyl-N,N0-di(ethyl-phthalimide) ethylenediamines (Di-CnPh, n = 6, 8, 10, 
12) [220], fluorinated gemini surfactants at different subphase pHs [116], and 18-2-18 with ions 
present in subphase [218]. Once again the buffer component (Na2HPO4) might have played a role in 
the relatively condensed monolayer at pH 7. Charge neutralization of the 16-7-16 molecules might 
have occurred which would have helped more molecules come closer together as a result of reduced 
repulsion. On top of that, the additional Na+ ions present in the buffer subphase may induce 
repulsions between the N+ atoms of the head group of the surfactant. Thus, 16-7-16 molecules 
remained at the air/buffer interface at pH 7 rather than undergoing rapid micellization (as observed at 
pH 4). Additionally, at pH 7 the maximum surface pressure of 36.5 mN/m is significantly higher than 
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the values at pH 4 or 9, indicative of the stable monolayer formation. On the other hand, the 16-7NH-
16 formed relatively condensed monolayers at both pH 7 and 9. At pH 7, the monolayer started rising 
at lower molecular area (139.9 Å2) and reached a maximum surface pressure of 40.1 mN/m. The A∞ 
for this isotherm is 88.6 Å2, which is significantly smaller than at pH 9 (112 Å2). The monolayer 
mostly remained at the LE-LC coexisting phase at pH 7 and 9. However, at pH 7, the monolayer is 
more condensed than at pH 9. 
Monolayers having high values of surface pressure are generally observed to be more stable 
than those having low surface pressure [104, 113]. Overall, the surface pressure values obtained at 
collapse for the 16-7-16 follows the trend: pH7 > pH 9 > pH 4. Thus, the most stable monolayer was 
formed at pH 7 with a surface pressure of 36.5 mN/m. On the other hand, 16-7NH-16 follows the 
trend pH 7 ≥ pH 4 > pH 9, where both pH 4 and 7 produces the more stable monolayer with a surface 
pressure ~40 mN/m. At pH 4, the 16-7NH-16 underwent several phase changes which did not occur 
at other pHs. The exact reason for this is not clear; however, it can be hypothesized that at low pH, 
16-7NH-16 becomes protonated, having 3 positive charges in the head-group, creating more 
electrostatic repulsion between the head groups of the 16-7NH-16 molecules at the air/buffer 
interface. Such an argument further supports that at pH 4, 16-7NH-16 forms a liquid expanded phase, 
and the rigidity of the monolayer is lower than that of pH 7 and 9.  
While comparing the Cs-1 at pH 7, 16-7-16 remains mainly at LE phase (Figure 4.1D). To 
better understand the results we have presented the compressibility modulus as a function of the 
mean molecular area in Appendix Figure A4.3(a). However, before the collapse pressure the 
monolayer showed the LE-LC coexisting phase (at the surface pressure of ~29-34 mN/m). The 
maximum Cs-1 values for this surfactant at pH 7 is 57.7 mN/m (Table 4.1). This value is slightly 
higher than the values of indicative LE phase (12.5-50 mN/m) [118, 215]. This implies that even at 
higher pH, 16-7-16 still remains at expanded state with less compaction of the monolayer. On the 
other hand, 16-7NH-16 showed LE phase at ~2-15 mN/m (Figure 4.1D, Appendix Figure A4.3(a)). 
And after this surface pressure, the monolayer remains in the LE-LC coexistence phase with the Cs-1 
values ranges from 50-77.9 mN/m. The higher compressibility modulus values for 16-7NH-16 
compared to 16-7-16 signifies that 16-7NH-16 forms a more rigid, and compacted monolayer. At pH 
7 the 16-7NH-16 molecule possesses two positive charges compared to three positive charges at pH 
4. Thus, the net repulsion between two adjacent 16-7NH-16 molecules reduced and allows for more 
molecules to come closer and form a relatively rigid monolayer.  
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At pH 9, the maximum Cs-1 was observed to be 51 mN/m at a surface pressure of 16 mN/m 
for 16-7-16 (Figure 4.1F and Appendix Figure A4.3(b)). As for pH 7, the 16-7-16 monolayer only 
appears to reach the LE phase, with no significant transition to more compressed phases. Above a 
surface pressure of ~16 mN/m the compressibility modulus drops until collapse of the monolayer, 
which signifies that monolayer undergoes LE-LC→LE phase transition and remained at the LE phase 
(Appendix Figure A4.3(b)). Thus, 16-7-16 showed a steady LE phase throughout the compression of 
the monolayer. In comparison, 16-7NH-16 showed LE-LC coexisting phase transition at the surface 
pressure ranging from 14 mN/m toward collapse (Figure 4.1F and Appendix Figure A4.3(b)). Cs-1 
values are similar at pH 7 and 9. Thus, the presence of two positive charge at 16-7NH-16 exhibits 
less repulsion forces between two 16-7NH-16 molecules, and formed more condensed monolayer 
compared with the values at pH 4 (protonation). Overall, the Cs-1 for 16-7NH-16 follows the trend pH 
7 ≥ pH9 > pH4.  
4.2.2. Minimum cross sectional area or limiting area of the pure system  
As mentioned earlier, the smaller the value of limiting area, more closely packed the 
monolayer is [119]. It is observed from our studies that the 16-7NH-16 monolayer mostly remains in 
LE or LE-LC phase, and the limiting area is high in all cases. This signifies that most of the 
molecules are not oriented vertically to the subphase, rather tilted towards the subphase, giving rise 
to the higher values of mean molecular area. Similar phenomena is also observed for 16-7-16 
monolayers. The head group area (a0) for the 16-7-16 and 16-7NH-16 are 8.9 and 13.3 Å2, 
respectively, and the alkyl tail length (l) is calculated at around 21.74 Å2 for these surfactants [200]. 
Therefore, if the surfactant molecules remain perfectly vertical to the subphase, one could expect that 
the molecular size of the experimental 16-7-16 or 16-7NH-16 to be less than 30 Å2. Moreover, if the 
monolayer is in a true LC or solid phase, the limiting area would also be near that value. Therefore, 
our compressibility modulus results (Figure 4.1B, D and F) correlates with the mean molecular area 
results. Similar results were observed for 18-2-18 series with a limiting area of 124 Å2 in air/water 
interface [218]. With the 18-s-18 surfactants, increasing the spacer length from 18-3-18 to 18-10-18 
increased the liming area from 128 Å2 to 236 Å2, respectively in air/water interface [54]. It was 
further reported that presence of DNA in the subphase substantially changed the limiting area. This 
was attributed to the expansion or contraction of the isotherm depending on the length of the spacer. 
Overall, their study suggests that there was complex monolayer formation between the gemini 
surfactant and the DNA on subphase which will be further discussed in later section.  
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4.2.3. Isotherm of the pure DOPE  
From Figure 4.3A it can be seen that, similar to the gemini surfactants discussed in the 
previous section, pure DOPE also exhibits pH dependent monolayer formation. The liftoff area 
(Table 4.1) was much higher at pH 4 than at pH 7 or 9. At pH 4, the monolayer reaches a maximum 
surface pressure of ~40.9 mN/m with large minimum cross sectional area of ~127 Å2 (Table 4.1). 
This signifies that the monolayer is relatively expanded than with the higher pHs. At pH 7, the 
maximum surface pressure of the monolayer is similar with pH 4. However, the minimum cross 
sectional area was ~79.2 Å2. This signifies that DOPE forms a more condensed monolayer at pH 7. 
At pH 9, the monolayer reaches a maximum surface pressure of ~46.3 mN/m, which is relatively 
higher than pH 4 and 7. The minimum cross sectional area for this monolayer is ~84 Å2, which is 
comparable with pH 7. 
 
 
 
 
 
 
 
 
Figure 4.3. Comparison of π-A isotherm (A) and compressibility modulus as a function of surface 
pressure (B) of pure DOPE monolayers at different pHs at buffers at 25°C. 
From the compressibility modulus results for DOPE (Figure 4.3B), at pH 4 we observe a G-
LE phase transition at a surface pressure between ~1 to 5 mN/m, followed by an LE-LC coexistence 
phase, can be inferred at the maximum of the peak in Cs-1 (i.e. an approximately constant 
compressibility modulus), at surface pressures of ~19 – 23 mN/m, followed by a return to the LE 
phase. At pH 7, no decrease in compressibility modulus is observed, and the DOPE monolayer 
remains in the LE phase, evidenced by the maximum Cs-1 value of ~74.6 mN/m. Interestingly, at pH 
9, the monolayer undergoes a sharp G to LE phase in the range of ~0-10 mN/m surface pressure 
followed by a transition from LE → LE-LC phase up to a surface pressure of ~27 mN/m. At higher 
surface pressures this monolayer reaches a LC phase with a maximum Cs-1 values of 123.5 mN/m. 
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Based on the compressibility modulus values, the overall rigidity of the monolayer was governed at 
the following trend pH 4 < pH 7 < pH 9 with monolayers found in the LE phase, the LE-LC phase, or 
the LC phase, respectively. 
From the chemical structure (chapter I, Figure 1.26), it is evident that DOPE is a neutral, 
zwitterionic phospholipid with an amphiphilic character [221]. Therefore, at different pHs it can 
participate in equilibrium reactions with both hydrogen ions and hydroxyl anions. As a result of 
adsorption of H+ and OH- ions on the surface of DOPE layer, the DOPE molecule can exist in three 
different forms:  
DOPE + H+ ↔ DOPE-H+ 
DOPE + OH- ↔DOPE-OH- 
DOPE + HOH ↔ DOPE-HOH 
A similar mechanism was reported for the phosphatidylethanolamine monolayer at air/water 
interface [222]. Thus, in our case, at pH 4, DOPE can have an additional positive charge on the 
amine group, resulting in increased electrostatic repulsions and expanded monolayer formation. At 
pH 7 this charge would not be present, allowing for formation of a less expanded monolayer, in our 
case, one likely in an LE-LC coexistence phase.  
The exact reason for the condensed monolayer formation at pH 9 is not clear. However, we 
hypothesized that at pH 9, DOPE may possess a negative charge. Additionally, we have used 
NaHCO3 as buffer component to prepare the pH 9 buffer. Apart from the production of OH- anions, 
the buffer also contains a large amount of Na+ ions. If DOPE is negatively charged at pH 9 due to the 
adsorption of the OH- ions, it is possible that the Na+ ions are adsorbed at the monolayer. This 
combined effect of cations and anions present in the sub-phase may have reduced the overall 
repulsion forces allowing DOPE molecules to come closer together. The exact extent of the effect of 
buffer species on the formation of DOPE monolayers is unknown. Further studies are required to 
understand this effect by varying the buffer components (using different anions and cations). In 
support of this argument, Alejo et al have previously reported that the 18-2-18 gemini surfactant 
showed condensed monolayer as the anions of the buffer subphase compensated the electric charges 
of the surfactant adsorbed at the air-water interface [218]. Additionally, the size of the divalent 
cations impacted the overall monolayer trend. As the size of the divalent cations increased from Mg2+ 
< Ca2+ < Sr2+ < Ba2+, a more condensed monolayer was formed. Their results further indicate the 
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importance of cations on the subphase with respect to changes in monolayer phase behavior. 
Additionally, Xu et al. have reported the importance of cations on the structural behavior of 
molecules at the air/water interface [223, 224]. Overall, these studies signifies that buffer 
components have substantial impact on the monolayer phase behavior.  
In general, the effect of pH on the conformation changes of DOPE is well known. 
Interestingly, our experimental results also shows that at lower pH values of Cs-1 values are relatively 
small indicating more fluidic monolayer. Moreover, DOPE has similar collapse pressures (πc) at pH 4 
and 7, with a higher value at pH 9. This suggests DOPE forms a more stable monolayer at pH 9 and 
relatively less stable monolayers at lower pHs. 
4.2.4. Brewster Angle Microscopy (BAM) of the pure components 
BAM is an effective technique to determine the surface structure of monolayers spread on an 
aqueous subphase at various surface pressures. BAM images at various surface pressures and pH 
values are shown in Figure 4.4 for the 16-7-16 surfactant; additional images can be found in 
Appendix Figure A4.4, 4.5 and 4.6. In Figure 4.4, it can be seen that at all surface pressures and pHs, 
no significant domain formation occurred for the 16-7-16 surfactant. It has previously been reported 
that these types of images, combined with the Langmuir isotherms obtained for 16-7-16, are 
indicative of the LE or G-LE phase (dark images) [220, 225]. Similar BAM images were obtained for 
the 18-2-18 surfactant in the G or G-LE phase [218]. Images obtained for 16-7NH-16, again at 
representative surface pressures at each pH, show evidence of much more interesting phase 
behaviour (Figures 4.5 and 4.6; additional images found in Appendix Figure A4.7, 4.8 and 4.9). At 
pH 4 the images are again generally featureless and dark, consistent with the G-LE or LE phase 
[220]. In some images very bright, large spots can be observed; these types of features are typically 
associated with dust particles and are not representative of any specific domain formation. 
Interestingly, at pH 4, no evidence of the higher order phase transitions seen in the surface pressure 
isotherm (Figure 4.1B) are detected using BAM. Thus, the BAM images at pH 4 is consistent with 
the compressibility modulus values presented in Figure 4.1B and Figure 4.2a (presence of LE or G-
LE phases).  
At higher pHs and higher surface pressures, i.e. ≥ 35 mN/m at pH 7 and ≥ 40 mN/m at pH 9, 
significant and heterogeneous domains are observed for 16-7NH-16 (Figure 4.6) as evidenced by the 
bright ribbon and dot-like or island features observed in the BAM images. These bright domains are 
consistent with more ordered structures (possessing a greater difference in refractive index as 
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compared to water), and are consistent with the higher compressibility modulus values obtained for 
16-7NH-16 (Figure 4.1 and Table 4.1). From these results, we conclude that the 16-7NH-16 
surfactant, at higher pH values, is forming more organized monolayers, likely the LE-LC coexistence 
or LC phases. 
Finally, images for pure DOPE monolayers at pH 4, 7 and 9 are shown in Figure 4.7 
(additional images found in Appendix Figure A4.10, 4.11 and 4.12). At very low surface pressures 
(0.11-2 mN/m), at all pH values, small bright domains consistent with a mixed G – LE phase can be 
observed. Given that DOPE has very limited solubility in water, and does not form micelles, but 
rather vesicles (with some energy input), the DOPE molecules have no other means of minimizing 
unfavourable solvation energies, other than film formation. As such, domains are observed at these 
low surface pressures. This is in contrast to the case for the surfactants, where some of the observed 
dark images may be due not only to a very heterogeneous G-LE phase, but also to a depletion of the 
monolayer by micelle formation occurring in the bulk. As the DOPE film is further compressed 
additional domain formation can be observed, consistent with the formation of LE and/or LC phases, 
as observed from the compressibility modulus results (Figure 4.3B).  
 
 
Figure 4.4. BAM image of 16-7-16 in different pHs at selected surface pressures. 
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Figure 4.5. BAM image of 16-7NH-16 in different pHs at selected surface pressures.
  
Figure 4.6. BAM image of 16-7NH-16 in pH 7 and 9 at selected surface pressures. 
 
Figure 4.7. BAM image of DOPE in different pHs at selected surface pressures. 
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4.2.5. Gemini Surfactant/DOPE mixed monolayers 
Studies have shown that the presence of the helper lipid DOPE may increase the transfection 
efficiency of gemini based lipoplexes by approximately 10 fold [35] . This is attributed to the fact 
that the addition of pure DOPE causes formation of mixed aggregates with higher (greater than unity) 
packing parameter; shifting micelle systems towards vesicles, and vesicle systems toward the 
inverted hexagonal or even cubic phases [35]. In addition, DOPE is thought to increase the fluidity of 
cellular membranes and thus facilitates the penetration of genetic materials into the cell. Furthermore, 
DOPE has been reported to help in disruption of the endosomal membrane, again by increasing 
membrane fluidity, at the endosomal escape phase leading to increased transfection efficiency [226-
231].  
 
Table 4.2: Monolayer properties for the mixed gemini surfactant/DOPE monolayers, at pH 4, 7, and 
9 at 25°C at the air/water interface. 
 pH AL (Å2) Ac (Å2) A∞ (Å2) π c (mN/m) Cs-1 
 4 156 39.8 128 41.3 59.6 
16-7-16/DOPE 7 136.7 57 92 42.5 101 
 9 147 61.8 100 42.1 90.7 
 4 123.5 45.6 96 43.5 74.9 
16-7NH-16/DOPE 7 116.7 55.4 88 45.3 109.1 
 9 117.2 56 88 43.7 101.9 
 4 120.4 33 76 40 65.0 
DOPE/DNA 7 146.8 54 104 41.1 71.0 
 9 127.9 55.6 89 42 93.3 
 4 173 35.2 127 40.9 56.7 
DOPE 7 125.3 38.7 79.2 41.6 74.6 
 9 118 56.2 84.0 46.3 123.5 
Parameters obtained from the π-A isotherms are liftoff area, AL; molecular area at collapse, Ac, 
collapse pressure, πc, minimum cross sectional area or limiting area, A and maximum 
compressibility modulus, Cs-1. 
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Figure 4.8. π -A isotherms (A, C, and E) and compressibility modulus as a function of surface 
pressure (B, D, and F) for the mixed gemini surfactant/DOPE monolayers at pH 4 (A, B); pH 7 (C, 
D); and pH 9 (E, F) at 25°C. 
 
 
Surface Pressure (mN/m)
0 5 10 15 20 25 30 35 40 45 50
C
o
m
p
r
e
ss
ib
il
it
y
 m
o
d
u
lu
s 
(m
N
/m
)
0
20
40
60
80
100
120 16-7NH-16/DOPE, pH9
16-7-16/DOPE, pH9
DOPE, pH9
Surface Pressure (mN/m)
0 5 10 15 20 25 30 35 40 45 50
C
o
m
p
r
e
ss
ib
il
it
y
 m
o
d
u
lu
s 
(m
N
/m
)
0
20
40
60
80
100
16-7NH-16/DOPE, pH7
16-7-16/DOPE, pH7
DOPE, pH7
Area per molecules (Å
2
)
0 25 50 75 100 125 150 175 200 225 250
S
u
r
fa
c
e
 p
r
e
ss
u
r
e
 (
m
N
/m
)
0
5
10
15
20
25
30
35
40
45
50
16-7NH-16/DOPE pH=9
16-7-16/DOPE pH=9
DOPE
Area per molecules (Å
2
)
0 25 50 75 100 125 150 175 200 225 250
S
u
r
fa
c
e
 p
r
e
ss
u
r
e
 (
m
N
/m
)
0
5
10
15
20
25
30
35
40
45
50
16-7NH-16/DOPE pH=7
16-7-16/DOPE pH=7
DOPE
Area per molecules (Å
2
)
0 25 50 75 100 125 150 175 200 225 250
S
u
r
fa
c
e
 p
r
e
ss
u
r
e
 (
m
N
/m
)
0
5
10
15
20
25
30
35
40
45
50
16-7NH-16/DOPE pH=4
16-7-16/DOPE pH=4
DOPE pH=4
Surface Pressure (mN/m)
0 5 10 15 20 25 30 35 40 45 50
C
o
m
p
r
e
ss
ib
il
it
y
 m
o
d
u
lu
s 
( m
N
/m
)
0
10
20
30
40
50
60
70
80
16-7NH-16/DOPE, pH4
16-7-16/DOPE, pH4
DOPE, pH4
A 
C 
B 
E F 
D 
64 
 
 
Figure 4.8 shows the isotherms and compressibility moduli for the mixed gemini 
surfactant/DOPE monolayers. In all cases, very different behaviour is observed as compared to the 
gemini surfactant monolayers alone (described in the previous section), with the isotherms now 
looking very similar to those obtained for pure DOPE. It would appear, at first glance, that the 
monolayer structure is being defined by DOPE and not the gemini surfactant. At pH 4, the lift off 
area and collapse pressure for the 16-7-16/DOPE are approximately 156 Å2 and 41.3 mN/n which are 
comparable to values for pure DOPE; 173 Å2 and 40.9 mN/m. The observed isotherm and the Cs-1 
plots reveal that the mixed monolayer undergoes similar G-LE →LE→LE-LC phase transitions that 
are seen for pure DOPE at pH 4. This indicates that there is in fact no substantial interaction between 
DOPE and 16-7-16 at pH 4. This is consistent with previous work in our lab, where an analysis of 
mixed aggregate formation between gemini surfactants and DOPE demonstrated that they interact 
antagonistically, i.e. the molecules prefer to form pure surfactant and pure lipid aggregates, rather 
than mixed aggregates [200]. The 16-7NH-16 surfactant appears to have somewhat more of an effect 
on the DOPE monolayer, at pH 4, with a smaller lift off area (123.5 Å2) and a higher collapse 
pressure (43.5 mN/m) that for the pure DOPE monolayer. Both the isotherm and the compressibility 
modulus show subtle changes that signifies that 16-7NH-16/DOPE forms a more condensed 
monolayer than 16-7-16/DOPE system at pH 4. At pH 7 and 9, the similarities between the mixed 
monolayers, and the pure DOPE monolayer are even more pronounced, with the 16-7-16/DOPE 
isotherm and compressibility modulus plots nearly overlapping those for the pure DOPE system 
(Figures 4.8 C, D, E, and F). For both mixed surfactant/DOPE monolayers, the isotherms and 
compressibility moduli suggest the systems remain mostly within the LE, LE-LC, or LC phases, 
depending upon pH and surface pressure.  
The BAM images for the 16-7-16/DOPE system show homogeneous film formation at pH 4 
without any substantial domain formation at higher surface pressure (Figure 4.9, additional images 
are in Appendix Figure A4.13). Similar BAM images was observed for the 16-7NH-16/DOPE 
system at pH 4 (Figure 4.9, additional images are in Appendix Figure A4.14). In general, the BAM 
images at pH 4 are indicative of LE or LE-LC phase transition. 16-7-16/DOPE at pH 7 and 9, 
showed similar BAM images (Figure 4.10 and 4.11, Appendix Figure A4.15 and A4.17). At higher 
surface pressure the monolayer showed some small domains. On the other hand, 16-7NH-16/DOPE 
showed some interesting domains at higher surface pressure (Figure 4.10 and Appendix Figure 
A4.16) at pH 7. If we compare the pure DOPE BAM images (Figure 4.7) and this mixed system, it is 
apparent that both of them showed bright domains at higher surface pressure in pH 7. Thus, domains 
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might be formed from the DOPE system. At pH 9, 16-7NH-16/DOPE showed initial network like 
domains at the G-LE phase, which was merged together and formed homogeneous film until collapse 
(Figure 4.11 and Appendix Figure A4.18).  
 
Figure 4.9. BAM image of 16-7-16 and 16-7NH-16/DOPE at pH 4 at selected surface pressures. 
 
 
Figure 4.10. BAM image of 16-7-16 and 16-7NH-16/DOPE at pH 7 at selected surface pressures. 
 
Figure 4.11. BAM image of 16-7-16 and 16-7NH-16/DOPE in pH 9 at selected surface pressures. 
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4.2.6. Gemini surfactant/DNA mixed monolayers 
The π -A isotherms and compressibility modulus plots for the mixed gemini surfactant/DNA 
monolayers indicate that DNA has a pronounced effect on the nature of monolayer, with distinct 
differences again observed as a function of pH. At pH 4, it is observed that 16-7-16/DNA monolayer 
has a non-zero initial surface pressure (similar to what was observed for the pure 16-7-16 monolayer, 
Figure 4.1A) and reaches a maximum value of around 36.6 mN/m. The monolayer undergoes a G to 
LE phase transition in the surface pressure range of ~2-21 mN/m at which point the behaviour 
becomes quite different from that for the pure 16-7-16 isotherm. At a surface pressure of ~ 25 mN/m, 
a distinct plateau is observed over a molecular area range of ~118 to 52 Å2 (Figure 4.12 A). From 
compressibility modulus (Figure 4.12 B) this corresponds to a sudden drop in Cs-1. This sudden drop 
might be explained based on the equation 4.1. (compressibility modulus); which signifies that if there 
is no changes in surface pressure the compressibility modulus values becomes zero. Noteworthy, the 
compressibility modulus value may be misleading at the plateau region and the results are artifact 
obtained from the equation. At this stage only change one can expect is the mean molecular area. 
Thus, to explain the plateau we have to assign the mean molecular area as a determining factor of 
monolayer behavior without any substantial changes in the surface pressure. Since the mean 
molecular area at this plateau decreased from 118 to 52 Å2, this indicates much compacted 
monolayer formation at this range. Thus we hypothesized that the plateau is LE-LC coexisting phase. 
With the exception of minor differences in the surface pressure associated with the transitions, the 
same behaviour is observed for the 16-7NH-16/DNA monolayer, and a key difference in that the 16-
7NH-16/DNA monolayer does enter an LE-LC phase with the compressibility modulus value of ~64 
mN/m before collapse (Table 4.3). 
Unsurprisingly, we believe that the observed plateau is likely due to the strong electrostatic 
interactions between the positive charge of the nitrogen atoms of the gemini surfactant and the 
negative charge of the phosphate groups of the DNA molecules. We hypothesized that in the plateau 
region, the DNA molecules are adsorbed at the positively charged gemini monolayer due to the 
electrostatic interaction. Further compressing the monolayer, the gemini molecules come closer and 
provides increased interaction with the DNA molecules. However, the adsorption of DNA reaches a 
saturation point, beyond which no more interaction is possible. This could be induced by the 
mechanical forces of the barrier which surpasses the electrostatic interaction between gemini and 
DNA; consequently, the isotherm started rising to reach to the collapse. Similar results were 
observed for the 16-3-16 system at air/water interface (data not shown). Interestingly, no plateaus are 
67 
 
 
observed at pH 7 for either the 16-7-16/DNA or 16-7NH-16/DNA monolayers, and they appear to 
transition smoothly from the gas phase (G) through the LE phase to remain at the LE or possibly LE-
LC phase with a maximum compressibility modulus value of around 65.4 and 75.5 mN/m (Table 
4.3), respectively (Figure 4.12C and D). The BAM images obtained for both the 16-7-16/DNA and 
16-7NH-16/DNA at pH 4 are again consistent with the system remaining in a G – LE transition state 
(Figure 4.13), while those at pH 7 are show the more highly ordered domains indicated by the 
isotherm and compressibility modulus data. 
At pH 9, the 16-7-16/DNA system appears to undergo multiple, small, phase transitions 
between ~20 mN/m to 33 mN/m surface pressure (Figure 4.12 E and F). The monolayer mainly 
remains in a G – LE or LE phase at these surface pressures. While the BAM images (Figure 4.15) are 
consistent with this, they unfortunately offer no insight into the multiple, weak, transitions seen in 
both the isotherm and compressibility plots. The 16-7NH-16/DNA monolayer appears to have a 
phase behaviour very similar to what was observed at pH 4 (comparing Figure 4.12 A and B with E 
and F), again possibly reaching an LE–LC coexistence phase. With the 18-s-18 surfactants, 
increasing the spacer length from 18-3-18 to 18-10-18 increased the limiting area from 12.8 Å2 to 3.6 
Å2, respectively in air/water interface [54]. It was further reported that presence of DNA in the 
subphase substantially changed the limiting area. This was attributed to the expansion or contraction 
of the isotherm depending on the length of the spacer. Overall, their study suggests that there was a 
complex monolayer formation with the gemini surfactant and the DNA on subphase which will be 
further discussed in later section. Additionally, Chen et al. shows the expansion of the gemini 
monolayer upon addition of DNA [125]. Relatively, expanded monolayer was also reported for the 
ester polar head group containing fluorinated gemini surfactant than the carboxylic acid head group 
containing gemini surfactant in presence of DNA on the subphase [116]. As can be seen from Figure 
4.13 (additional images are provided in Appendix Figure A4.19 and A4.20), BAM images illustrates 
the presence of LE phase transition for the 16-7-16/DNA system in pH 4 which is consistent with the 
observed isotherm and compressibility modulus results (Figure 4.12A and B). Similar BAM images 
are observed for the 16-7NH-16/DNA monolayer at pH 4 (Figure 4.13). From Figure 4.14 (additional 
images are presented in Appendix Figure A4.21 and A4.22), it can be seen for the 16-7-16/DNA 
system that at higher surface pressure around > 25 mN/m, the smaller domains increased in size and 
brightness are observed which is an indication of the LE-LC phase. In the same pH, 16-7NH-
16/DNA system also formed homogeneous film with the presence of LE-LC phase at higher surface 
pressure (Figure 4.14). Likewise, the presence of LE phase is observed for the 16-7-16/DNA 
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monolayer at pH 9 (Figure 4.15, additional images are in Appendix Figure A4.23 and A4.24). For the 
16-7NH-16/DNA system a homogenous film with LE-LC phase was observed at higher surface 
pressure at pH 9 (Figure 4.15). Overall the BAM images are consistent with the observed isotherm 
and compressibility modulus results (Figure 4.12).  
 
 
Figure 4.12. π-A isotherms (A, C and E) and compressibility modulus as a function of surface 
pressure (B, D, and F) for the mixed gemini surfactant/DNA monolayers at pH 4 (A, B); pH 7 (C, D); 
and pH 9 (E, F) at 25°C. The red dashed line in B, D and F indicates the region of LE phase.  
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Table 4.3: Monolayer properties for the mixed gemini surfactant/DNA monolayers at various pHs. 
System pH AL (Å2) Ac (Å2) A∞ (Å2) π c (mN/m) Cs-1 
 4 - 35.2 79.8 36.6 49.5 
16-7-16+DNA 7 112.9 47.7 77.9 32.1 65.4 
 9 - 32.2 94.6 35.8 46.5 
 4 171.3 34.1 66.6 48.4 64.2 
16-7NH-16+DNA 7 193.4 84.9 130.3 32.9 75.5 
 9 201.6 30.8 77.2 46.8 67.2 
 4 120.4 33 76 40 65.0 
DOPE+DNA 7 146.8 54 104 41.1 71.0 
 9 127.9 55.6 89 42 93.3 
 4 170.4 62.4 96 31.5 78.1 
16-7-16+DOPE+DNA 7 142.8 51.9 86 34 66.4 
 9 147.5 54.4 92 30.3 66.4 
 4 165 36 128 43.3 81 
16-7NH-16+DOPE+DNA 7 134.5 61.9 92 43.7 112.2 
 9 129.3 54.8 88 41 98.8 
Parameters obtained from the π-A isotherms are liftoff area, AL; molecular area at collapse, Ac; 
collapse pressure, πc; minimum cross sectional area or limiting area, A and maximum 
compressibility modulus, Cs-1. 
 
 
Figure 4.13. BAM image of (A) 16-7-16/DNA and (B) 16-7NH-16/DNA in pH 4 buffer. 
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Figure 4.14. BAM image of gemini/DNA system in pH 7 at selected surface pressures.  
 
 
Figure 4.15. BAM image of gemini/DNA system in pH 9 at selected surface pressures. 
4.2.7. Effect of DNA on DOPE monolayer 
It can be seen in Figure 4.16 that the monolayer behavior was at both pH 4 and 7, but clearly 
NOT at pH 9, influenced by the pH of the subphase. At pH 4, the DOPE seems to have some 
interactions with the DNA molecules. The minimum cross sectional area decreased from 127 for pure 
DOPE to 76 Å2/molecule for the DOPE/DNA system, respectively (Table 4.1 and 4.3, respectively). 
This implies that the presence of DNA induced condensation of the DOPE monolayer at pH 4.  
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As mentioned earlier, zwitterionic DOPE may carry positive charges at low pH, which can 
undergo electrostatic interactions with the DNA molecules. This can reduce repulsions between the 
adjacent DOPE molecules, and induce enhanced compaction of the monolayer upon compression. 
This observation is further supported by the behaviour of the monolayer at pH 9, in which presence 
of negative charge at the head group of DOPE causes repulsions to the negatively charged DNA 
molecules. Therefore, at pH 9, and do not observe any substantial interactions between DOPE and 
DNA. In this case and the monolayer isotherm and compressibility modulus data is nearly identical 
to that for pure DOPE (Figure 4.16 E and F). At pH 7, both the pure DOPE and DOPE/DNA systems 
showed identical similar phase behavior; (Figure 4.16 C and D). However, the monolayer is 
expanded in the presence of DNA compared with the pure DOPE, as the based on the minimum cross 
sectional areas are (~79.2 and 104 Å2/molecule for the DOPE and DOPE/DNA monolayers, 
respectively). Castano et al. have investigated the interactions of bis(guanidinium)-tris(2-
aminoethyl)amine-cholesterol (BGTC) with DNA in presence or absence of DOPE using BAM and 
PM-IRRAS. Their study revealed that, where they determined that DOPE does not directly interact 
with the DNA at air/water interface [120]. The BAM images of the DOPE/DNA system show 
homogeneous film with the presence of LE-LC phase (Figure 4.17, Appendix Figure A4.25). At 
higher surface pressure (≥41 mN/m), BAM images shows the presence of LE-LC coexisting domains 
(bright domain with dark spaces). These results are in good agreement with the observed isotherm 
and compressibility modulus for this system (Figure 4.16). On the other hand at pH 7, BAM images 
shows similar domain formation at higher surface pressure (>25 mN/m) (Figure 4.17, Appendix 
Figure A4.26). We have observed earlier that the pure DOPE monolayer at pH 7 shows more 
domains formation than other pH 4 or 9 (Figure 4.7). However, at pH 9, the DOPE/DNA system 
exhibited (Figure 4.17 and Appendix Figure A4.27) less domain formation compared to the pure 
DOPE (Figure 4.7) indicative of the LE-LC phase.  
72 
 
 
Area per molecules (Å2)
0 25 50 75 100 125 150 175 200 225 250
S
u
r
fa
c
e
 p
r
e
ss
u
r
e
 (
m
N
/m
)
0
5
10
15
20
25
30
35
40
45
50
DOPE pH 9
DOPE/DNA pH 9
Surface Pressure (mN/m)
0 5 10 15 20 25 30 35 40 45 50
C
o
m
p
r
e
ss
ib
il
it
y
 m
o
d
u
lu
s 
(m
N
/m
)
-10
0
10
20
30
40
50
60
70
80
90
100
110
120
DOPE/DNA pH 9
DOPE at pH 9
Area per molecules (Å2)
0 25 50 75 100 125 150 175 200 225 250
S
u
r
fa
c
e
 p
r
e
ss
u
r
e
 (
m
N
/m
)
0
5
10
15
20
25
30
35
40
45
50
DOPE pH 7
DOPE/DNA pH 7
Surface Pressure (mN/m)
0 5 10 15 20 25 30 35 40 45 50
C
o
m
p
r
e
ss
ib
il
it
y
 m
o
d
u
lu
s 
(m
N
/m
)
-10
0
10
20
30
40
50
60
70
80
DOPE/DNA pH 7
DOPE at pH 7
Area per molecules (Å2)
0 25 50 75 100 125 150 175 200 225 250
S
u
r
fa
c
e
 p
r
e
ss
u
r
e
 (
m
N
/m
)
0
5
10
15
20
25
30
35
40
45
50
DOPE pH 4
DOPE/DNA pH 4
Surface Pressure (mN/m)
0 5 10 15 20 25 30 35 40 45
C
o
m
p
r
e
ss
ib
il
it
y
 m
o
d
u
lu
s 
(m
N
/m
)
-10
0
10
20
30
40
50
60
70
DOPE/DNA pH 4
DOPE at pH 4
A 
B 
C D 
E F 
Figure 4.16. π -A isotherms (A, C and E) and compressibility modulus as a function of surface 
pressure (B, D, and F) for the DOPE/DNA monolayers at pH 4 (A, B); pH 7 (C, D); and pH 9 (E, F) 
at 25°C. 
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Figure 4.17. BAM image of DOPE/DNA in different pHs at selected surface pressures. 
4.2.8. Mixed gemini surfactant/DOPE/DNA monolayers 
The isotherms for the complete gemini surfactant/DOPE/DNA mixed monolayers are shown 
in Figure 4.18, along with the compressibility modulus plots; monolayer properties are listed in Table 
4.3. From Figure 4.18 A and B, we observe that the 16-7-16/DOPE/DNA monolayer at pH 4 
undergoes a G to LE phase transition at a molecular area of approximately 170.4 Å2 and undergoes a 
smooth transition into an LE – LC coexistence phase, confirmed by the compressibility modulus, and 
reaches a maximum surface pressure of ~31.5 mN/m. If we recall from previous sections that the 16-
7-16/DNA without DOPE (Figure 4.12A and B) reached only the LE phase at pH 4, while pure 
DOPE reached an LE – LC coexistence phase, or possibly an LC phase. Looking at the shape of the 
isotherm and compressibility modulus plots, it seems that again the nature of the monolayer is 
governed to a great extent by the absence or presence of DOPE; although from comparison of Tables 
4.1 to 4.3, it is clear that all 3 components are involved in the overall structure of the monolayer. 
Similar results are observed for the 16-7NH-16/DOPE/DNA system at pH 4 (Figure 4.18 A 
and B and Figure 4.19). As can be seen from Figure 4.19, the monolayer undergoes a G→LE phase 
transition with a parabola like appearance in the compressibility modulus in the range of molecular 
areas of ~175 to 116 Å2. The lift off area for this system is similar to that of 16-7-16/DOPE/DNA at 
pH 4; however, the monolayer reaches a maximum surface pressure of ~43.3 mN/m (Table 4.3). 
Again, the monolayer mostly remains in the LE-LC phase for surface pressures in the range of ~15 
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mN/m to collapse (Figure 4.18 B and 4.19). Clear differences are observed between 16-7NH-
16/DNA and the 16-7NH-16/DNA/DOPE monolayers, where DOPE induces condensation in the 
monolayer. Seemingly contrary to this, the minimum cross sectional area for 16-7NH-
16/DNA/DOPE and 16-7NH-16/DNA system are 128 and 66.6 Å2/molecules, respectively (Table 
4.3). The higher value of cross sectional area for the 16-7NH-16/DNA/DOPE monolayer can be 
explained based on their electrostatic interaction phenomena. 16-7NH-16 will have three positive 
charges at pH 4, and DOPE may also carry a net positive charge. Therefore, gemini and DOPE may 
electrostatically repel one another at the air/buffer interface. This electrostatic repulsion likely 
inhibits the possibility for compressing this monolayer to a small molecular area. Since, DNA 
molecules are present at the subphase, it will undergo electrostatic interactions with the gemini as 
well as slightly with DOPE molecules. Moreover, the interaction behavior of the mixed system can 
be further explained based on the mixing behavior of the DOPE with the GS based system in 
presence of DNA. In our previous studies by Akbar et al, we have shown that the mixing behavior 
between the DOPE and a series of GS (16-3-16, 16-7-16, 16-7NH-16) is antagonistic in nature, 
because the DOPE tends to form inverted or bilayer structures whereas GS forms micellar structures 
in the aqueous phase [200]. This factor may also have caused the overall repulsion of the molecules 
subsequently formed expanded monolayer.  
At pH 7, 16-7NH-16/DOPE/DNA system formed the most rigid monolayer, with indications 
of the LC phase at higher surface pressure (Figure 4.18 C and D, Table 4.3). The phase transition for 
the 16-7-16/DOPE/DNA is again similar to that for pure DOPE. At pH 9, the 16-7-16/DOPE/DNA 
monolayer remained at the LE phase whereas the 16-7NH-16/DOPE/DNA monolayer reaches a LE-
LC coexisting phase (Figure 4.18 E and F, Table 4.3). Both of these systems showed Cs-1 values 
lower than for pure DOPE indicating that the condensation effect of DOPE is less prominent at pH 9 
than at pH 4. Interestingly, the Cs-1 values exhibits clear differences between 16-7NH-16/DNA and 
the 16-7NH-16/DNA/DOPE monolayers at pH 9, where DOPE induces condensation in the 
monolayer. Similar results are observed at pH 7 for this systems. In general, our results suggests that 
presence of DOPE induces condensation in the 16-7NH-16/DOPE/DNA system regardless of the 
pHs. Conversely, comparing the 16-7-16/DNA with 16-7-16/DOPE/DNA system, DOPE induces 
condensation effect at pH 4 and 9 (relatively lower than pH 4), however, at pH 7 compressibility 
modulus values were similar indicative of no effect. In general, the rigidity of the 16-7NH-
16/DOPE/DNA monolayer follows the trend: pH4 < pH9 < pH7; whereas the 16-7-16/DOPE/DNA 
system follows the trend: pH9 < pH7 < pH4. 
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Figure 4.18. π -A isotherms (A, C and E) and compressibility modulus as a function of surface 
pressure (B, D, and F) for the mixed gemini surfactant/DOPE/DNA monolayers at pH 4 (A, B); pH 7 
(C, D); and pH 9 (E, F) at 25°C. 
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Figure 4.19. Compressibility modulus and surface pressure as a function of mean molecular area of 
the GS/DOPE/DNA at pH 4. 
At pH 4, the 16-7-16/DOPE/DNA system formed a homogeneous film with mostly dark 
BAM images, indicative of the LE or LE-LC phase (Figure 4.20, additional images are presented in 
Appendix Figure A4.28). The results are in good agreement with the surface pressure isotherm and 
compressibility modulus values as presented in Figure 4.18 A and B. The 16-7NH-16/DOPE/DNA 
system surface pressure >30 mN/m exhibited fibril type domains which is indicative of the LE or LE-
LC phase. The fibril or network like structure is presented in Figure 4.22 for better understanding. 
The fibril structure contains numerous ‘white dot’ like domains. If we recall the 16-7NH-16/DNA 
monolayer which shows a plateau region (Figure 4.12) at around ~30 mN/m (due to the electrostatic 
interactions between the gemini and DNA), and the BAM images of the 16-7NH-16/DOPE/DNA 
system also exhibits the complex fibril structure ~33 mN/m. Thus, combining the BAM images with 
the surface pressure area isotherm, there is a strong interaction present in the 16-7NH-
16/DOPE/DNA system at pH4. Interestingly, Chen at al. have shown the presence of DNA with the 
18-s-18, s = 3-10 gemini surfactant formed complex monolayer with fibril structures [54]. Their 
results are consistent with our observations. The exact role of DOPE in this system is not clearly 
understood, however, the condensation effect of DOPE is seen from the surface pressure isotherm 
data. This further signifies that DOPE may reside on top of the fibrils or attached to the fibril 
structures due to the hydrophobic interactions at pH 4. This phenomena will be further explained at 
the AFM and KPFM section. The BAM images of the 16-7-16/DOPE/DNA system at pH 7 and 9 is 
indicative of the LE-LC phase (Figure 4.20, additional images are in Appendix Figure A4.29 and 
A4.30) which is consistent with the isotherm and compressibility modulus results (Figure 4.18 C, D, 
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E and F). However, 16-7NH-16/DOPE/DNA showed domain formation at the LC phase of the 
monolayer (~42 mN/m), Figure 4.23. The 16-7NH-16/DOPE/DNA monolayer showed small 
domains at surface pressure > 40 mN/m which is an indication of LE-LC or LC phase (Figure 4.24). 
Thus the BAM images are in consistent with the isotherm and compressibility modulus observed for 
this system.  
  
Figure 4.20. BAM image of 16-7-16/DOPE/DNA in pH 4 buffer. 
 
 
Figure 4.21. BAM image of 16-7NH-16/DOPE/DNA in pH 4 buffer. 
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Figure 4.22. BAM image of 16-7NH-16/DOPE/DNA in pH 4 buffer at surface pressure of 35 mN/m. 
The red lines indicate the fibril or platform structures in the monolayer. 
 
 
Figure 4.23. BAM image of 16-7NH-16/DOPE/DNA in pH 7 buffer. 
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Figure 4.24. BAM image of 16-7NH-16/DOPE/DNA in pH 9 buffer. 
4.2.9. AFM and KPFM studies of the gemini/DOPE/DNA systems 
To better understand the interaction mechanism of the gemini/DOPE/DNA system, AFM and 
KPFM studies have been conducted. For the 16-7NH-16/DOPE monolayers, the AFM images show 
the presence of vesicle or donut (round) shape complexes. KPFM images for the same monolayers 
indicate that these vesicles are positively charged at the outer layer, with the core being neutral 
(Figure 4.25A). In an AFM studies of the 18-10-18 gemini surfactant monolayer, Chen et al. showed 
the presence of surface micelle [119]. Thus, we hypothesized that at pH 4 DOPE possesses one and 
the 16-7NH-16 three positive charge, and may be present in the outer layer of the round shape 
complex and the alkyl tail may reside in the core (a micelle formation). Nevertheless, the exact role 
of DOPE in this vesicle or donaut shape structure formation is not clear, which might need further 
investigation.  
As can be seen from the AFM images (Figure 4.26), the 16-7NH-16-DOPE system with 
DNA (at 15 mN/m surface pressure) shows branched or relatively irregular fibrils (yellow color 
arrow), parallel fibrils (red color arrow), and the main platform (blue color arrow) with few fibrils 
structures. Chen et al. have observed similar AFM images for the 18-s-18, s = 3,4,6,8,10,12 gemini 
surfactant in presence of DNA [54, 125]. Similar structural features are observed from the monolayer 
deposited at higher surface pressure (35 mN/m) (Figure 4.26 A and B). The AFM images can 
interpreted if we assume that the positively charged gemini surfactants are interacting with negatively 
charged DNA molecules that have been deposited as a layer on the substrate. The 16-7NH-16 
molecule are bound to this layer, forming the fibril structures. This gives rise to charge neutralization 
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in the region of the fibrils, showing up as black regions of zero charge in the KPFM images. This 
implies that the GS is solely interacting with DNA, and DOPE remains unaffected. Additionally, the 
KPFM shows the background area (other than the fibril structure) as net positive charges. We 
hypothesized that the free GS or DOPE molecules which have not undergone any interactions with 
DNA, are present in the background or there could be DOPE/DNA system in the background. Again 
at pH 4, 16-7NH-16 should have three positive charges, whereas DOPE should be having one 
positive charge. Therefore, there should be some kind of repulsions between these two head groups 
(GS and DOPE) which was evident from the isotherm of these systems (Figure 4.8). The only 
interaction between these two systems could be the hydrophobic interaction between the tail groups 
of 16-7NH-16 and DOPE. Interestingly, it is observed from the isotherm of 16-7NH-16-DOPE-DNA 
(Figure 4.18) that the DOPE is dominating the shape of isotherm. Our previous findings also showed 
the antagonistic interactions between gemini surfactant and DOPE system characterized by surface 
tensiometry and Clint’s, Rubingh’s, and Motomura’s theories for mixed micellar formation [200]. 
Additionally, from the DOPE-DNA isotherm (Figure 4.16), we can observe that the isotherm is more 
like DOPE, a minor change have been observed in terms of maximum surface pressure, collapse 
pressure or the mean molecular area (Table 4.1 and 4.3). For instance, the maximum compressibility 
modulus for the pure DOPE and DOPE-DNA at pH 4 is ~ 56.7 and 65 mN/m, respectively. And the 
collapse pressure (πc) is ~40.9 mN/m and 40 mN/m; molecular area at collapse (Ac) is around 35.2 Å2 
and 33 Å2. Thus, the complex structure formation in AFM studies are in good agreement with the 
BAM images for the 16-7NH-16/DOPE/DNA at pH 4, in which we have seen similar fibril structure 
(Figure 4.21 and 4.22).  
From Figure 4.27, the 16-7-16-DOPE-DNA system also shows the fibril formation. KFPM 
image exhibits the dominant positive charge on the image. Increasing the surface pressure form 15 
mN/m to 25 mN/m, the fibril structure increased. We hypothesized that the charge neutralization is 
less in this case, and we observed thread like fibril structure and less platform structure than that of 
the 16-7NH-16-DOPE-DNA system (Figure 4.26). This indicates that the 16-7-16 is not as effective 
as 16-7NH-16 for interacting with negatively charged DNA. This is also evident from the weak 
interaction of 16-7-16-DOPE system with DNA in comparison to the 16-7NH-16-DOPE in terms of 
πc (~ 31.5 mN/m and 43.3 mN/m, respectively); and Ac (~62.4 and 36 Å2, respectively) (Table 4.3). 
That means more compacted monolayer with higher surface pressure is formed with the 16-7NH-
16/DOPE/DNA system at pH 4 than 16-7-16/DOPE/DNA system. Thus, AFM images further 
justified that DOPE caused condensation in the mixed gemini/DOPE/DNA monolayer. 
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Figure 4.25. Small-scale AFM and KPFM images of 16-7NH-16/DOPE monolayers, with cross 
sections. The top and bottom two figures are in the scale bar of 10x10 and 20x20μm. In all cases, the 
deposition pressure was = 15 mN/m. 
 
Figure 4.26. Small-scale AFM and KPFM images of A. 16-7NH-16/DOPE/DNA monolayers at 
surface pressure 15 mN/m, B. 16-7NH-16/DOPE/DNA monolayers at surface pressure 35 mN/m, 
with cross sections (adapted from the reference with permission [232]). The top row figures are at the 
scale bar of 2x2 μm and the bottom row figures are 10x10 μm scale. The Yellow, Red and Blue color 
arrow in indicates the irregular fibrils, parallel fibrils, and the main platform, respectively. 
 
 
16-7NH-16/DOPE, π=15 mN/m 
AFM KPFM 
20 μm x 20 μm  10 μm x 10 μm  
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Figure 4.27. Small-scale AFM and KPFM images of A. 16-7-16/DOPE/DNA monolayers at surface 
pressure 15 mN/m, B. 16-7-16/DOPE/DNA monolayers at surface pressure 25 mN/m, with cross 
sections.  
 
4.2.10. PM-IRRAS characterization of the mixed monolayers 
To further investigate the effect of DNA on the monolayer of gemini-DOPE mixed system, 
PM-IRRAS was used. Initially, we have determined the attenuated total reflection (ATR) spectrum 
for the pure gemini surfactant to determine the IR bands. It is observed from Figure 4.28 that both 
gemini surfactants possesses a CH2 symmetric stretch (vs(CH2)) at 2850 cm-1 and a CH2 asymmetric 
stretch (va(CH2)) at 2917 cm-1 attributed to the methylene groups present in the alkyl tails of the 
surfactants [54, 120]. The observed band at ~1470 cm-1 is indicative of a CH2 bending vibration, 
again from the alkyl tail [233]. We next attempted to find the same bands in the PM-IRRAS 
spectrum for the pure gemini surfactant monolayers. Unfortunately, we were unable to separate the 
bands due to the surfactants from the noise arising from the aqueous subphase (data not shown). This 
could be due to the higher solubility of the gemini surfactant in subphase, as compared to the mixed 
monolayer; this is consistent with our isotherm and BAM characterizations of the pure gemini 
surfactant monolayers. 
10 μm x 10 μm  
2 μm x 2 μm  
5 μm x 5 μm  
2 μm x 2 μm  
A. 16-7-16/DOPE/DNA, π=15 mN/m  B. 16-7-16/DOPE/DNA, π=25 mN/m  
AFM KPFM AFM KPFM 
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Figure 4.28. ATR spectra of 16-7-16 and 16-7NH-16. Both gemini surfactants have similar 
transmittance value, hence, 16-7NH-16 was subtracted (value of 25) from the original value for 
better representation in the graph.  
 The gemini/DOPE monolayers provided clear spectra; specific regions of the IRRAS spectra 
are presented in Figure 4.29. As can be seen, the characteristic vs(CH2) signal is observed at 2851cm-1 
and the va(CH2) signal at 2926 cm-1 at surface pressure of 30 mN/m; this surface pressure 
corresponds to that of cellular membranes which vary in surface pressure from 30-35 mN/m). The 
frequencies of these bands are sensitive to the conformation of the phospholipid acyl chains. 
Therefore, these bands provide substantial information about the molecular orientation of the lipid 
acyl chains at the air/water interface [210, 234-237]. In general, if the peaks are shifted to values 
lower than 2920 and 2850 cm-1 (i.e. red shifted), this indicates higher chain ordering in the film. 
Higher values (i.e. blue shifted) indicates chain disordering [238, 239]. Our literature review suggests 
that va(CH2) is often found in a narrow range from 2915 to 2918 cm-1, and vs(CH2) from 2846 to 2850 
cm-1 for all-trans conformations of the fully extended tail chains [54]. Noteworthy, a red shift is an 
indicative of an ordered all-trans conformation of the chain, whereas a blue shift is indicative of 
chain disordering associated with the gauche conformation [238]. As can be seen from Figure 4.29, 
the va(CH2) and vs(CH2) bands have moved slightly to higher values of 2926 cm-1 and 2851 cm-1 from 
the ideal 2920 and 2850 cm-1 values, respectively. This is an indication of the disordered acyl chains 
that would be associated with the liquid expanded monolayer film, an interpretation that is consistent 
with our isotherm and compressibility modulus data. Rubio-Magnieto et al. have reported similar 
results for gemini amphiphilic pseudopeptides at the air/water interface [104], in which pure lipid 
Wave number (cm
-1
)
5001000150020002500300035004000
%
 T
ra
n
sm
it
ta
n
ce
40
60
80
100
16-7-16
16-7NH-16
84 
 
 
monolayer exhibited wavenumber higher than the 2920 and 2850 cm-1, and corresponded to the LE 
phase of the film with disordered acyl chain. The IRRAS study of gemini surfactant (18-s-18, s = 3 ,6 
,8) in presence of DNA in the subphase, revealed the presence of va(CH2) and vs(CH2) bands at 
around 2924 and 2854 cm-1 at the air/water interface [54], which is comparable to our results.  
DOPE possesses similar δ(CH2) acyl chains bands, a band characteristic of ester groups 
ν(C=O) at 1737 cm-1, and the asymmetric (va(PO2−)) and symmetric phosphate (vs(PO2−) stretches at 
1220 and 1080 cm-1, respectively [120, 240]. The ester ν(C=O) stretch band of lipids may range from 
1710 to 1740 cm-1 [235], as such the observed band at 1726 cm-1 can be attributed to DOPE (Figure 
4.48). The va(PO2−) is observed at 1231 cm-1 at 30 mN/m surface pressure. This band was further 
shifted to higher values upon increase of the surface pressure. The exact reason for the shifts of this 
band to higher values is not clear; however, va(PO2−) is sensitive to hydration and ion binding [235]. 
It is possible that some structural or orientation changes in the DOPE head group resulted in 
increased access of water molecules to the phosphate group. This could be an indication that, at pH 4, 
the phosphate group might have formed hydrogen bonding with water molecules, resulting in a shift 
of the band higher values at higher surface pressure. An IRRAS study of the diphosphoryl Lipid A (a 
precursor of lipopolysaccharide) revealed the presence of three overlapped features in the 
asymmetric phosphate band region. The bands at 1225, 1238 1258 cm-1 corresponded to dihydrated, 
monohydrated, and unhydrated phosphate groups, respectively. These multiple bands were attributed 
to the accessibility of Lipid A molecules to nearby water molecules [235].  
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Figure 4.29. PM-IRRAS spectra of the 16-7NH-16/DOPE monolayer at pH 4 and various surface 
pressures. 
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Figure 4.30. PM-IRRAS spectra of the 16-7NH-16/DOPE in presence of DNA at pH 4 at different 
surface pressures. 
Braun et al. have showed the FT-IR spectra of the B form DNA has bands due to the 
guanine/thymine carbonyl (C=O) stretch at 1715 cm-1, the thymine aromatic amine stretch (1328 cm-
1), vs(PO2−) and va(PO2−) stretches at around 1088 and 1222 cm-1, respectively; and a strongly 
coupled sugar-phosphodiester signal at around 970 cm-1 [241]. Thus we can expect to see the similar 
bands in the PM-IRRAS spectrum in presence of DNA in our systems. Figure 4.30 shows that for 16-
7NH-16/DOPE in the presence of DNA at pH 4 the va(CH2) and vs(CH2) bands are red shifted to 
2930 and 2854 cm-1, respectively, similar to the red shift observed with increases in pressure for the 
16-7NH-16/DOPE system at higher surface pressures but greater in magnitude. This is again an 
indication that the alkyl chains of the 16-7NH-16/DOPE/DNA complex monolayer remain in a more 
disordered state with a greater number of gauche conformations. Again these results are consistent 
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with the both the isotherm and compressibility modulus results for the 16-7NH-16/DOPE/DNA 
system (Figure 4.18 A and B) at pH 4.  
With respect to the bands associated with DNA, we have not observed any changes in the 
C=O band at 1724 cm-1. Interestingly, Marty et al. have reported that cationic ion−base interactions 
can induce changes in the vibrational band of adenine at 1609-1606 cm-1 towards lower values [242]. 
Neault et al. showed that the bands observed at 1606 and 1590 cm−1 were attributed to an aspirin-
DNA interaction [243]. The drug was mainly bound through the backbone of the PO2- group and the 
A-T bases (DNA). The interaction was mediated through the guanine and adenine N7 atoms and 
thymine O2 in the major and minor grooves of DNA duplex [243]. Given this, the band we observe 
at 1606 and 1588 cm-1 (Figure 4.30) may be due to the interactions of the quaternary ammonium head 
groups of the gemini surfactant with the adenine N7 or thymine O2 atoms. Therefore, this spectral 
feature is suggestive of the presence of ion−dipole interactions in the gemini/DOPE/DNA complex 
monolayers. The addition of DNA on the sub-phase substantially shifted the phosphate asymmetric 
band to 1248 cm-1 (Figure 4.30). Both DOPE and DNA can contribute to this phosphate group region 
of the PM-IRRAS spectra, and the shift in the va(PO2−) stretches to higher values is a further 
indication of the gemini-PO2− interaction. This interpretation is also consistent with FT-IR studies 18-
s-18 (s = 3,6,8) gemini surfactant/DNA deposited LB films which showed a similar shift of the 
va(PO2−) band to higher values corresponding to the gemini-PO2− interaction [54].  
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Figure 4.31. PM-IRRAS spectra of the 16-7NH-16/DOPE without DNA at pH 7 at different surface 
pressures. 
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Figure 4.32. PM-IRRAS spectra of the 16-7NH-16/DOPE with DNA at pH 7 at different surface 
pressures. 
The PM-IRRAS spectrum of the 16-7NH-16/DOPE system at pH 7, showed similar bands at 
the 3000-2800 cm-1 region (Figure 4.31). There were some changes of the vs(CH2) from 2850 cm-1 to 
higher values. Thus at both pH 7 and 4, the results shows similar disordered alkyl tails at the 
air/buffer interface consistent with an LE-LC or LC phase for the monolayer. All other spectra at pH 
7 are similar to the bands observed at pH 4 (Figure 4.31). It is observed from the Figure 4.32 that the 
16-7NH-16/DOPE in presence of DNA at pH7 shows similar characteristics peaks as observed in 
Figure 4.30 (pH 4). Interesting changes are observed in the 3000-2800 cm-1 region with relatively 
higher values for the symmetric and asymmetric bands of the alkyl tails. At higher surface pressure 
(40 mN/m), more ordering of the alkyl tails are observed, with a blue shift from 2939 to 2923 cm-1). 
It was observed from the compressibility modulus values that the 16-7NH-16/DOPE/DNA 
monolayer is found in the LC phase at higher surface pressures 35 mN/m (Figure 4.18 B), consistent 
with the observed blue shift in the IRRAS spectrum. Similar changes in the spectra are observed for 
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pH 4 in the region 1300-950 cm-1 are seen at pH 7. At pH 9, the 16-7NH-16/DOPE IRRAS spectrum 
is consistent with a relatively ordered monolayer since the alkyl tail bands have not shifted 
significantly to higher values (Figure 4.33). In the presence of DNA (Figure 4.34), increased disorder 
in the alkyl tails is again observed as a red shift in the asymmetric CH2 stretch band. The spectra 
region at the 1800 to 1400 cm-1 and 1300 to 950 cm-1 is again similar to the spectra observed at pH 4.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.33. PM-IRRAS spectra of the 16-7NH-16/DOPE without DNA at pH 9 at different surface 
pressures. 
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Figure 4.34. PM-IRRAS spectra of the 16-7NH-16/DOPE with DNA at pH 9 at different surface 
pressures. 
We have further investigated the PM-IRRAS spectra of the 16-7-16/DOPE system in 
presence or absence of DNA. As can be seen from the Figure 4.35 at pH 4, that the CH2 band regions 
of the alkyl tails resembles the disoriented structure (LE or LE-LC phase). The asymmetric PO2- 
shifted to higher value (around 1239 cm-1) indicative of the interaction at the gemini- PO2− 
interaction. We have observed similar PM-IRRAS spectra at pH 7 (Figure 4.36) and pH 9 (data not 
shown). In general, the presence of the LE or LE-LC phase is observed for the 16-7-16/DOPE/DNA 
system in all pHs. These results are in good agreement with the isotherm and compressibility 
modulus results (Figure 4.18). 
Several models have been proposed to elucidate the complex properties of the cationic 
lipid/DNA complex:  
1. Electrostatic interactions between the lipid head group and phosphate group of DNA;  
Wave number (cm
-1
)
28002850290029503000
N
o
rm
a
li
z
ed
 P
M
-I
R
R
A
S
 s
ig
n
a
l
0.04
0.06
0.08
0.10
0.12
0.14
30 mN/m
35 mN/m
40 mN/m
2848
2933
Wave number (cm
-1
)
14001500160017001800
N
o
rm
a
li
z
ed
 P
M
-I
R
R
A
S
 s
ig
n
a
l
-0.04
-0.03
-0.02
-0.01
0.00
30 mN/m
35 mN/m
40 mN/m
1728
1606
1587
Wave number (cm
-1
)
9501000105011001150120012501300
N
o
rm
a
li
z
ed
 P
M
-I
R
R
A
S
 s
ig
n
a
l
0.000
0.005
0.010
0.015
0.020
30 mN/m
35 mN/m
40 mN/m
1089
1248
92 
 
 
2. Base binding between lipid polar groups and the bases donor atoms; and  
3. Hydrophobic interactions between aliphatic tails [54, 244, 245].  
In general, the PM-IRRAS spectra revealed that the complex monolayer of 16-7NH-16/DOPE/DNA 
undergoes electrostatic, ion-dipole as well as hydrophobic interactions among the components. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.35. PM-IRRAS spectra of the 16-7-16/DOPE with DNA at pH 4 at different surface 
pressures. 
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Figure 4.36. PM-IRRAS spectra of the 16-7-16/DOPE with DNA at pH 7 at different surface 
pressures. 
4.3. Summary 
Based upon our detailed characterization of the mixed gemini surfactant/DOPE/DNA 
systems, we can conclude that both the DOPE and DNA play important roles in defining the nature 
of the monolayers formed. The DOPE tends to condense the monolayers formed by gemini 
surfactants, both in the presence or absence of DNA. In the presence of DNA, KPFM demonstrates 
that the gemini surfactant strongly undergoes electrostatic interactions with DNA, fibril type complex 
structures. We believe that the DOPE may not participate in this gemini/DNA complex but rather 
resides outside of this complex (based upon our interpretation of the AFM results). The exact role of 
DOPE in this transfection complex is not clear, other than the described condensation effect. Further 
investigation is required to completely elucidate the role of DOPE in the system, and importantly it’s 
effect on model biological membranes. Thus, in the following chapter (Chapter V), we have 
evaluated the effect of the gemini/DOPE/DNA system on monolayers that represent a model 
endosomal membrane.  
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Chapter V 
 
Interactions of Gemini surfactant-phospholipid based transfection system with 
model endosomal cell membrane. 
 
5. 1. Results and Discussion 
5.1.1. π-A isotherm and compressibility modulus of the model membrane components 
The surface pressure-area (π–A) isotherms at different pHs are shown in Figure 5.1 A, C, and 
E, for pure DPPC, pure cholesterol and a 75/25% mixture of DPPC/cholesterol, which is used as a 
representative model for the endosomal membrane. As can be seen, pure cholesterol forms a typical 
condensed monolayer with liftoff areas of ~52.4, 43.2, 37.8 Å2 at pH 4, 7 and 9, respectively. 
Regardless of the pH, the collapse pressure of the monolayer is ~45 mN/m, and the minimum cross 
sectional area for cholesterol in the monolayer ranges from 31 to 49 Å2 /molecule (Table 5.1). All of 
the parameters determined in this work for the cholesterol monolayers are consistent with the results 
described in the literature [156, 246-249]. Cholesterol forms a condensed monolayer in which 
molecules arrange themselves in a vertical position or slightly tilted towards the surface.  
To fully understand the monolayer phase behavior, the compressibility moduli (Cs-1) were 
evaluated [215] and are presented in the Table 5.1 and Figure 5.1 B, D, and F. The higher the 
compressibility modulus values, the lower the interfacial elasticity of the monolayer. At pH 4, the 
cholesterol monolayer remains in the G phase from ~250 Å2 to 52 Å2 molecular area (Figures 5.1A 
and 5.2B). Liftoff occurs (at a molecular area of approximately 52 Å2) in which the monolayer 
undergoes a sharp change from the G to LC phase over a narrow surface pressure range (0-5 mN/m). 
Between 5 and 20 mN/m, the monolayer remains in the LC phase before finally reaching the S phase 
at ~21 mN/m (pH 4). Both pH 7 and 9 showed similar phase behavior to that at pH 4. Interestingly, at 
pH 9, the monolayer exhibited the greatest rigidity based on the maximum Cs-1 values (593 mN/m). 
The maximum Cs-1 value of cholesterol monolayer has been observed to reach values of between 650 
to 693 mN/m on a water subphase [156, 249]. Under surface pressure conditions consistent with 
natural cellular membranes (30–35 mN/m), cholesterol is found in a solid or S phase for all pH 
conditions. 
BAM images of the cholesterol monolayer at the air/buffer (pH 4) are presented in Figure 
5.3. At low surface pressures, where the cholesterol monolayer is in the G phase, circular or ovoid 
solid domains are observed (0.27 mN/m). Upon increasing the surface pressure, the domains merged 
95 
 
 
together, and mixed G-S phase domains are observed (3.86 mN/m). As the monolayer is further 
compressed, the domains merged together and formed a homogeneous solid film (> 20 mN/m), 
indicative of the solid S phase. Here the steroid rings of cholesterol are likely to be oriented vertically 
toward the air side of the air/buffer interface. At higher surface pressures, and beyond collapse, 
bright domains begin to appear, consistent with aggregate or multilayer formation. Similar BAM 
images are observed at pH 7 and pH 9, and are provided as Appendix Figure A5.1 and A5.2. Our 
results are similar to the results obtained by Miñones et al. [156].  
At pH 4, the DPPC monolayer exhibits a G-LE phase transition in the surface pressure range 
of 0 to ~0.8 mN/m (Figures 5.1 A and B). An LE phase is observed for surface pressures between 0.9 
and ~5 mN/m (shown as a loop in Figure 5.2A), followed by an LE-LC phase transition at surface 
pressures between 6 and 16 mN/m, with Cs-1 values increasing to ~100 mN/m. The monolayer 
remains in the LC phase until collapse (~52 mN/m). There is a distinct plateau observed in the 
isotherm in the region of ~5.2 to 6.6 mN/m surface pressure (Figure 5.1A, indicated with arrow ‘LE-
LC’), which is a characteristic feature of the DPPC monolayer. The same plateau is observed at 
approximately the same region of surface pressures at pH 7, and at slightly higher surface pressures 
of ~6.2 to 7.0 mN/m at 9 (Figure 5.1 C and D). This plateau is attributed to changes in the 
orientations of the DPPC molecules upon compression. It has been previously reported the DPPC 
monolayer exhibits first order phase transition from the LE to LC state (also referred as gel to liquid 
crystal transition) over a similar range of surface pressures as the plateau observed in this work (i.e. 5 
– 7 mN/m) [113]. In our case the transition is not first order since the surface pressure does not 
remain constant. Similar results are reported by Minones et al.[156]. Our results of DPPC monolayer 
behavior at air/buffer interface are in good agreement with the published data [156, 180, 249-251]. 
Regardless of the pH, the DPPC monolayer displayed similar cross sectional area (~60 Å2) as well as 
maximum surface pressure (53 mN/m; Table 5.1); however, the monolayer is relatively expanded at 
pH 4 compared to pH 7 or 9 (Figure 5.1 and Table 5.1). In the range of natural membrane surface 
pressures the DPPC monolayer remained in the LC phase (enclosed with the dotted lines in Figure 
5.1 B, D, and F); although at pH 9, Cs-1 is closer to values associated with a solid phase. Figure 5.4 
shows BAM images of the pure DPPC monolayer at pH 4. At low surface pressures (0.07 mN/m), 
when the monolayer is found in the G phase, network like domains are observed. As the surface 
pressure increases in the range of 0.21 to 4 mN/m, the monolayer is observed as a fairly homogenous 
film with minor defects and corresponds to the G-LE phase transition and the LE phase (1-4 mN/m). 
In the LE phase, the acyl tails of the lipids are neither ordered nor protruding vertically from the 
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surface, resulting in less reflection of the incident light and dark BAM images. At the phase 
transition of LE-LC (π ≥ 5 mN/m), small bright circular and irregular, lobed domains suspended in a 
darker phase are observed. These domains increased in size as the monolayer undergoes LE to LC 
phase transition with higher surface pressure. At the LE-LC phase transition the different tilt of the 
alkyl chain of the DPPC molecules induces differing reflectivity (anisotropy) with respect to the 
plane of incident [156, 252]. As the surface pressure further increases, the domains merge together 
and gradually blur, giving rise to relatively homogenous BAM images prior to monolayer collapse. 
BAM images are similar regardless of the pH of the subphase (images at pH 7 and 9 are provided as 
Appendix Figure A5.3 and A5.4) and are consistent with the published results [156, 253]. 
Table 5.1. Monolayer properties of the DPPC, Cholesterol and their mixture at air/buffer interface. 
System pH AL 
(Å2) 
Ac (Å2) π c 
(mN/m) 
A∞ 
(Å2) 
Cs-1 (mN/m) 
      30 mN/m 35 mN/m Max 
 4 97.0 36.5 52.6 53.6 135.8 134.7 163.4 
DPPC 7 117.7 47.3 53.3 60.2 191.8 193.6 235.7 
 9 130.8 50.4 52.8 62.9 238.3 220.6 271.4 
 4 52.4 39.5 44.8 49.2 253.8 207.9 265.9 
Cholesterol 7 43.2 34.4 45.2 39.7 238.4 337.7 376.0 
 9 37.8 28.4 45.9 31.3 503.9 581.3 593.6 
 4 74.2 37.6 52.3 48.1 287.3 256.6 315.2 
DPPC/Cholesterol  7 74.3 38.2 52.1 49.0 174.8 191.1 222.4 
 9 64.4 34.3 52.3 41.4 249.0 252.9 338.5 
Parameters obtained from the π-A isotherms are liftoff area, AL; molecular area at collapse, Ac; 
collapse pressure, πc; minimum cross sectional area or limiting area, A. Compressibility modulus 
(Cs-1) at 30 mN/m, 35 mN/m surface pressure and the maximum compressibility modulus values. 
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Figure 5.1. π-A isotherm (A, C, and E) and compressibility modulus (B, D, and F) of the DPPC, 
Cholesterol, their mixture (DPPC: cholesterol = 75:25 %) at pH 4 (A, B), 7(C, D) and 9 (E, F). The 
LE-LC phase is shown in Figure A. The dotted line encloses the compressibility modulus values at 
the 30-35 mN/m.  
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Figure 5.2. Compressibility modulus values of the DPPC (A), Cholesterol (B) and model membrane 
(DPPC: cholesterol= 75:25 %) (C) at air /buffer (pH 4) interface.  
As mentioned earlier in Section 1.6.2b the amount of cholesterol in the plasma membrane 
varies from 30% to 50% [147, 159]. Van Meer et al. have suggested that the early and late 
endosomes may have a cholesterol content lower than 30% [147] or it may vary from 25 to 30% 
[160]. Additionally, some recent Langmuir monolayer studies have utilized 30% cholesterol as 
model mammalian cell membrane along with the DPPC (70%) [156, 161]. We have used the molar 
ratio of DPPC/cholesterol =75/25 % for our experiment to simulate the endosomal membrane. The 
DPPC/cholesterol mixed monolayer system along with their corresponding compressibility modulus 
values is presented in Figure 5.1 and Table 5.1. As can be seen from Figure 5.1A and B, and 5.2C, 
the monolayer undergoes a G-LE phase transition at ~0.6 mN/m surface pressure at pH 4, then an 
LE-LC phase transition is observed between 0.6 to 13 mN/m. The monolayer reaches the S phase at 
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~27 mN/m surface pressure. At the cell membrane surface pressure range, the DPPC/cholesterol 
monolayer is in an S phase (Figure 5.1B), indicative of rigid monolayer formation. Similar rigid 
monolayer behaviour can be seen at pH 9 (Figure 5.1F); however, at pH 7, the monolayer is found in 
the LC phase indicating a relatively less rigid monolayer. Noteworthy, there is no plateau formation 
observed for the DPPC/cholesterol system at surface pressures where the DPPC monolayer 
underwent the LE-LC transition. This indicates that addition of cholesterol in the system causes 
condensation of the monolayer. The condensation effect of cholesterol is well known and our results 
are consistent with the published results of other research groups [156, 180, 254-258]. The 
condensation effect of cholesterol is observed at low surface pressure regardless of the pH of the 
subphase [254]. Additionally, the minimum cross sectional area of the mixed system ranges from 41 
to 49 Å2/molecules, indicating relatively vertical orientation of the molecules at the air/buffer 
interface (Table 5.1).  
BAM images for the mixed DPPC/cholesterol monolayer are presented in Figure 5.5 at the 
air/buffer (pH 4) interface. At low surface pressure (~0.27 to 1.22 mN/m), where DPPC/cholesterol 
monolayer is in the G-LE phase transition, exhibits circular or ovoid domains. Upon compressing the 
monolayer, the LE phase undergoes LC phase transition and a blur images are observed at 2.34 
mN/m. As the monolayer is further compressed, the domains merged together and formed solid film 
(> ~25mN/m) Interestingly, the lobbed domains of pure DPPC at low surface pressure (Figure 5.4, 
below 10 mN/m) in not observed in the DPPC/cholesterol mixture, which is indicative of the 
condensing effect of cholesterol [156, 249]. Similar BAM images are observed at pH 7 and 9 (images 
are provided as Appendix Figure A5.5 and A5.6) are similar to the pH 4. 
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Figure 5.3. BAM image of the pure cholesterol monolayer at the air/buffer (pH 4) interface at 
various surface pressures. 
 
Figure 5.4. BAM images of the pure DPPC monolayer at the air/buffer (pH 4) interface at various 
surface pressures. 
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Figure 5.5. BAM images of the model membrane (DPPC/cholesterol=75/25 %) monolayer at the 
air/buffer (pH 4) interface at various surface pressures. 
 
5.1.2. Effect of pure gemini surfactants on the model membrane 
To the best of our knowledge, the interactions of gemini/DOPE/DNA system with the model 
membrane (DPPC/cholesterol) has not yet been reported. To get a better insight of the interactions, 
we have injected the surfactant systems under the subphase at each pH, mixed them and subsequently 
spread the DPPC/cholesterol model membrane monolayer on top of this subphase that now contains 
the components of the gene delivery system. We believe that this unique study design will provide 
insight with respect to the relevance of our systems in a real biological system (for example an 
intravenous injection of lipoplexes into the aqueous environment of the blood stream where they can 
eventually interact with cell membranes at the site of action[14]). Several researchers have used the 
DPPC/cholesterol based system to evaluate drug-membrane interactions [249], phospholipid-model 
membrane interactions [180], or sterol-phospholipid interactions [156]. Since the surface pressure of 
the actual cell membrane ranges from around 30-35 mN/m, we will take a closer look at this surface 
pressure range along with the detailed analysis of the isotherm in the following discussions.  
The effect of 16-7-16 based systems with the model DPPC/cholesterol membrane are shown 
in Figure 5.6. At first we have determined the 16-7-16 with the DPPC/cholesterol system at pH 4. As 
can be seen from Figure 5.6A and 5.7A that the 16-7-16 induces fluidization in the model membrane 
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at pH 4. The Cs-1 values revealed the presence of LE-LC phase up to the surface pressure of 30 mN/m 
(Figure 5.7A). At the cell membrane surface pressure range (30-35 mN/m), the 16-7-
16/DPPC/cholesterol system shows the presence of LE phase whereas the pure DPPC/cholesterol 
exhibits S phase (Cs-1 values ranges from ~287 to 256 mN/m) (Figure 5.7B, Table 5.1 and 5.2). Thus, 
16-7-16 substantially changed the rigidity of the model membrane which corresponds to the 
fluidization. The fluidization effect of the drug to the model membrane has been evaluated by several 
researchers, for instance, paclitaxel [259], prazosin [169], and natamycin [249] with the 
DPPC/cholesterol, tetracaine with the 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC)/ 
cholesterol [260], hexadecylphosphocholine and erucylphosphocholine with the POPC/cholesterol 
[261], and toremifene with the dipalmitoyl-phosphatidyl-glycerol (DPPG) model membrane [262]. In 
all cases, presence of the drug molecule substantially reduced the compressibility modulus of the 
pure model membrane, which was considered to be the fluidizing effect of drug to the model 
membrane.  
At pH 7, DPPC/cholesterol monolayer exhibits a LC phase transition (Cs-1 values ranges from 
~131 to 120 mN/m) in presence of the pure 16-7-16 (Figure 5.7 D). In comparison with the 16-7-
16/DPPC/cholesterol with the pure DPPC/cholesterol monolayer (Figure 5.7D), it is found that the 
16-7-16 reduced the rigidity of model membrane. However, this reduction in rigidity is not as 
prominent as was observed at pH 4. At pH 9, similar LC phases are observed at the 30-35 mN/m 
surface pressure (Figure 5.7F). Overall, the 16-7-16 system induced fluidization at the model 
membrane regardless of the pHs, and the observed trend is pH4 > pH7 > pH9. The BAM images 
(Figure 5.12) in presence of pure 16-7-16 system revealed that the DPPC/cholesterol monolayer 
exhibits the G-LE phase transition at the low surface pressure (~1-10 mN/m), with the presence of 
dot like domains in dark background. At 30-35 mN/m, the image is suggestive of the LC phase 
transition with bright dots in a homogeneous film. However, this feature are not observed at the pure 
DPPC/cholesterol monolayer (Figure 5.5). Thus, 16-7-16 induced some domain formation which 
might be due to the penetration of the surfactant or adsorption of the surfactant to the 
DPPC/cholesterol monolayer. In the LC phase, the acyl tails of the lipids are relatively ordered, 
however, not perfectly vertical to the plane; thus, increased reflection of the incident light occurs and 
results in the formation of small bright domains at the BAM images. In our case, adsorption might 
have disoriented the alkyl tail group of the lipids and BAM images shows smaller domains instead of 
homogenous film (as observed for the pure DPPC/cholesterol). Similar BAM images were observed 
for the DPPC/cholesterol monolayer in presence of pure 16-7-16 at pH 7 or 9 (data not shown). Thus, 
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the BAM images are clear indication of the fluidization of the monolayer in presence of the 
surfactant.  
On the other hand, it is observed form Figure 5.8 and Table 5.2, 5.3 and 5.4, the 
DPPC/cholesterol in presence of 16-7NH-16 system formed more expanded monolayer at pH 4 (AL = 
105 Å2) than at pH 7 (AL = 96.4 Å2) and 9 (AL = 88.7 Å2). A∞ is approximately 85.4, 73.4 and 67.4 
Å2/molecules at pH 4, 7 and 9, respectively; indicating relatively condensed monolayer formation at 
higher pHs. In presence of 16-7NH-16 the DPPC/cholesterol monolayer remained at LE-LC phase 
transition at pH 4, whereas the monolayer exhibits LC phase transition >15 mN/m at pH 7 and 9 
(Figure 5.7 A, C, and E). In the cell membrane surface pressure range, the pure DPPC/cholesterol 
possess S phase (Cs-1 = >250 mN/m) (Figure 5.7B) at pH 4, which was substantially reduced (Cs-1 = < 
~100 mN/m) in the presence of 16-7NH-16 (Figure 5.7B). This is a clear indication of substantial 
membrane fluidization effect by the 16-7NH-16 at pH 4. However, at pH 7 and 9, the 
DPPC/cholesterol monolayer was not influenced by the 16-7NH-16 (Figure 5.7 D, and F). These 
results are in good agreement of our hypothesis that at pH 4, the 16-7NH-16 possess three positive 
charge, and undergoes strong electrostatic interaction with the negatively charged model membrane. 
Whereas at pH 7 or 9, 16-7NH-16 may possess two positive charges in their head group and causes 
less interaction comparing to pH 4. The negative charge of the DPPC/cholesterol model membrane 
may be attributed to the presence of phosphate or hydroxyl group at the DPPC and cholesterol polar 
head groups, respectively. Comparing the monolayer with of 16-7-16/DPPC/cholesterol, 16-7NH-16 
induced relatively more rigidity than the 16-7-16 system in all pHs. This could be explained based on 
the phase behavior of the pure 16-7NH-16 which shows the presence of LE-LC or LC phase whereas 
the 16-7-16 shows LE phase (Figure 5.7 B, D, and F). 
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Figure 5.6. π-A isotherm of the 16-7-16 based systems with the model membrane (DPPC/cholesterol 
= 75/25 %) at pH 4 (A), 7 (B) and 9 (C). 
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Figure 5.7. Compressibility modulus of the pure components at various pHs (A, C, and E) and at 30-
35 mN/m surface pressure range (B, D, and F). 
Surface pressure (mN/m)
0 10 20 30 40 50 60
C
o
m
p
r
e
ss
ib
il
it
y
 m
o
d
u
lu
s 
(m
N
/m
)
-50
0
50
100
150
200
250
300
350 DPPC/Cholesterol= 75/25
16-7-16 with model membrane
16-7NH-16 with model membrane
pure 16-7-16 
pure 16-7NH-16
A, pH=4
Surface pressure (mN/m)
0 5 10 15 20 25 30 35 40 45 50 55 60
C
o
m
p
r
e
ss
ib
il
it
y
 m
o
d
u
lu
s 
(m
N
/m
)
0
50
100
150
200
250
DPPC/Cholesterol=75/25
16-7-16 with model membrane
16-7NH-16 with model membrane
pure 16-7-16 
Pure 16-7NH-16
C, pH=7
Surface pressure (mN/m)
30 31 32 33 34 35
C
o
m
p
r
e
ss
ib
il
it
y
 m
o
d
u
lu
s 
(m
N
/m
)
0
50
100
150
200
250
DPPC/Cholesterol=75/25
16-7-16 with model membrane
16-7NH-16 with model membrane
pure 16-7-16 
Pure 16-7NH-16
D, pH=7
Surface pressure (mN/m)
30 31 32 33 34 35
C
o
m
p
r
e
ss
ib
il
it
y
 m
o
d
u
lu
s 
(m
N
/m
)
-50
0
50
100
150
200
250
300
350
DPPC/Cholesterol= 75/25
16-7-16 with model membrane
16-7NH-16 with model membrane
pure 16-7NH-16
B, pH=4
Surface pressure (mN/m)
0 5 10 15 20 25 30 35 40 45 50 55 60
C
o
m
p
r
e
ss
ib
il
it
y
 m
o
d
u
lu
s 
(m
N
/m
)
-50
0
50
100
150
200
250
300
350
400
DPPC:Cholesterol=75:25
16-7-16 with model membrane
16-7NH-16 with model membrane
pure 16-7-16
pure 16-7NH-16
E, p=9
Surface pressure (mN/m)
30 31 32 33 34 35
C
o
m
p
r
e
ss
ib
il
it
y
 m
o
d
u
lu
s  
(m
N
/m
)
0
50
100
150
200
250
300
350
400 DPPC:Cholesterol=75:25
16-7-16 with model membrane
16-7NH-16 with model membrane
pure 16-7-16
pure 16-7NH-16
F, p=9
106 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.8. π-A isotherm of the 16-7NH-16 based systems with the model membrane 
(DPPC/cholesterol = 75/25 %) at pH 4 (A), 7 (B) and 9 (C). 
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Figure 5.9. Compressibility modulus for the 16-7-16-based system (A, B) and 16-7NH-16-based 
system (C, D) in pH 4. M = model membrane (DPPC/cholesterol = 75/25 %). 
 
 
 
 
 
 
 
 
 
Surface pressure (mN/m)
0 5 10 15 20 25 30 35 40 45 50 55 60
C
o
m
p
re
ss
ib
il
it
y
 m
o
d
u
l u
s 
(m
N
/m
)
0
50
100
150
200
250
300
350
16-7-16/DOPE+M
16-7-16/DNA+M
16-7-16/DOPE/DNA+M
Pure DPPC:Cholesterol 75:25
Surface pressure (mN/m)
0 5 10 15 20 25 30 35 40 45 50 55 60
C
o
m
p
re
ss
ib
il
it
y
 m
o
d
u
l u
s 
(m
N
/m
)
-50
0
50
100
150
200
250
300
350
16-7NH-16/DOPE+M
16-7NH-16/DNA+M
16-7NH-16/DOPE/DNA+M
Pure DPPC:Cholesterol 75:25
A, pH 4 
C, pH 4 
Surface pressure (mN/m)
30 31 32 33 34 35
C
o
m
p
re
ss
ib
il
it
y
 m
o
d
u
lu
s 
(m
N
/m
)
0
50
100
150
200
250
300
350
16-7NH-16/DOPE+M
16-7NH-16/DNA+M
16-7NH-16/DOPE/DNA+M
Pure DPPC:Cholesterol 75:25
Surface pressure (mN/m)
30 31 32 33 34 35
C
o
m
p
re
ss
ib
il
it
y
 m
o
d
u
lu
s 
(m
N
/m
)
0
50
100
150
200
250
300
350
16-7-16/DOPE+M
16-7-16/DNA+M
16-7-16/DOPE/DNA+M
Pure DPPC:Cholesterol 75:25
B, pH 4 
D, pH 4 
108 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.10. Compressibility modulus for the 16-7-16-based system (A, B) and 16-7NH-16-based 
system (C, D) in pH 7. M = model membrane (DPPC/cholesterol = 75/25 %). 
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Figure 5.11. Compressibility modulus for the 16-7-16-based system (A, B) and 16-7NH-16-based 
system (C, D) in pH 9. M=model membrane (DPPC/cholesterol = 75/25 %). 
5.1.3. Effect of mixed 16-7-16 systems on the model membrane 
The 16-7-16 based system and their interaction with model membrane is presented in Figure 
5.6, and the corresponding compressibility modulus values in Figure 5.9 to 5.11. In the presence of 
16-7-16/DOPE in the subphase, the DPPC/cholesterol isotherm shows the AL ~ 102, 94 and 150Å2 at 
pH 4, 7 and 9, respectively (Figure 5.6 and Table 5.2, 5.3 and 5.4). The A∞ values are ~ 73.5, 75 and 
71.2 Å2/molecules at pH 4, 7 and 9, respectively; signifying the relatively condensed monolayer 
formation in all pHs. In comparison with the 16-7-16/DPPC/cholesterol system, the addition of 
DOPE caused condensation at the DPPC/cholesterol monolayer regardless of the pHs. At pH 4, in the 
presence of 16-7-16/DOPE, the DPPC/cholesterol monolayer undergoes a LE-LC phase transition at 
the surface pressure between 10-20 mN/m and reaches a LC phase > 32 mN/m. The 16-7-16/DOPE 
system induces fluidization of the model membrane, since an S phase of the model membrane 
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reduced into LE-LC or LC phase in the 30-35 mN/m range. On the other hand, at pH 7 (Figure 5.10 
A and B), the 16-7-16/DOPE system induces similar phase transition at the DPPC/cholesterol 
monolayer to pH 4; however, it remained at the LC phase at surface pressure approximately ≥ 
18mN/m. This suggests that the 16-7-16/DOPE with the model membrane forms relatively rigid 
monolayer at pH 7 than at pH 4. At the surface pressure range of plasma membrane (30-35 mN/m), 
16-7-16/DOPE/DPPC/cholesterol shows the presence of LC phase (Cs-1 = ~193 to 180 mN/m), which 
is relatively higher than that of pH 4 (Cs-1= ~79.8 to 139.8 mN/m), (Table 5.2, Figure 5.10). At pH 7, 
the pure DPPC/cholesterol shows Cs-1 values of around 200 mN/m which was not reduced by the 
presence of 16-7-16/DOPE system. This signifies that there is subtle effect of this system in 
fluidization of the DPPC/cholesterol membrane. On the other hand, at pH 9, as can be seen from the 
isotherm and the compressibility modulus values (Figure 5.6C, 5.11 A and B; Table 5.3, 5.4), the 16-
7-16 monolayer possess similar phase transitions to pH 7, and forms a LC phase at higher surface 
pressure (> 25 mN/m). Interestingly, at the 30-35 mN/m range, the monolayer exhibits a LC phase 
(Cs-1 = 100 mN/m) at the lower end of ideal LC phase values (100-250 mN/m for the LC phase 
[215]). Thus, at pH 9, the 16-7-16 induces fluidization of the model membrane. These results are 
consistent with the isotherm obtained for the pure 16-7-16/DOPE monolayer at pH 4, 7 and 9 
(chapter IV, Figure 4.8). We have observed the most rigid monolayer formation at pH 7, whereas, at 
pH 4 was the most expanded one. In the current study, the trend of fluidization induced by the 16-7-
16/DOPE is: pH4 > pH9 > pH7. BAM images of the DPPC/cholesterol monolayer in the presence of 
16-7-16/DOPE system at pH 4 are shown in Figure 5.13. It is observed from the images, the circular 
domains on black background are present at the low surface pressure (~1-4 mN/m). At the 30-35 
mN/m range, the BAM images shows the dot like domains, whereas the pure DPPC/cholesterol 
(Figure 5.5.) does not possess this domains. As we hypothesized before, the 16-7-16/DOPE can be 
adsorbed in the DPPC/cholesterol monolayer. This, could lead to the changes in the overall 
orientation of the DPPC/cholesterol molecules in the air/buffer interface. This images further 
supports the fluidization effect of the model membrane in presence of 16-7-16/DOPE. Similar BAM 
images are observed at pH 7 or 9 (Figure 5.16). 
We have combined the DNA with the 16-7-16 to observe the interaction of this system with 
the DPPC/cholesterol model membrane (Figure 5.6, 5.9 to 5.11, Table 5.2, 5.3 and 5.4). From the 
isotherm it is observed that at the AL =122.4, 138.2, 117.7 Å2 at pH 4, 7 and 9, respectively. The A∞ 
values are ~78, 96 and 95 Å2/molecules at pH 4, 7 and 9, respectively; indicating relatively 
condensed monolayer formation at pH 4 than at pH 7 or 9. At pH 4, in presence of 16-7-16/DNA 
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system, the DPPC/cholesterol monolayer undergoes LC phase transition at pressures ≥ 20 mN/m 
(Figure 5.9A). At the 30-35 mN/m surface pressure range, the presence of 16-7-16/DNA shows 
reduction in the Cs-1 values of the pure DPPC/cholesterol monolayer. Surprisingly, at pH 7 (Figure 
5.10B), at 30-35 mN/m, the presence of 16-7-16/DNA dramatically reduced the Cs-1 values of the 
pure DPPC/cholesterol monolayer. Similar results are obtained at the pH 9 (Figure 5.11B). In 
general, these results suggests that 16-7-16/DNA system may induce fluidization in the 
DPPC/cholesterol monolayer. Interestingly, this effect is prominently observed at the 30-35 mN/m 
surface pressure range. The exact reason for this phenomena is not known, however, in chapter IV, 
Figure 4.12 we have shown that there is a strong electrostatic interaction between the gemini amine 
group and the DNA phosphate group at the surface pressure ~28-35 mN/m, and the compressibility 
modulus values were reduced to exhibit the G-LE phase transition. Figure 5.14 shows the BAM 
images of the model membrane in presence of 16-7-16/DNA system. The presence of circular 
domains at the low surface pressure (~0.03 to 2 mN/m) is indicative of the G-LE phase. Some small 
bright dots are observed at the 30-35 mN/m surface pressure indicating the monolayer remained at 
the LC phase with relatively less orientations of the DPPC/cholesterol. In comparison with the BAM 
images of the pure DPPC/cholesterol (Figure 5.5) with this system, it seems to have reduced the solid 
phase of the model membrane to a LC phase, which is an indication of fluidization. BAM images 
shows small bright domain formation at pH 7 and 9, which implies to the fluidization of the 
monolayer. Thus, BAM images of the DPPC/cholesterol monolayer in presence of 16-7-16/DNA 
system, are well correlated with the observed isotherm as compressibility modulus of these system in 
all pHs.  
The DPPC/cholesterol monolayer behaviors in presence of 16-7-16/DOPE/DNA system are 
demonstrated in Figure 5.6, 5.9 to 5.11. The isotherm possess AL = 99.1, 108.4, 92.6 Å2 at pH 4, 7 
and 9, respectively and the A∞ values ~66.5, 73 and 62.6 Å2/molecules at pH 4, 7 and 9, respectively. 
Once again the relatively condensed monolayer is formed at pH 4 than at pH 7 or 9. At the cell 
membrane surface pressure (30-35 mN/m), the 16-7-16/DOPE/DNA shows the Cs-1 values ~149.2 to 
141.2 mN/m which was considerably lower than the pure DPPC/cholesterol monolayer (~ 287 to 256 
mN/m) at pH 4 (Figure 5.9B and Table 5.2). Considering the Cs-1 values at the 30-35 mN/m range, 
16-7-16/DOPE/DNA system also shows the fluidization effect at pH 7 (Figure 5.10B). Overall, the 
16-7-16/DOPE/DNA system fluidized the model membrane follows the trend: pH4 > pH7 > pH9. 
We believe that the 16-7-16/DOPE/DNA complex may undergo overall net positive zeta potential 
[35], and cause electrostatic interaction with the phosphate or hydroxyl group of the 
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DPPC/cholesterol monolayer. By this way the complex system may adsorb at the model membrane 
and cause changes in the fluidity. We have not found any similar studies to our system as references. 
However, Lopes-Costa el al. have demonstrated the adsorption effect of the DNA on the 
octadecylamine (ODA) monolayers [263]. Their study revealed that the presence of DNA causes 
expansion in the ODA monolayer and also lowered the compressibility modulus. They have 
hypothesized that the electrostatic interaction between the phosphate group of DNA and the positive 
charge of ODA molecules are responsible for this phenomena. This study signifies that depending on 
the system (gemini/DNA which may undergo an electrostatic interaction and form a net positive 
charge) present at the subphase; the complex system (gemini/DNA) may adsorb or penetrate to the 
DPPC/cholesterol monolayer and cause the condensation or fluidization effects. Apart from the 
electrostatic interaction and adsorption of the 16-7-16/DOPE/DNA system on the DPPC/cholesterol 
monolayer, penetration of these system may also occur into the model membrane. The minimum 
cross sectional area of the pure DPPC/cholesterol is ~ 48, 49, 41 Å2/molecules at pH 4, 7 and 9, 
respectively; whereas the presence of 16-7-16/DOPE/DNA increased the values to ~66.5, 73 and 
62.6 Å2/molecules, at corresponding pHs. Thus, there is approximately 1.5 times increase in the cross 
sectional area of the DPPC/cholesterol in presence of the 16-7-16/DOPE/DNA. This signifies two 
possibilities, 1. the adsorption of the complex might have disoriented the monolayer, and 
subsequently (2) penetration of the system into the monolayer. Based on the experimental results 
both are possible in our case. Cárdenas et al. showed that positively charged 
dioctadecyldimethylammonium bromide (DODAB) and DODAB/disteroylphosphatidylcholine 
(DSPC) monolayers were influenced by the presence of DNA at the subphase [99]. The electrostatic 
interaction was the major factor for the fluidization of the monolayer. Additionally, they have not 
found any penetration effect of DNA into the monolayer since the minimum cross sectional area was 
not increased substantially. Castano et al. have injected the DNA under the cationic 
bis(guanidinium)-tris(2-aminoethyl)amine-cholesterol (BGTC) or BGTC/DOPE monolayer air/water 
interface. Their study revealed that regardless of the charge (positive or negative) of the monolayer, 
the double strands of the DNA molecules oriented parallel to the lipid monolayer plane and adsorbed 
to the monolayer (Chapter I, Figure 1.14). Same research group further included zwitterionic 1,2-
dimyristoyl-sn-glycero-3-phosphocholine (DMPC) with the BGTC lipid [264]. When DNA was 
injected into the subphase, it adsorbs to BGTC/DMPC monolayers regardless of the lipid monolayer 
composition.  
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The BAM images for 16-7-16/DOPE/DNA with model membrane revealed the presence of 
G-LE phase transition at the surface pressure of ~0.26 to 2.16 (Figure 5.15). The images at the 30-35 
mN/m surface pressure is different than that of the pure DPPC/cholesterol BAM images. Similar 
BAM images are found for at the pH 7 and 9 (Figure 5.16). However, the extent of the fluidization 
effect is not possible to calculate from the BAM images. Further studies are required to elucidate the 
mechanism and extent of enhanced model membrane fluidization by the 16-7-16/DOPE/DNA system 
at pH 4 than at pH 7 or 9. Lopes-Costa et al. have shown that the presence of the DNA in the 
subphase changed the dendritic domains of the octadecylamine (ODA) at air/water interface [263]. 
The adsorption of the DNA to the ODA molecules caused these changes in the domains of the ODA. 
We also believe that the 16-7-16/DOPE/DNA may form complexes at the aqueous subphase with net 
positive charges, which may interact with the polar head group of the DPPC/cholesterol molecules 
and induces adsorption as well as the penetration of the complexed molecules to the membrane, and 
consequently reduced the rigidity. The penetration effect of the16-7-16/DOPE/DNA is crucial to 
disrupt the endosomal membrane and release the DNA into the cytoplasm.  
Table 5.2: DPPC/cholesterol monolayer properties in presence of various mixed system in pH 4. 
System AL(Å2) Ac 
(Å2) 
π c 
(mN/m) 
A∞ 
(Å2) 
Cs-1 
     30mN/m 35mN/m Max 
DPPC/Cholesterol 74.2 37.6 52.3 48.1 287.3 256.6 315.2 
16-7-16 154.1 43.6 49.4 85.5 30.1 40.4 96.2 
16-7-16/DOPE 102.7 43.6 50.7 73.5 79.8 139.8 178.7 
16-7-16/DNA 122.4 53.7 48.0 78.0 149.2 155.3 168.9 
16-7-16/DOPE/DNA 99.1 45.5 48.9 66.5 149.1 141.2 172.9 
16-7NH-16 104.9 43.9 51.4 85.4 85.5 59.9 122.6 
16-7NH-16/DOPE 101.04 50.7 51.3 74.3 139.7 181.7 216.4 
16-7NH-16/DNA 116.1 49.9 52.5 81.6 136.9 120.6 184.1 
16-7NH-
16/DOPE/DNA 
108.7 47.4 51.8 74.3 140.9 137.5 166.4 
Parameters obtained from the π-A isotherms are liftoff area, AL; molecular area at collapse, Ac; 
collapse pressure, πc; minimum cross sectional area or limiting area, A. Compressibility modulus 
(Cs-1) at 30 mN/m, 35 mN/m surface pressure and the maximum compressibility modulus values.  
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Table 5.3: DPPC/cholesterol monolayer properties in presence of various mixed system in pH 7. 
System AL 
(Å2) 
Ac (Å2) πc 
(mN/m) 
A∞ 
(Å2) 
Cs-1 
     30mN/m 35mN/m Max 
DPPC/Cholesterol  74.3 38.2 52.1 49.0 174.8 191.1 222.4 
16-7-16 115.1 43.7 51.2 83.0 131.5 120.8 153.0 
16-7-16/DOPE 94.0 46.9 50.6 75.4 193.7 180.0 193.7 
16-7-16/DNA 138.2 52.1 51.1 96.9 137.4 36.3 143.4 
16-7-16/DOPE/DNA 108.4 49.9 49.1 73.0 142.0 152.1 159.1 
16-7NH-16 96.4 49.6 51.9 73.4 203.1 199.9 215.7 
16-7NH-16/DOPE 83.8 45.0 50.3 62.7 182.0 204.4 238.5 
16-7NH-16/DNA 95.3 48.0 50.5 63.7 176.2 189.3 214.3 
16-7NH-16/DOPE/DNA 104.3 49.5 51.0 76.6 173.4 181.8 198.8 
 
Table 5.4: DPPC/cholesterol monolayer properties in presence of various mixed system in pH 9. 
System AL 
(Å2) 
Ac (Å2) πc 
(mN/m) 
A∞ 
(Å2) 
Cs-1 
     30mN/m 35mN/m Max 
DPPC/Cholesterol 64.4 34.3 52.3 41.4 249.0 252.9 338.5 
16-7-16 116.4 48.5 53.5 75.4 169.0 135.7 177.0 
16-7-16/DOPE 150.3 40.3 53.0 71.2 101.7 113.6 129.2 
16-7-16/DNA 117.7 49.8 51.1 95.7 158.5 75.5 172.3 
16-7-16/DOPE+DNA 92.6 47.7 51.8 62.6 187.9 197.0 270.2 
16-7NH-16 88.7 51.0 51.8 67.4 258.8 251.2 304.4 
16-7NH-16/DOPE 84.6 49.6 52.0 64.5 288.0 251.3 296.7 
16-7NH-16/DNA 93.7 50.6 50.5 67.2 213.4 214.6 255.0 
16-7NH-16/DOPE/DNA 94.5 47.1 51.5 68.1 218.1 205.4 247.0 
Parameters obtained from the π-A isotherms are liftoff area, AL; molecular area at collapse, Ac; 
collapse pressure, πc; minimum cross sectional area or limiting area, A. Compressibility modulus 
(Cs-1) at 30 mN/m, 35 mN/m surface pressure and the maximum compressibility modulus values. 
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Figure 5.12. BAM images of DPPC/cholesterol monolayer at the air/buffer (pH 4) interface at in 
presence of pure 16-7-16 system on the subphase. 
 
 
Figure 5.13. BAM image of DPPC/cholesterol monolayer at the air/buffer (pH 4) interface in 
presence of 16-7-16/DOPE system on the subphase. 
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Figure 5.14. BAM image of DPPC/cholesterol monolayer at the air/buffer (pH 4) interface in 
presence of 16-7-16/DNA system on the subphase. 
 
Figure 5.15. BAM image of DPPC/cholesterol monolayer at the air/buffer (pH 4) interface in 
presence of 16-7-16/DOPE/DNA system on the subphase. 
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Figure 5.16. BAM image of DPPC/cholesterol monolayer at the air/buffer (pH 7 and 9) interface in 
presence of 16-7-16 system on the subphase. GS = 16-7-16, M = model membrane 
(DPPC/cholesterol = 75/25 %). The images are presented at the 30-35 mN/m surface pressure.  
 
5.1.4. Effect of mixed 16-7NH-16 systems on the model membrane 
The π-A isotherm and Cs-1-π curve of the DPPC/cholesterol monolayer in presence of mixed 
16-7NH-16 systems are mentioned at Figure 5.8 and 5.9 to 5.11, respectively. At pH 4, the 16-7NH-
16/DOPE possess a lift-off are of ~101, 83.8 and 84.6 Å2 at pH 4, 7 and 9, respectively (Table 5.2, 
5.3, 5.4). Thus, the monolayer is expanded at pH 4 than at pH 7 or 9. The A∞ is ~ 74.3 62.7, 64.5 
Å2/molecules at pH 4, 7 and 9, respectively. This implies that the DPPC/cholesterol forms relatively 
condensed monolayer at all pHs. At the 30-35 mN/m surface pressure, the DPPC/cholesterol shows 
the presence of LC phase transition (Cs-1 = 139.7 to 181.7 mN/m) at pH 4 (Figure 5.9 B). Similar LC 
phase transition was observed at pH 7 and 9 (Figure 5.10 B and 5.11 B), however, the values of the 
Cs-1 are higher in case of pH 7 and 9 than pH 4. While comparing the Cs-1 values of the pure 
DPPC/cholesterol monolayer, presence of 16-7-16/DOPE substantially reduced the rigidity of the 
pure monolayer (Figure 5.9B). As mentioned earlier, this is an indication of the membrane 
fluidization. In comparison, the 16-7NH-16/DOPE system could not induce any significant changes 
in the Cs-1 values of the pure DPPC/cholesterol at pH 7 and 9 (Figure 5.10 and 5.11). This result is 
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consistent to the hypothesis that 16-7NH-16 protonates at pH 4, and induces more fluidization to the 
model membrane [35]. Additionally, Figure 5.17 represents the BAM images of the 
DPPC/cholesterol monolayer in presence of the 16-7NH-16 system. The small circular domains on 
dark images are indicative of the G-LE phase at low surface pressure (~2-4.29 mN/m). As the 
monolayer is further compressed the LE-LC phase transition is visible with the appearance of small 
dot like domains on the dark LE phase (> 7 mN/m). At the cell membrane surface pressure (30-35 
mN/m), the presence of 16-7NH-16 induced substantial small dot like domains at the 
DPPC/cholesterol monolayer, which was not observed at the pure DPPC/cholesterol monolayer at pH 
4 (Figure 5.5). Thus, the S phase of the pure DPPC/cholesterol was reduced to the LC phase, 
indicating the membrane fluidization. At pH 7 or 9, the BAM images showed more condensed and 
small domains, which might be indication of presence of higher ordering of the DPPC/cholesterol 
monolayer at those pHs (data not shown).  
16-7NH-16/DNA with the model membrane is shown in Figure 5.8. Based on the lift-off area 
(Table 5.2, 5.3 and 5.4), the 16-7NH-16/DNA system causes expansion of the DPPC/cholesterol 
monolayer at pH 4 than at pH 7 or 9. At the 30-35 mN/m surface pressure range, in presence of 16-
7NH-16/DNA the DPPPC/cholesterol monolayer exhibits a LC phase transition than the S phase 
transition (for the pure DPPC/cholesterol), Figure 5.9B. This substantial reduction in the S phase to a 
LC phase by the 16-7NH-16/DNA system implies that the mixed system interacts with the 
DPPC/monolayer at low pH. As mentioned earlier, the protonation of the 16-7NH-16 helps in strong 
binding of the 16-7NH-16 with the DNA molecule. We have observed a plateau for the 16-7NH-
16/DNA monolayer at this surface pressure range (chapter IV, Figure 4.12) due to the electrostatic 
interaction between the 16-7NH-16 with DNA. Thus, 16-7NH-16/DNA complex may adsorb or 
penetrate to the DPPC/cholesterol monolayer. This phenomena was not observed at pH 7 or 9, 
indicating the strong effect of pH on the fluidization of the 16-7NH-16/DNA system on the model 
membrane. In presence of the 16-7NH-16/DNA system, the DPPC/cholesterol monolayer also 
showed the domains of G-LE phase transition at low surface pressure (0.2-2 mN/m), Figure 5.18. At 
30-35 mN/m, the images possess relatively small bright domains, which might be the indication of 
the LC phase than S phase. Both at pH 7 and 9, condensed monolayer with the bright domains are 
observed (Figure 5.20). Thus, 16-7NH-16/DNA might have induced fluidization at pH 4 but not at 
pH 7 or 9 and further supports the surface pressure area isotherm results.  
To our greatest interest, in presence of the complete system (16-7NH-16/DOPE/DNA), the 
DPPC/cholesterol monolayer showed reduction of the rigidity (Figure 5.9). At the 30-35 mN/m 
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surface pressure, the Cs-1 values of the DPPC/cholesterol monolayer were substantially reduced from 
287 mN/m to ~ 140 mN/m in absence or presence of 16-7NH-16/DOPE/DNA system, respectively. 
This suggests that the model membrane is fluidized by the 16-7NH-16/DOPE/DNA at pH 4. On the 
other hand, there were no effect of this system at pH 7 (Figure 5.10). There were subtle reduction of 
the Cs-1 values at pH 9 (Figure 5.11). Thus, the results resembles the strong pH dependent membrane 
fluidization of the 16-7NH-16/DOPE/DNA system. Additionally, in presence of 16-7NH-
16/DOPE/DNA system the DPPC/cholesterol resembles the A∞ values approximately 74.3, 76.6, 
68.1 Å2/molecules at pH 4, 7 and 9, respectively. Once again, these values are ~ 1.5 times higher than 
the pure DPPC/cholesterol at the corresponding pHs (Table 5.2, 5.3, 5.4). Increase in the cross 
sectional area of the hydrocarbon chains of the DPPC/cholesterol monolayer signifies the 
disorientation of the molecules at the air/buffer interface [119]. Which might have induced by the 
penetration of the complex to the monolayer [99]. Furthermore, the BAM images of the 
DPPC/cholesterol monolayer in presence of 16-7NH-16/DOPE/DNA at pH 4 is presented at the 
Figure 5.19. As can be seen, the G-LE phase transitions are visible at the BAM images at the surface 
pressure of 0.21 to 2.02 mN/m. Upon further compression, the monolayer undergoes LE-LC phase 
transition, and remains at the LC phase at higher surface pressure (> 14mN/m). At this stage, the 
homogeneous film with small bright dot like domains are visible in the BAM images until the 
monolayer collapse. At 30-35 mN/m, the images are substantially different form the pure 
DPPC/cholesterol (Figure 5.5), and indicative of the monolayer fluidization. However, at pH 7 and 9, 
more bright BAM images with homogenous dot like domains are observed. This could be the 
indication of highly condensed monolayer formation at pH 7 or 9 (Figure 5.20). Overall, the BAM 
images further supports the isotherm results and signifies that the 16-7NH-16 based system reduced 
the rigidity of the DPPC/cholesterol monolayer in a pH dependent manner.  
In general, the 16-7NH-16/DOPE/DNA complexes may carry net positive charges due to 
protonation of the 16-7NH-16 at pH 4. Subsequently this complex may be adsorbed at the 
DPPC/cholesterol monolayer due to the electrostatic interaction of the positively charged complex 
with the negatively charged phosphate or hydroxyl group DPPC and cholesterol molecules or some 
of the complex may penetrate into the monolayer, and ultimately fluidized the membrane. Adsorption 
of DNA to the octadecylamine (ODA) monolayer was evaluated by Lopes-Costa et al. [263] and 
Hansda et al. [265]. In another study by Gromelski and Brezesinski showed that the presence of 
cation (Mg2+, Ca2+) in subphase mediated strong adsorption of the calf thymus DNA into the 
zwitterionic lipid 1,2- dimyristoyl-phosphatidylethanolamine (DMPE) monolayer [266]. They also 
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showed that at low lateral pressure, the DNA partially penetrated into the lipid monolayer, however, 
it squeezed out at high pressure. They have proposed that the divalent cations may interact with the 
DMPE lipid, and the head group become positively charged, therefore, it interacts with the DNA in 
the form of electrostatic interaction. This study may not directly be applicable to our system; 
however, this suggests that the gemini/DOPE/DNA complex may undergo probable electrostatic as 
well as hydrophobic interaction to the DPPC/cholesterol monolayer; and adsorption as well as 
penetration may occur. From the zeta potential measurement it was observed that the 16-7NH-
16/DOPE/DNA complex possess ~ +62 mV at pH 4 whereas at pH 9 it was just above 0 mV [35]. 
Also the particle size was substantially larger at low pH than at high pHs. It was believed that the 
protonation of this surfactant helps in disruption of the endosomal membrane, and enhanced 
transfection efficiency at COS-7 and PAM 212 cells [35]. Thus, our current results correlated well 
with the in vitro results [35].  
 
Figure 5.17. BAM image of DPPC/cholesterol monolayer at the air/buffer (pH 4) interface in 
presence of 16-7NH-16 system on the subphase.  
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Figure 5.18. BAM image of DPPC/cholesterol monolayer at the air/buffer (pH 4) interface in 
presence of 16-7NH-16/DNA system on the subphase.  
 
Figure 5.19. BAM image of DPPC/cholesterol monolayer at the air/buffer (pH 4) interface in 
presence of 16-7NH-16/DOPE/DNA system on the subphase.  
122 
 
 
 
Figure 5.20. Comparative images of the DPPC/cholesterol monolayer in presence of mixed 16-7NH-
16 systems at pH 7 and 9 at surface pressure 30-35 mN/m. GS = 16-7-16, M = model membrane 
(DPPC/cholesterol = 75/25 %). 
 
5.1.5. PM-IRRAS studies of the pure DPPC, Cholesterol or their mixture 
We have conducted PM-IRRAS studies of the mixed gemini/DOPE/DNA system to have 
further insight of the interaction mechanism of these system on DPPC/cholesterol model membrane. 
As mentioned earlier in chapter IV, section 4.2.10, the characteristic symmetric stretch vs(CH2) is 
observed at around 2850 cm-1 and asymmetric stretch va(CH2) at around 2920 cm-1. The frequencies 
of these bands are sensitive to the conformation of the phospholipid acyl chains. Therefore, these 
bands provide substantial information about the molecular orientation of the lipid acyl chains at the 
air/water interface [210, 234-237]. In general, if the obtained values are lower (red shift) than 2920 
and 2850 cm-1, it indicates higher chain ordering in the film. In contrary, the higher values (blue 
shift) indicates the chain disordering [238, 239]. Our literature review suggests that the va(CH2) is 
often found at narrow ranges from 2915 to 2918 cm-1, and vs(CH2) from 2846 to 2850 cm-1 for all-
trans conformations of the fully extended tail chains [54]. Noteworthy, the red shift denotes for the 
ordered all-trans conformation of the chain, whereas blue shift stands for the chain disordering with 
the gauche conformation [238]. As can be seen from Figure 5.21 that the pure DPPC at pH 4 possess 
va(CH2) band ~2924 cm-1 and vs(CH2) at ~ 2851 cm-1 at surface pressure 30 and 35 mN/m. This 
suggests that the slightly disordered acyl chains of lipid in presence of LC or LE-LC phase. The 
123 
 
 
isotherm and compressibility modulus results (Figure 5.1 A and B) in which pure DPPC monolayer 
at pH 4 remained mostly at LC phase, are in good agreement with the PM-IRRAS results. Similar 
results with slightly higher wave number of the alkyl tails bands are reported in the literature for the 
DPPC monolayer [213, 235, 240, 267-269]. The characteristics ester groups ν(C=O) are found at 
~1720 cm-1. The asymmetric (va(PO2−)) and symmetric phosphate (vs(PO2−)) stretches are observed at 
~ 1230 and 1088 cm-1, respectively. The pure cholesterol monolayer shows (Figure 5.22) the 
characteristics va(CH2) band at around 2928 cm-1 and vs(CH2) at ~ 2852 cm-1 and the CH3 symmetric 
stretch at ~ 2887 cm-1 [249]. The mixed DPPC/cholesterol PM-IRRAS spectra is observed at Figure 
5.23. The va(CH2) and vs(CH2) has shifted to the lower values than the ideal 2920 and 2850 cm-1. 
This implies to the higher ordering (almost vertical orientation of the alkyl tails to the plane) of the 
molecules at the biologically relevant surface pressure (30- 35mN/m). From the isotherm (Figure 
5.1A and 5.2A), it was observed that DPPC/cholesterol forms the S phase at this surface pressure. 
The minimum cross sectional area of the DPPC/cholesterol system at pH 4 was around 48 
Å2/molecules (Table 5.1). These values remained less than 48 Å2/molecules regardless of the pH of 
the subphase which indicates the closely packed vertically oriented DPPC/cholesterol molecules at 
the air/buffer interface. Thus, PM-IRRAS results strongly correlates to the obtained results of 
isotherm. The ν(C=O) band shifted from 1720 cm-1 (pure DPPC) to 1730 cm-1 (DPPC/cholesterol), 
indicating the probable hydrogen bonding between the DPPC and cholesterol molecule. Similar 
hydrogen bonding was observed for the DPPC/cholesterol mixture in presence of photosensitizer at 
the subphase which was attributed to the higher shift of ν(C=O) band. Additionally, Lewis et al. have 
shown that the ν(C=O) band is sensitive to hydrogen bonding and shifts to higher wave number upon 
the bond formation [270]. Moreover, the asymmetric (va(PO2−)) and symmetric phosphate (vs(PO2−)) 
stretches also are observed at around 1216, 1248 and 1087 and 1097 cm-1. There is a clear shift of the 
phosphate band to the higher values which are indicative of interactions. The va(PO2−) is sensitive to 
hydration and ion binding [235]. An IRRAS study of the diphosphoryl Lipid A (a precursor of 
lipopolysaccharide) revealed the presence of three overlapped features at the asymmetric phosphate 
band region. The 1225, 1238 1258 cm-1 corresponded to the dihydrated, monohydrated, and 
unhydrated phosphate groups, respectively. This was attributed to the accessibility of Lipid A 
molecules to nearby water molecules [235]. Thus, there might be two possibilities in our results: 
intramolecular hydrogen bonding between the two adjacent DPPC molecules and the hydrogen bonds 
between the DPPC polar head groups with the cholesterol hydroxyl group. This bonding caused the 
closer packing of the DPPC/cholesterol molecules at the air/buffer interface, consequently resulted in 
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the S phase at the monolayer. Similar effects was observed for the DPPC/cholesterol monolayer at 
pH 7 and 9 (data not shown). 
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Figure 5.21. PM-IRRAS spectra of the pure DPPC at air/buffer (pH 4) interface.  
 
Figure 5.22. PM-IRRAS spectra of the pure cholesterol at air/buffer (pH 4) interface.  
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Figure 5.23. PM-IRRAS spectra of the pure DPPC/cholesterol at air/buffer (pH 4) interface. 
 
As can be seen form Figure 5.24, in presence of 16-7NH-16/DOPE/DNA the 
DPPC/cholesterol monolayer showed characteristic va(CH2) band ~ 2922.5 cm-1 and vs(CH2) band at 
~ 2851 cm-1 at surface pressure 30 mN/m. Comparing with the pure DPPC/cholesterol (Figure 5.23), 
the observed bands are shifted to higher values, which is indicative of the disordered acyl chains of 
the lipids. Thus, the highly ordered transzigzag conformation of alkyl chain may have changed the 
conformation to the gauche conformations [271, 272]. This further indicates that the S phase of pure 
DPPC/cholesterol monolayer might be reduced into LC phase. This is a clear indication of membrane 
fluidization in presence of 16-7NH-16/DOPE/DNA system at pH 4. At pH 7 the va(CH2) and vs(CH2) 
band remained constant with regards to the pure DPPC/cholesterol band (data not shown). This 
signifies that the monolayer is unaffected at pH 7 and it may have remained at the S phase. On the 
other hand, ν(C=O) band of the monolayer was not affected by the system. As mentioned in chapter 
IV, the B form of DNA possess guanine/thymine carbonyl (C=O) stretch at 1715 cm-1, thymine 
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aromatic amine stretch (1328 cm-1), vs(PO2−) and va(PO2−) stretches at ~1088 and 1222 cm-1, 
respectively; and a strongly coupled sugar-phosphodiester signal at approximately 970 cm1 [241]. 
From Figure 5.24 it is observed that there are two band at 1606 and 1581 cm-1 which are attributed to 
the vibrational band of adenine. Marty et al. have reported that cationic ion−base interaction can 
induce changes in the vibrational band of adenine 1609-1606 cm-1 towards lower values [242], in our 
case 1581 cm-1. Neault et al. showed that the bands observed at 1606 and 1590 cm−1 was attributed 
to the aspirin-DNA interaction [243]. Thus, the observed band at 1606 and 1581 cm-1 (Figure 5.24) 
might be due to the interactions of the quaternary ammonium head groups of gemini surfactant with 
the dipoles of bases (adenine N7 atoms or thymine O2). Even though the 16-7NH-16/DOPE/DNA 
was in the subphase, this characteristic DNA band is clearly observed at the monolayer. It is only 
possible if the part of the 16-7NH-16/DOPE/DNA adsorbs and penetrates the model membrane. This 
findings further supports that the 16-7NH-16/DOPE/DNA system may have penetrated the 
DPPC/cholesterol, and the PM-IRRAS signal detected those bands. Additionally, these spectral 
features (band at 1606 and 1581 cm-1) are suggestive of the presence of ion−dipole interaction in the 
gemini/DOPE/DNA complex monolayers. 
The symmetric and asymmetric v(PO2−) band is contributed from DPPC, may also be 
attributed to the DOPE and DNA (due to the adsorption and penetration); thus it is not easy to 
exactly elucidate the mechanism of interaction at the v(PO2−) in presence of 16-7NH-16/DOPE/DNA 
system. Interestingly, the sugar-phosphodiester signal of the DNA observed at around 983 cm-1 
further shows the presence of DNA in the monolayer. In general, there is complex interaction 
occurring on between the DPPC/cholesterol and the 16-7NH-16/DOPE/DNA system. The mixed 
system adsorbed on as well as penetrated the model membrane, which was the major factor for 
membrane fluidization (as observed in the isotherm results at 30-35 mN/m surface pressure). At pH 7 
or 9, the alkyl tail band at the 2920 and 2850 cm-1 remained unchanged, indicating the overall S 
phase of the DPPC/cholesterol monolayer at higher pHs (Appendix Figure A5.7 and A5.8). Thus, our 
study further suggests that the 16-7NH-16/DOPE/DNA system induces membrane fluidity in a pH 
dependent manner.  
Finally, we have introduced the 16-7-16/DOPE/DNA system on the subphase of 
DPPC/cholesterol monolayer at pH 4 (Figure 5.25). At surface pressure 30 mN/m, the characteristic 
va(CH2) band is at ~2916 cm-1 and vs(CH2) band is ~2847 cm-1. This implies that the presence of 16-
7-16/DOPE/DNA might not induce substantial changes at the orientation of the alkyl tails even 
though the compressibility modulus values showed LC phase for this system (Figure 5.9). Similar 
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results was observed at pH 7 and 9 (data not shown). The PM-IRRAS results confirms that the 
membrane fluidization effect is much stronger for the 16-7NH-16/DOPE/DNA system than the 16-7-
16/DOPE/DNA system at pH 4. The C=O band remained unchanged. Interestingly, Figure 5.25 
shows the merged band at 1600 to 1584 cm-1, indicating the adsorption or penetration of the complex 
into the subphase. However, the extent of penetration of the 16-7-16/DOPE/DNA system is 
unknown. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.24. PM-IRRAS spectra of the pure 16-7NH-16/DOPE/DNA with DPPC/cholesterol model 
membrane at air/buffer (pH 4) interface. 
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Figure 5.25. PM-IRRAS spectra of the pure 16-7-16/DOPE/DNA with DPPC/cholesterol model 
membrane at air/buffer (pH 4) interface. 
At pH 4, based on the compressibility modulus and isotherm results, both 16-7NH-
16/DOPE/DNA and 16-7-16/DOPE/DNA showed similar fluidization effect on the DPPC/cholesterol 
model membrane (Figure 5.9). However, the PM-IRRAS results confirm that the 16-7NH-
16/DOPE/DNA is superior to the later system in terms of interaction which induces more alkyl tail 
disorientation. Moreover, the fluidization effect was much prominent at pH 4 than at pH 7 or 9. This 
is in good agreement with the isotherm and compressibility modulus results (Figure 5.9 to 5.11). 
Thus, our current system resembles the membrane fluidization at the real biological cell membrane 
surface pressure (30-35 mN/m) at pH 4. Therefore, this results further clarifies the fact that 16-7NH-
16 system (due to protonation at low pH), may induce the adsorption to the endosomal membrane, 
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cause penetration and ultimately disrupt the membrane and release the DNA into cytoplasm, 
subsequently, enhanced the transfection efficiency [35].  
5.2 Summary 
In the current study, we have successfully characterized the model endosomal membrane by 
DPPC/cholesterol = 75/25 %. The mixed monolayer showed solid phase at the natural cell membrane 
surface pressure (30-35 mN/m) at pH 4, indicating the rigid structure of the membrane. Interestingly, 
introducing the mixed 16-7-16 and 16-7NH-16 based system substantially reduced the rigidity of the 
membrane and induced fluidity. This was not only attributed to the adsorption of the 
gemini/DOPE/DNA system, but also to the penetration of this system into the model endosomal 
membrane. The fluidization effect of 16-7NH-16 based system was strongly pH dependent (at low 
pH more fluidization). This was due to the protonation of the 16-7NH-16 molecules at pH 4, and 
hence causes enhanced interaction with the DNA, and ultimately interacts with the membrane 
through adsorption and penetration. PM-IRRAS results also revealed that the membrane fluidization 
was prominent with the16-7NH-16 based system than the 16-71-16 systems. Our study, directly 
correlates to the in vitro transfection efficiency results in which 16-7NH-16 showed enhanced 
transfection due to the protonation and strong interaction with the endosomal membrane [35].  
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Chapter VI 
Conclusion and future direction 
In the current project, we have characterized non-viral gene therapy lipoplexes based on 
gemini surfactants (16-7-16 and 16-7NH-16) along with the helper lipid DOPE, using the Langmuir 
monolayer technique. Combining the π-A isotherm, compressibility modulus, BAM images, AFM 
and KFPM images and the PM-IRRAS results, we can conclude that the gemini/DOPE/DNA system 
possess a complex mixing behavior. The 16-7NH-16 surfactant undergoes strong electrostatic 
interaction with the DNA at the natural cell membrane surface pressure (30-35 mN/m) at pH 4 due to 
the protonation of the central secondary amine group. This was further evident from the formation of 
fibril type complex structures, observed at higher resolution using AFM and KPFM. Unfortunately, 
the exact role of DOPE in this transfection system remains unclear. Generally, DOPE causes 
condensation of the gemini surfactant monolayers; however whether or not this is due specifically the 
DOPE and gemini surfactant is unclear.  
Subsequently, we have evaluated the effect of gemini/DOPE/DNA system on the model 
endosomal membrane (DPPC/cholesterol = 75/25 %). Mixed DPPC/cholesterol monolayer formed 
homogenous film at the natural cell membrane surface pressure indicating the presence of rigid and 
solid phase. Interestingly, injecting the mixed 16-7-16 and 16-7NH-16 based system in presence of 
DNA substantially reduced the rigidity of the membrane and caused fluidity. The mixed system was 
adsorbed at the DPPC/cholesterol membrane. The increase in the minimum cross sectional area of 
the DPPC/cholesterol molecules indicates the penetration of the gemini/DOPE/DNA system into the 
monolayer. The fluidization effect of 16-7NH-16 based system was strongly pH dependent (at low 
pH more fluidization). PM-IRRAS results also revealed that the membrane fluidization and 
penetration was prominent with the 16-7NH-16/DOPE/DNA system than the 16-71-16/DOPE/DNA 
systems. Our study, suggests that there may be a correlation to the in vitro transfection efficiency 
results in which 16-7NH-16 showed enhanced transfection due to the protonation and strong 
interaction with the endosomal membrane [35]. 
Further studies are required with the AFM and KPFM to understand the exact role of the 
DOPE in the endosomal membrane fluidization in the current system. To elucidate the exact 
mechanism of the membrane fluidization of the current GS/DOPE/DNA system, further studies with 
the AFM and KPFM are required.  
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For future studies, the 16-7-16/DOPE/DNA and 16-7NH-16/DOPE/DNA based system may 
be subjected to the model cancer cell membrane using the POPC/cholesterol = 75/25 %. 
Additionally, different types of gemini surfactants such as phy-3-m and phy-7NH-m (m = 12, 16, and 
18) could be used since this system has shown better transfection efficiency in our recent study and 
relatively more hydrophobic than the 16-s-16 series [34, 48]. We may introduce some C22 
containing gemini surfactant for better monolayer studies due to their higher hydrophobicity. The 
effect of specific buffer components on the GS/DOPE/DNA system may also be investigated. In our 
current study we have used double stranded salmon sperm DNA to produce the GS/DOPE/DNA 
system. However, a comparative study between the single stranded (ssDNA), double stranded 
(dsDNA) and circular plasmid DNA (pDNA) may be evaluated along with the salmon DNA to 
mimic the real biological condition, and application of these system(s) in gene therapy. Based on the 
literature, it is suggested that the cholesterol level reduces from plasma membrane to the lysosomal 
membrane. In lysosomal membrane it is almost 15 %. Therefore, a systematic study of different 
membrane compartment may be evaluated e.g. DPPC/cholesterol = 70/30 %, 75/25 %, 85/15 % to 
mimic the plasma membrane, early endosomal membrane and late endosomal membrane or 
lysosomal membrane, respectively. In addition to this, the outer leaflet of plasma membrane contains 
more sphingomyelin, phosphatidylcholine and cholesterol. Thus, a complex monolayer with the 
phosphatidylcholine/cholesterol/sphingomyelin = 75/20/5 % may be studied to mimic the outer layer 
of the plasma membrane. Another important study could be done with the negatively charged 
phosphatidylserine and phosphatidylinositol to mimic the negative charge of the plasma membrane. 
This lipids are specifically present in the inner leaflet of the plasma membrane. Additionally the late 
endosome is rich in lysobisphosphatidic acid (LBPA) or bis(monoacyl glycero)phosphate (BMP) and 
a lysosome specific lipid which is not found elsewhere in the cells. Thus incorporating LBPA along 
with cholesterol could be a good model membrane study for the late endosome.  
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Appendix 
 
 
Figure A4.1. Schematic representation of the 16-7-16 molecules (A) having hydrophobic 
interactions between two alkyl tails, and the flexible spacer length provides the alkyl tails to lie flat 
on the air/buffer interface. (B). The short spacer length of the surfactant restricts the alkyl tail to 
remain flat on the surface, rather they remains slightly tilted at the air/buffer interface and occupies 
smaller molecular area.  
Figure A4.2. Schematic representation of the 16-7NH-16 monolayer at pH 4. The acetate buffer 
components resides in-between the positively charged 16-7NH-16 molecules, reduces the overall 
repulsions forces of the surfactant molecules, and consequently the monolayer may be compressed to 
smaller molecular area. During this charge neutralization by the acetate components, the monolayer 
undergoes a LE → G phase transition.  
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Figure A4.3. Compressibility modulus and surface pressure (Y axis) as a function of mean molecular 
area of the pure gemini surfactants at pH 7 (a) and 9 (b). The blue and red continuous line represents 
surface; and black continuous and dotted line represents values of the compressibility modulus of 
respective gemini surfactants.  
 
 
Figure A4.4. BAM image of 16-7-16 in pH 4 buffer. 
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Figure A4.5. BAM image of 16-7-16 in pH 7 buffer. 
 
Figure A4.6. BAM image of 16-7-16 in pH 9 buffer. 
 
Figure A4.7. BAM image of 16-7NH-16 at pH 4. 
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Figure A4.8. BAM image of 16-7NH-16 in pH 7 buffer. 
 
Figure A4.9. BAM image of 16-7NH-16 in pH 9 buffer. 
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Figure A4.10. BAM image of DOPE at pH 4. 
 
 
 
Figure A4.11. BAM image of DOPE in pH 7 buffer. 
 
 
 
Figure A4.12. BAM image of DOPE in pH 9 buffer. 
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Figure A4.13. BAM image of 16-7-16/DOPE at pH 4 buffer. 
 
 
Figure A4.14. BAM images of 16-7NH-16/DOPE at pH 4 buffer. 
 
Figure A4.15. BAM image of 16-7-16/DOPE in pH 7 buffer. 
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Figure A4.16. BAM image of 16-7NH-16/DOPE in pH 7 buffer. 
 
Figure A4.17. BAM image of 16-7-16/DOPE in pH 9 buffer. 
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Figure A4.18. BAM image of 16-7NH-16/DOPE in pH 9 buffer. 
Figure A4.19. BAM image of 16-7-16/DNA in pH 4 buffer. 
 
Figure A4.20. BAM image of 16-7NH-16/DNA in pH 4 buffer. 
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Figure A4.21. BAM image of 16-7-16/DNA in pH 7 buffer. 
 
 
Figure A4.22. BAM image of 16-7NH-16/DNA in pH 7 buffer. 
 
 
Figure A4.23. BAM image of 16-7-16/DNA in pH 9 buffer. 
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Figure A4.24. BAM image of 16-7NH-16/DNA in pH 9 buffer. 
 
 
Figure A4.25. BAM image of DOPE/DNA in pH 4 buffer. 
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Figure A4.26. BAM image of DOPE/DNA in pH 7 buffer. 
 
 
Figure A4.27. BAM image of DOPE/DNA in pH 9 buffer. 
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Figure A4.28. BAM image of 16-7-16/DOPE/DNA in pH 4 buffer. 
 
 
Figure A4.29. BAM image of 16-7-16/DOPE/DNA in pH 7 buffer. 
 
 
Figure A4.30. BAM image of 16-7-16/DOPE/DNA in pH 9 buffer. 
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Figure A 5.1. BAM image of cholesterol at the air/buffer (pH 7) interface at different surface 
pressures. 
 
 
Figure A 5.2. BAM image of cholesterol at the air/buffer (pH 9) interface at different surface 
pressures. 
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Figure A 5.3. BAM image of DPPC at the air/buffer (pH 7) interface at different surface pressures. 
 
 
 
Figure A 5.4. BAM image of DPPC at the air/buffer (pH 9) interface at different surface pressures. 
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Figure A5.5. BAM image of model membrane (DPPC/cholesterol = 75/25 %) at the air/buffer (pH 7) 
interface at different surface pressures.  
 
 
Figure A5.6. BAM image of model membrane (DPPC/cholesterol=75/25 %) at the air/buffer (pH 9) 
interface at different surface pressures. 
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Figure A5.7. PM-IRRAS spectra of the pure 16-7NH-16/DOPE/DNA with DPPC/cholesterol model 
membrane at air/buffer (pH 7) interface. 
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Figure A5.8. PM-IRRAS spectra of the pure 16-7NH-16/DOPE/DNA with DPPC/cholesterol model 
membrane at air/buffer (pH 7) interface. 
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